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Vaccine-preventable diseases are responsible for about 25% of the 10 million deaths 
occurring annually for children under five years of age. The World Health 
standardized guidelines for vaccine storage and distribution, but often fail to 
accommodate the unique infrastructure between and within countries. In order to 
better regulate the temperature of vaccines as they travel through countries, we have 
selected and characterized an appropriate phase change material (PCM) that will 
resist temperature fluctuations outside of a range of 2-8 °C, based on appropriate 
thermophysical properties. Additionally, we have integrated the selected PCM within 
a geometrically and thermally optimized cold box, maintaining long-term 
stabilization of temperatures within a range of 2-8 °C. In meeting these objectives, we 
have demonstrated the feasibility of a technological solution that may be readily 
implemented in the existing vaccine distribution supply chain, or that holds potential 
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The cold chain is only as strong as its weakest link.  
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Chapter 1: Introduction 
Research Objectives 
Today, vaccine-preventable diseases are responsible for about 25% of the 10 
million deaths occurring annually for children under five years of age (WHO & 
UNICEF)
Immunization (EPI) succeed in providing standardized guidelines for vaccine storage 
and distribution, but often fail to accommodate the unique infrastructure between and 
temperature stabilization relies on insulated vaccine carriers storing ice packs, or cold 
boxes, but poor design often renders vaccines impotent due to freeze damage (T. 
Wirkas, Toikilik, S., Miller, N., Morgan, C., & Clements, C.J., 2007). 
In order to better regulate the temperature and preserve a greater percentage of 
vaccines as they are shipped through lower-middle income countries (LMICs), 
significant improvements are required in our fundamental understanding of passive 
refrigeration technology  ways of cooling cargo without an active power source 
 and the integration of such knowledge into design strategies for more efficient 
passive temperature stabilization. 
Towards this end, we propose the following specific objectives: 
Objective 1:  To survey problems in the existing cold chain including technical and 
human errors to develop a clear set of design criteria for our project 




Objective 2: To select and comprehensively characterize an appropriate phase 
change material (PCM) that will resist temperature fluctuations outside 
of a range of 2-8 °C , based on appropriate thermophysical properties. 
Objective 3: To examine the influence of PCM geometry and organization on 
temperature stabilization by theoretically and experimentally 
incorporating the selected PCM within a cold box in a variety of 
configurations and evaluating temperature stability. 
Objective 4:  To use the data generated in objectives 2 and 3 to create an effective 
thermally-optimized prototype cold box that meets the design criteria 
from objective 1. 
Objective 5: To develop a clear and concise plan for the implementation of the 
aforementioned prototype into the existing cold chain.  
By meeting these objectives, we will prototype thermal innovations that may 
be readily incorporated both specifically into the existing vaccine distribution supply 
chain, and also into temperature stabilization systems in general. 
Scientific Significance 
Our research will combine lab bench measurements and numerical 
simulations towards the optimization of temperature stability for vaccines as they 
move through the cold chain. Characterization of several PCMs will use well-
established experimental techniques in materials characterization to obtain data. This 
ired 




greatest impact of our proposed work is the development of novel strategies for more 
efficient integration of PCM technology into engineering design. The majority of 
current strategies that incorporate PCMs into passive refrigeration systems simply use 
more PCM to deliver temperature stability for a longer duration. The innovation of 
our approach is actually quite intuitive; we hypothesize that it is not just the quantity 
of a PCM, but the arrangement, or configuration, of PCMs with respect to heat 
sources, heat sinks, and the environment that will optimize temperature stability at 
multiple temporal and spatial scales. Our design criteria for the proposed project are 
guided by the necessity to decrease freeze damage to vaccines and increase payload 
volume, as well as considering ease of use for operators to minimize human errors, 
thereby increasing efficiency of vaccine delivery. However, through comprehensive 
materials characterization, novel and more accurate predictive simulation approaches 
that build on such characterization and experimental validation of these theoretical 
models, fundamental principles elucidated through our work should broadly 
transform the engineering of passive refrigeration systems. This can lead to further 
innovations by allowing for a series of experiments that can develop a thermally 
optimized system, a unique approach to the use of modeling programs. 
Significance of F indings 
Our literature review of studies documenting vaccine freezing and general 
deficiencies in the existing cold chain provides a comprehensive summary of 
scientific evidence in the field. We have consolidated these studies in a visual, open-




collaboration, with hope that it may be utilized by investigators in the field. 
Furthermore, our team translated the findings from these studies to a two-minute 
online motion graphics animation, which depicts the challenges in the cold chain for 
the viewer (See Appendix H).  
The concept behind our prototype, a traveling vaccine container, offers several 
opportunities for preventing error in vaccine storage and handling throughout the cold 
chain. Since vaccines are kept in the internal storage compartment within our PCM 
cold box throughout the cold chain, there is no exposure to sunlight or fluorescent 
light for select vaccines that are susceptible to light-related damage (BCG, Measles, 
MR, MMR and rubella vaccines). Furthermore, healthcare workers no longer need to 
be trained for placing vaccines in the proper orientation within refrigerators or cold 
rooms to reduce risk of damage. Temperature stability of vaccines is position-
independent and vaccines can simply remain in any part of the internal storage 
compartment. Our design utilizes existing cold chain infrastructure and accessories, 
including transport routes, freezers, and ice packs. There is only one scenario in 
which our cold box requires expert repair: if PCM panels break, the PCM cold box 
will be sent back to origin. By incorporating a culturally-relevant country sticker or 
slogan on the box, healthcare workers may handle our cold box with more care. 
Furthermore, the Instruction Manual (See Appendix E) includes a detailed decision-
making flow chart that may be adapted to simpler language for future use in the field. 





Even though our team had a structured plan for approaching the problem of 
vaccine freezing, we realized that there are certain factors that could have been 
limiting to our success. The largest limitation we faced was our lack of field 
experience. While our members come from diverse fields of study and have studied 
the cold chain extensively, there is no substitution for having experienced the cold 
chain in the local health centers. With the exception of one member, no one on our 
team has seen how vaccines are delivered in developing regions of the world. This 
lack of experience could have affected our ability to predict practical considerations 
for our cold box. 
 Another limitation is that we did not have the time or resources to test our 
cold box in a cold chain setting. Through our extensive physical experiments, we 
temperature for a long duration; however, we were not able to send our box through 
the cold chain, which would be the definitive test to determine whether our concept 
was valid. With the aforementioned lack of field experience as well as our inability to 





Chapter 2: L iterature Review 
Background 
In 2003 alone, vaccines are estimated to have prevented two million diseases 
and 600,000 deaths. However, at the same time, it is estimated that 27 million 
children and 40 million women were not vaccinated (Wolfson et al., 2008). As the 
public health impact of vaccines has become increasingly clear, interest in and 
funding for new vaccine development and improvements in the refrigerated vaccine 
distribution system (cold chain) has surged.  
Since the World Health Organization (WHO) launched the Expanded 
Programme on Immunization (EPI) worldwide in the mid-1970s, most countries have 
been using a standard package of six vaccines measles, tetanus, diphtheria, 
pertussis, tuberculosis, and polio in their national immunization schedule. As part of 
the  strategy to achieve  for  by 2000, it set a goal in 1977 to 
provide universal immunization to all children by 1990. Since then, many low- and 
middle-income countries have modified their vaccination package to include hepatitis 
B (HepB) and Haemophilus influenza type b (Hib) for routine infant immunization 
schedules, and many are in the process of adding pneumococcal conjugate vaccine 
and rotavirus vaccines to their schedules. The WHO  remains committed to 
expanding the  targeted groups to include older children, adolescents, and 




Immunization is a proven tool for controlling and even eradicating infectious 
diseases, as proven by the examples of smallpox, polio, and measles. Before the 
1967-1977 WHO campaign that resulted in the eradication of smallpox, the disease 
threatened 60% of the world's population and killed every fourth victim. Since the 
Global Polio Eradication Initiative in 1988, polio infections have fallen by 99% and 
polio is on the brink of eradication. Between 2000 and 2008, measles deaths dropped 
worldwide by over 78%, and some regions have since focused on eliminating the 
disease. Maternal and neonatal tetanus have been eliminated in 20 of the 58 high-risk 
countries, a feat that has saved millions of lives (WHO, 2012). 
A Global E ffort 
As an in
since it protects individuals and populations at low cost, but also provides a platform 
for delivering other health interventions, such as vitamin A supplementation 
(Stephenne, 2011). The primary responsibility for ensuring sufficient financing for 
immunization services rests with governments of LMICs (Low and Middle-Income 
Countries, as recognized by WHO); however, since national governments alone may 
not be able to provide all of the required funding, it is a shared responsibility of the 
central government, district governments, and communities to identify and mobilize 
the necessary resources to sustain safe and effective immunization services (USAID, 
2003).  
In many instances, the efforts of LMIC governments are not sufficient in 




improving immunization services. International partners like USAID, PATH, 
UNICEF, GAVI, and WHO have recognized that campaigns conducted in a 
pooled together are more effective than campaigns directed by just one organization. 
WHO and at future vaccine supply 
chains can safely and routinely handle rapidly changing vaccine and delivery 
technologies while maintaining the ability to adapt to unexpected challenges, such as 
global pandemics (Milstien, 2002). Project Optimize continues to survey existing 
systems, test new processes and technologies, work with the pharmaceutical industry 
to innovate the presentation and packaging of vaccine products, and integrate their 
efforts with other health campaigns (PATH, 2009).  
While these immunization campaigns are being conducted, the vaccine 
landscape is changing dramatically. The 2006-2015 Global Immunization Vision and 
Strategy (GIVS) points to a dramatic scale-up of new lifesaving vaccines for standard 
immunization programs (Wolfson et al., 2008). Furthermore, an extensive analysis by 
PATH notes that more vaccines are becoming widely available and more money is 
being invested in research and development of vaccines than ever before (PATH, 
2009). However, the new vaccines that are being developed are much more costly 
than traditional vaccines. For example, there are several producers of traditional 
vaccines, such as measles, diptheria-tetanus-pertussis (DTP), leading to low unit cost 
for vaccines, often between US$0.10 and US$0.25 per dose. The cost of newer 
vaccines is significantly higher, typically between US$3.65 and US$15.00 per dose. 




never reach the low prices of traditional vaccines (PATH, 2009). Many experts and 
policy-makers are now investigating ways to finance the new vaccines. One way of 
ensuring access to vaccines in LMICs is to match the price to the level of economic 
development of the target country. tiered pricing,  this system allows for 
innovative financing mechanisms such as advance market commitments or offers of 
long-term and high-volume contracts to vaccine producers (Stephenne, 2011). 
Vaccine Delivery 
Despite tremendous efforts over the past few decades to provide access to 
vaccines to as many people as possible, many technical, social, and programmatic 
obstacles remain. Vaccines are temperature-sensitive biological substances that must 
be carefully regulated to maintain potency (Craig, 2008). There are a wide variety of 
obstacles in the way of effective delivery which can depend on transportation routes 
and the final destination, such as a remote village with no electricity. Although it is 
nearly impossible to develop a specific protocol for each region, there exists a global 
distribution network of refrigeration equipment and procedures for maintaining 
vaccine quality during transport and storage (PATH, 2008). This supply network 
dedicated to delivering vaccines is called the cold chain.  
Protecting Vaccines 
Because vaccines contain temperature-sensitive biological substances, they 
must be kept cool from the time of production until usage to maintain efficacy and 




freezing), vaccines are rendered ineffective. DTP, TT, DT, DPT combinations, liquid 
Hib, HepB and any HepB combinations may have freeze damage if not properly 
stored (PATH, 2003a). Furthermore, not all vaccines require the same temperature 
range. While freezing destroys some vaccines, it extends the shelf life of others. 
Those that are damaged by freezing temperatures must, in general, be stored between 
2-8 °C (Craig, 2008). 
Literature has shown that freezing is a larger problem in the cold chain than 
overheating. While vaccine damage due to overheating is gradual, freeze damage is 
nearly instantaneous (U. PATH, 2006). Tailored packing, transportation and storage 
arrangements for different types of vaccines are required to provide protection from 
temperatures outside of specified ranges by the WHO (WHO, 1999).  
In a typical cold chain, large shipments of up to 150,000 vials of vaccines are 
shipped or flown in refrigerated containers from the manufacturer to the national 
airport of the destination country (UNICEF, 2004). The vaccines are stored in a cold 
room at the airport until a refrigerated truck delivers them to the primary vaccine 
delivered periodically to regional centers, provincial health centers, local health 
centers, and eventually individual outreach clinics (WHO, 2002). The length of the 
entire delivery process depends on demand and can be as short as a month or as long 
as three months (UNICEF, 2004). The broad range stems from many factors that play 
a role in the efficacy of the cold chain in distributing viable vaccines. Though a 
typical cold chain routine was outlined above, customs clearance, inspection, 




country, and even within a country between geographic and socioeconomic areas 
(Frost, Reich, & Harvard Center for Population and Development Studies., 2008).  
Stages of the Cold Chain 
The cold chain begins at the vaccine manufacturer and ends once the vaccine 
is administered. Along the way, the vaccines pass through international airports, 
vaccine stores, and local dispensaries.  
When vaccines are shipped by air, the shipping cost is proportional to the 
weight of the package. During 1997, UNICEF and WHO reviewed actual vaccine 
packing practices in order to begin eliminating non-essential packing and devised a 
standardized vaccine arrival report, which simulates ongoing documentation and 
analysis on international vaccine shipments (WHO, 1999, 2005). This form also acts 
as a feedback mechanism for countries to correct problems in vaccine handling during 
international transport. The vaccine arrival report provides assurance for donors who 
want to track how their financial investments are being used, and for the Ministries of 
Health who are responsible for protecting their populations. 
Vaccine manufacturers sometimes do not comply with international standards 
and procedures related to vaccine shipment. Documented problems include vaccines 
arriving without advance notification, ice packs, cold chain monitors, proper 
documentation/ labeling, or requested vial sizes. Furthermore, vaccines may arrive 
with short expiration dates without regard for black-out dates, be trans-shipped via 




For each country, the Ministry of Health and vaccine suppliers work together 
to specify procedures for receiving international vaccines and delegating 
responsibility for each step in the process of ordering, receiving, and documenting 
vaccine shipments. For each international shipment of vaccines, the recipient 
completes the vaccine arrival report and officially submits it to the supplier or, in the 
case of vaccines supplied through UNICEF, to UNICEF and WHO (WHO, 1999). A 
recent analysis suggests that the international community is pursuing improved 
coordination between organizations that donate and ship vaccines and the host-
country officials who receive and distribute the vaccines, as well as better training for 
supply-chain managers (Kaufmann, Miller, & Cheyne, 2011). 
After vaccines leave the international airport, they are stocked at primary 
vaccine stores. These stores typically contain cold rooms (insulated, refrigerated 
enclosures that maintain a temperature above 0 °C), freezer rooms (insulated, 
refrigerated enclosures that maintain temperatures below 0 °C), iced-lined 
refrigerators, or a packaging area ("Guidelines for Establishing or Improving Primary 
and Intermediate Vaccine Stores," 2002). Primary vaccine stores exist at both the 
provincial and district levels with the number of primary vaccine stores varying by 
country. Larger vaccine stores are typically found at the provincial level, while at the 
district level, stores usually consist of smaller storage devices such as iced lined 
refrigerators (ILRs). Operations within the cold stores typically involve the constant 
monitoring of internal temperatures of storage facilities by personnel. The principle 
problem that arises at this stage of the cold chain is temperature instability within cold 




improper placement of vaccines around the cold rooms and ILRs or malfunctioning, 
outdated or poorly maintained equipment (WHO, 1999). 
From the primary store, the vaccine shipment is then taken to the next 
intermediate storage facility, which also uses cold rooms and freezer rooms. This 
stage is altogether omitted if the country delivers vaccines directly from the primary 
store to the health facility where vaccines will be transported. As such, every country 
has its own unique cold chain and associated problems from this point 
onward. Freezing during transport is attributed to the storage method en route, which 
generally consists of boxes lined with ice packs. Vaccines that come in direct contact 
with the ice packs will likely freeze. However, placing a buffer region in between the 
vaccines and ice requires larger transport containers and greater transport capacity, 
thus increasing costs. Furthermore, trucks carrying 
vaccines often struggle to transport them due to poor 
roads or lack of roads in remote areas (Hopkins, 
1985). 
A number of studies have documented freezing 
in the cold chain. A study of the cold chain in Papua 
New Guinea showed that, on average, the only steps of 
the cold chain that did not report freezing temperatures 
were storage sites at the Ministry of Health and 
provincial vaccine stores. During transport from the 
provincial vaccine stores to local health centers and 
subsequent outreach clinics, vaccine loads were partially 
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Figure 1: Path of 
vaccines through a 




freeze-damaged, reaching an average temperature of -3 °C (T. Wirkas, Toikilik, S., 
Miller, N., Morgan, C., & Clements, C.J., 2007). In contrast, a study of vaccine 
freezing in the Indonesian cold chain found freezing at higher rates in storage than in 
transport (C. M. Nelson, Wibisono, H., Purwanto, H., Mansyur, I., Moniaga, V., & 
Widjaya, A., 2004). It appears that freezing is not just a problem at a single stage, but 
rather is manifested throughout the cold chain. 
Once the vaccines reach the villages, the most basic refrigeration technology 
and transportation methods are used to deliver and store the vaccines. The power 
supply becomes increasingly intermittent and transportation becomes more difficult. 
This problem manifests throughout the local level of the cold chain, resulting in 
inefficient and unsafe delivery of vaccines. At this stage, many vaccines are kept in 
ice-lined boxes which can cause the vaccines to freeze, rendering them useless (T. 
Wirkas, Toikilik, Miller, Morgan, & Clements, 2007). Figure 1 documents the path 
vaccines travel in reaching their destination.  
Evidence of F reezing in Vaccine Delivery 
A multitude of studies have shown that vaccines in the cold chain within a 
wide range of countries including Thailand, India, Malaysia, Indonesia, Papua New-
Guinea, Vietnam, New Zealand, Australia, Bolivia, Ethiopia, and even the United 
Kingdom and the United States are often exposed to freezing (<0 °C) temperatures, 
likely causing them to lose their potency due to the inactivation of key organic 
components (D. M. Matthias, Robertson, Garrison, Newland, & Nelson, 2007; C. M. 




Techathawat, 2007; T. Wirkas, Toikilik, S., Miller, N., Morgan, C., & Clements, C.J., 
2007). Such vaccine losses result in financial loss for immunization programs, as well 
as potential danger to the patient. One of the most prevalent factors attributed to 
vaccine freezing is the lack of stable temperatures in the cold boxes, which contain 
ice packs at 0 °C (PATH, 2008).  
Unstable internal temperatures in cold boxes have made overheating and 
freezing the primary threats to vaccine potency. In a study of the vaccine cold chain 
in Thailand, 31 out of 42 routes experienced freezing temperatures for periods long 
enough to render the vaccines impotent. Researchers estimated that 70% of vaccines 
were tossed away upon delivery, mostly because they were unusable due to freeze-
damage (Techathawat, 2007)
transporting HepB vaccines to eight health centers in Indonesia, similarly found 
instances of frozen vaccines in 75% of the shipments (C. M. Nelson et al., 2004).  
In 2007 Matthias et al. conducted a systematic literature review on studies 
from January 1985 to June 2006 demonstrating vaccine freezing in the cold chain. 
The authors recommended that more rigorous and comprehensive studies be done to 
examine the exposure of vaccines to freezing temperatures through all transport and 
storage segments of the cold chain. The image below (Figure 2) is a snapshot of an 
open-source Google Map our team has created to visually demonstrate the literature 
on vaccine freezing in the cold chain. Each marker is accompanied by the percentage 




and link to the article were included, if available. Placement of the marker is only 
accurate to the country level; the locations are not precise within each country.  
 
Figure 2: Open-source Google Map depicting literature on vaccine freezing in the 
cold chain 
Since 2006, more data has emerged documenting challenges and opportunities 
to prevent vaccine damage in the areas of improved management, monitored 
mechanisms, and the structure of the cold chain. If vaccines are improperly handled 
so that they are damaged by incorrect temperature maintenance, the tremendous effort 
to scale up vaccinations will be wasted. The major problem areas continue to be: 
improperly maintained or outdated refrigeration equipment, poor compliance with 
cold chain procedures, inadequate monitoring, and poor understanding of the dangers 




Sociopolitical Challenges in Vaccine Delivery 
 As Frost et al. point out in their report on increasing access to healthcare, 
used, or achieve its potential to bring good health, especially for poor people in poor 
coun (Frost et al., 2008). Technologies can be used in many ways, but can also 
be mishandled and misappropriated in manners that nullify their potential. Despite the 
immense effort and resources WHO expends on both technology and methodology of 
delivering health care, it cannot control what happens on the ground in LMICs whose 
governments are newly developed, infrastructure is young and cultures are unique 
(Vickers, 2005).  
Some technologies are not accepted because they contradict cultural norms 
and are associated with negative social stigmas. In addition, in some countries, rival 
warfare and government instability can be a major roadblock towards vaccine 
delivery and healthcare in general (GAVI, 2008); therefore, WHO and other 
international organizations can be international regulators of health, but cannot be 
intranational overseers (WHO, 1985). 
In certain areas, the local level has no power supply at all and, as such, 
their own homes  such as a 
motorbike, to replenish the supply of vaccines. In the Peruvian Amazon, it is a two-
day riverboat ride to the nearest hospital where 
river villages are staffed by doctors assigned to work there as part of a year of service 




Himalayas, donkey caravans carrying vaccines are used to reach secluded Afghan 
tribes (GAVI, 2008). 
 Freezing has also been demonstrated in the cold chains of developed 
countries with modern technology and reliable power supplies. General practitioner 
vaccine providers in Australia (Wawryk, Mavromatis, & Gold, 1997) and the United 
Kingdom both recorded freezing temperatures in vaccine storage (Thakker Y & 
Woods, 1992). Similarly, physicians  offices in Georgia, United States, reported 
frozen vaccines 11.4% of the time (Bell, Hogue, Manning, & Kendal, 2001), and 
researchers in Colorado, United States, concluded that a majority of vaccines in the 
community have been exposed to conditions that could reduce or destroy their 
(Woodyard, Woodyard, & Alto, 1995).  
Weaknesses in the Cold Chain 
Cold Chain Equipment and Maintenance 
Much of the cold chain in LMICs is outdated and in disrepair, or must be 
replaced due to new environmental regulations, which further complicates 
immunization processes (Levin, Levin, Kristensen, & Matthias, 2007). 
     
A typical cold chain has a diverse set of equipment and provisions for staff to 
operate (C. M. Nelson, Wibisono, H., Purwanto, H., Mansyur, I., Moniaga, V., & 
Widjaya, A., 2004). These include ice-lined refrigerators, cold boxes (E rror! 
Reference source not found.3), cold rooms, data loggers, pre-filled injection devices 
(Uniject), vaccine vial monitors (VVM), and freeze indicators (Freeze Watch, E rror! 




assured quality, defined by WHO as one[s] that consistently meets appropriate levels 
of purity, potency, safety and efficacy (Knezevic, 2009). Table 1 describes the 
functionality and cold chain equipment used to check for frozen vaccines. 
Table 1: Some cold chain devices used to prevent vaccine freezing. 




 Heat-sensitive label 
 Time and temperature cause inner 
square to darken 
 Higher temperature, faster color 
change 
 Indicates to a health 
worker when a vaccine 
can be used/should be 
discarded 
 Either on vaccine label 
or cap 
Shake Test 
 Freeze a vaccine as the frozen 
control 
 Let frozen vaccine thaw 
 Shake vaccine from batch and 
control together vigorously 10-15 
seconds 
 If sedimentation (formation of large 
particles) occurs faster in the test 
vaccine, it is not damaged 
 If sedimentation occurs equally fast 
in the test and control vaccines, the 
test one is damaged and should be 
discarded 
 Determines whether a 
vaccine should be 
discarded or not 
 Should be done 
independently with all 
batches that are 
suspected for freezing 
 For use with adsorbed 
vaccines (DPT, DT, 
Td, TT, hepatitis B, 
Hib liquid, and 
combinations of these) 
FreezeWatch 
stickers 
 Placed in refrigerators to warn of 
freezing temperatures 
 Dark ink stains paper when freezing 
temperatures are reached 
 Can signal that further 
freeze inspection 






In Nelson et al. (2004), monitoring packets were prepared by combining a 
data logger, a VVM on a card, and a freeze indicator in a sealed plastic bag. These 
packets were placed inside boxes containing 100 Uniject devices. Boxes that 
contained monitoring packets were marked to indicate the site for delivery. 
Monitoring packets were prepared immediately before the vaccines were packed into 
shipping containers. At each stage of the cold chain, staff from the Ministry of Health 
recorded the time and date of arrival and departure of the vaccine shipments, as well 
as the status of the vaccine vial monitor and the condition of the Freeze Watch device. 
Staff at each level received training on completion of forms and study procedures (C. 
M. Nelson et al., 2004). 
The WHO mandates that all vaccines have VVMs, which will indicate heat 
exposure that may negatively affect vaccine potency (WHO, 1999). Oral Polio 
Vaccines (OPV) are considered one of the most unstable vaccines, with an ideal 




Figure 4: A typical cold chain cold box Figure 3: FreezeWatch indicator 







wide immunization campaign in order to ascertain how long an especially sensitive 
vaccine would remain potent in ambient temperatures. As vaccines were exposed to 
maximum temperature of 47.1°C and lasted a maximum of 86.9 hours in ambient 
temperatures, the authors looked at the VVMs to determine potency. Laboratory 
testing was conducted to confirm VVM results, and the authors concluded that the 
VVM served as an accurate indicator of heat exposure (Zipursky et al., 2011). 
 In another study in India, cold chain equipment and VVMs were evaluated 
at 46 health centers in a rural district to see if they met WHO guidelines. Nine percent 
had indicated that vaccines had been 
spoiled and should be discarded. The authors concluded that the cold chain was not 
adequately maintained at the primary and sub-health centers, and recommended that 
well-maintained ice packs and vaccine carriers be added (Samant et al., 2007). 
local vaccine stores in Ethiopia showed that the intermittent power supply 
necessitated the use of back-up power sources which are often not reliably in place. In 
theory, the back-up power sources are designed to safely power down the equipment 
when the main power supply cuts off, but improper wiring of these sources leads to 
unstable conditions for the vaccines. The evaluation concluded that electricity needs 
are not integrated in health center planning (USAID, 2008).  
Data loggers present hope for detecting temperature throughout the cold 
chain. Kartoglu, et. al. published an article recently that discussed their invention, the 




data from various points inside a closed space and can signal to the user when the 
temperature has gone outside the desired 2-8 °C range. One study evaluated the use of 
data loggers in quantifying the cold chain failure rate within the Texas Harris County 
Hospital District community health center network. The researchers used Extech 
TH10 digital data loggers to study 54 refrigerators at 13 community health centers, 
and took a close look at storage of acellular pertussis vaccines, which must not be 
stored at less than 0 °C. Approximately 24% of the refrigerators studied exposed 
vaccines to considerable durations of subzero temperatures. The inadequate storage 
would not have been detected or quantified without the use of the digital temperature 
data loggers, and the authors conclude that adopting digital data loggers may be more 
effective than continuing the standard practice of twice-daily readings from 
thermometers (McColloster & Vallbona, 2011). 
Health information systems may also significantly bolster cold chain 
management. One of the best tools utilized in the United States to ensure vaccine 
safety is the Vaccine Safety Datalink, which attempts to find associations between 
vaccines and potential health outcomes and provide signals for when a vaccine may 
be unsafe (Salmon, Pavia, & Gellin, 2011). In a case study on the vaccine supply 
chain in Ethiopia, the authors analyzed needs and offered recommendations for 
improving health information systems through the use of mobile and software 
technology. The authors noted that health centers are predominantly paper-based and 
includes the use of stock cards, which are both inefficient and prone to errors, 




tedious to extract useful information for decision-making at any level of the supply 
chain (Sabtala, Anene, Owoluganda, & Nanteza Walusimb, 2011). 
The authors recommended that a pilot study be undertaken to test mobile 
tracking technology, such as the one provided by Logistimo, in the field. In order to 
evaluate this intervention, the team could measure outcomes such as (1) the number 
of children under five that have been immunized, (2) the quantity of consignment 
dispatched that has been utilized, and (3) the quality of service of a health center 
through prompt transfer of information. Another promising technology is 
CoolComply, a solar-powered wireless detection system, which monitors the doses 
and the temperature of the medication, relaying readings wirelessly to the local 
healthcare workers to track temperature and intervene when necessary. CoolComply 
is currently employed for drug treatment for Multiple Drug Resistant Tuberculosis 
(MDR-TB). Finally the authors recommended that more technology and best 
practices, including the use of microchips from radio-frequency identification 
(RFID), be strengthened (Sabtala et al., 2011). 
Mismanagement of the Cold Chain 
The problem of vaccine wastage is often attributed to a lack of temperature 
control infrastructure in LMICs; however studies have shown that vaccine packaging 
and administration can also cause wastage. The WHO estimates that 50% of all 
vaccines produced globally are not appropriately administered, and therefore wasted 
(Guichard & Hymbaugh, 2008). Matthias, et al., alluded to the importance of 




(2007). Several studies have focused on further assessing the need, and testing 
tailored strategies to improve cold chain management in their communities. 
Using a temperature data logger, researchers in Papua New Guinea attempted 
to identify and locate if and where vaccines destined for use in peripheral health units 
were subject to freezing temperatures. Findings demonstrated that freeze damage was 
often a consequence of incorrect packing of vaccines in vaccine carriers for transport 
between stores and the field (T. Wirkas et al., 2007). 
One retrospective study conducted by WHO and the Bangladashi government 
examined the immunization system in Bangladesh, a country that boasts an excellent 
record for administrating vaccines to children. The study employed a standard two-
stage cluster sampling technique for assessing injection safety at the local level. Data 
on quantity of vaccine vials provided, distributed, used, and returned 
opened/unopened at the service delivery levels was collected by WHO surveyors. 
Vaccine receipts and distributions were recorded in the Daily Vaccine Distribution 
Register and the Upazila Vaccine Stock Register. Vaccination Tally Sheets were used 
for each immunization session. While there were many causes for wastage, the study 
highlighted a few key areas that require supervision or increased training for 
healthcare workers. For example, field workers had difficulty drawing out the 
submerged in the water of the vaccine carrier, destroying their potency (Guichard & 
Hymbaugh, 2008). 
In another recent article published by Lee et al., in 2011, the authors replaced 




wasted vaccines in the Trang Province of Thailand. Healthcare workers generally had 
to open vials to use a few doses, but discarded remaining unused doses. This also led 
to risk of contamination from having repeatedly drawn vaccine doses from one ten-
dose vial. However, the increased number of vials proved problematic, as it presented 
space issues in the refrigerators, and the doctors noticed more vials were broken as a 
result of mishandling (Lee et al., 2011). 
In a 2004 study of the Bolivian Cold Chain, each of twelve vaccine storage 
centers monitored recorded temperatures below 0 °C (C. Nelson et al., 2007). Two of 
the health centers recorded freezing temperatures 50% of the time. Ice-lined 
refrigerators  and domestic front-end refrigerators were predominantly used in 
all levels of storage, and all recorded freezing temperatures; freezing was even found 
in district level stores that housed vaccines for up to 22 days. Additionally, freezing 
was widespread in transport, particularly where freezer rooms are used to freeze ice 
packs that will line vaccine shipments in insulated boxes. The authors of this study 
attributed the prevalent freezing of vaccines to poor healthcare worker awareness and 
understanding of vaccine freezing. Only 15 out of 34 workers were able to correctly 
identify which vaccines are damaged through freezing, and only half could 
distinguish a freeze-damaged vaccine from a potent and undamaged one. Regular 
staff turnover led to healthcare workers who were not adequately educated regarding 
vaccine shipments and storage. Hence, in addition to the healthcare workers  lack of 
awareness mentioned above, they also frequently changed the adjustable thermostat, 




Similarly, in a study of the Mongolian cold chain, vaccine freezing was also 
attributed to the actions of healthcare workers. The once-a-month trip into the 
regional vaccine store takes hours of driving through the rugged countryside, and 
though the store personnel know a shipment is due to leave, the timing is often 
erratic. As a result, upon arrival, vaccines are hastily loaded onto the truck in an effort 
to minimize the time spent traveling, resulting in negligence of the crucial step that 
brings the deeply frozen ice packs up to 0 °C (Edstam, Dulmaa, Tsendjav, 
Dambasuren, & Densmaa, 2004). 
One study collected information regarding the state of the cold chain among 
public, private, and community hospitals in Thailand, where there is little regulatory 
control over drug distribution and transportation. Each distributor is thus responsible 
for the quality of vaccine shipments. One notable finding was that temperature-
sensitive drugs were without controlled temperature boxes to private, public and 
community hospitals at the rates of 46.7%, 48.3% and 72.9%, respectively. The rate 
of cold storage drugs (-20 °C,) i.e. polio vaccine arriving with a temperature higher 
than 8 °C or ice melting in the box, was 22.9%, 12.7% and 35.0% at the private, 
public and community hospitals, respectively. The authors recommended more 
regulations across all hospitals for cold chain management (Sooksriwong & 
Bussaparoek, 2009). 
Improving Management 
Delegating responsibility is critical to manage the many moving parts of the 




Immunization (IPPI) campaign demonstrated that management of equipment was 
desperately needed. For example, the authors recommended ensuring an adequate 
number of certain equipment, such as exhaust fans and voltage stabilizers, and 
providing an uninterrupted power supply, since power outages reportedly occurred 2-
4 hours a day. Reorientation of the training program of all health functionaries was 
recommended (Galhotra, Goel, Pathak, Kumar, & Swami, 2007).  
 Performance of trainers and training content are important parameters that 
can influence the effectiveness of training. One effective immunization intervention 
in Turkey included vaccines, national vaccination schedule, cold chain and 
management, planning and regulation of immunization, tracking the trends and 
increase in vaccination coverage, and immunization recording. Eighteen intensive 
immunization workshops were held between January and March 2004, lasting for 
about 54 weekdays in total. The intervention increased both the knowledge of 
primary healthcare workers and the rate of vaccination coverage in the study region 
(Uskun, Uskun, Uysalgenc, & Yagiz, 2008).  
After conducting a baseline survey of cold chain equipment in 2008, the 
authors identified key areas to intervene within the Kolkata cold chain system. Using 
evidence-based training techniques, the research team delegated responsibility to 
nized the different points at which the vaccines were 
handled. The success achieved after intervention included significant improvement of 
interior condition of cold chain equipment, placement of vaccines, temperature 
maintenance and creation of a designated cold chain handler in each cold chain point. 




stabilizers, backup generator services and separate and adequate cold chain room, 
which mainly depended on policy makers and funding. Preventive maintenance of 
cold chain equipment on a fixed day monthly, temperature maintenance on holidays 
and  formulating a proper emergency contingency plan were also unsatisfactory 
(Mallik et al., 2011). 
There are several programs that have been developed to strengthen training 
for healthcare workers responsible for different segments of the cold chain. The 
Centers for Disease Control and Prevention (CDC) has provided extensive materials 
for cold chain management, including tips on administering and timing immunization, 
keeping records, and maintaining general guidelines for all immunization procedures 
(Kroger, Atkinson, Marcuse, & Pickering, 2006) (Middleton, Zimmerman, & 
Mitchell, 2007). Some research teams have implemented structured methods in the 
field. In their 2010 article, Roger, et al., emphasized the responsibility of the US 
government to provide the resources needed to effectively train US cold chain 
employees, and the obligation of companies to ensure that employees are utilizing 
them once available (Rogers, Dennison, Adepoju, Dowd, & Uedoi, 2010). 
Outside of the United States, countries are taking steps to improve cold chain 
management at several levels. In Kenya, the Merck Vaccine Network  Africa (MVA 
 A) is an educational program to improve the managerial and analytical skills of the 
mid-level managers of Kenya Expanded Programme on Immunisation (KEPI), 
utilizing the WHO EPI Mid-level Management Course for EPI Managers (Ayaya, 
Liechty, Conway, Kamau, & Esamai, 2007). This serves as an example of a targeted 




Alternatives to Cold Chain 
Alternative vaccines 
Considering the great number of factors that contribute to improper vaccine 
storage and handling, thermostable vaccine products may greatly improve the safety 
of immunization (Levin et al., 2007).  
Many areas in LMICs are plagued with unreliable power supplies, civil wars, 
cultural taboos, untrained workers, and rugged terrain; it is not surprising that it is 
thus difficult for the cold chain to successfully deliver viable vaccines. Rather than 
spending significant time and money on overcoming these challenges, some of which 
are insurmountable, the simple solution is to spend time and money developing 
vaccines that are durable enough to endure harsh environmental conditions, and may 
be easily handled by untrained workers. 
Thermostable measles, DTP-hep B, BCG, and YF vaccines in single-dose 
presentations are potentially cost-effective interventions to reduce childhood deaths 
and disability in low-resource settings in Asia and Africa. These programs could save 
money due to reduced vaccine wastage and improved efficiency in delivery. There 
would also no longer be a need to invest in temperature infrastructure, such as cold 
rooms or refrigerators. In complex emergency situations, when the cold chain is likely 
to break down, the benefit is also very clear (Levin et al., 2007). 
Alternatives to traditional injected liquid vaccines are being developed in the 
form of dry-powder and liquid that can be administered orally. Dry powder vaccines 
are typically freeze-dried so that vaccine proteins can be stabilized by 




adjuvants has proven to improve the thermal stability of the vaccine compared to the 
liquid form (Hirschberg, van de Wijdeven, Kraan, Amorij, & Kersten, 2010). The 
ideal inhaled dry powder vaccine would have a small enough particle size for deep 
lung delivery, be able to aerosolize upon inhalation, and be simple to administer. It 
should also be engineered with compounds that stimulate innate immunity to improve 
the vaccine  immune response at a low cost with a shelf-life of 0.5-2 years without 
refrigeration (Sou et al., 2011). Various proteins and peptides (main antigenic 
biomacromolecules used in vaccines) have already been developed in the form of dry 
inhaled powders (Sou et al., 2011).  
The best method for creating dry powder vaccines requires further 
investigation. Even following the identification of the appropriate method for 
developing dry powder vaccines, pre-clinical and clinical trials still need to be 
conducted (Amorij, Huckriede, Wilschut, Frijlink, & Hinrichs, 2008). The most 
recent developments, a dry powder vaccine for measles and tuberculosis, are not 
expected to undergo clinical trials for another two years in India and South Africa, 
respectively (Sou et al., 2011). Needle-free injection still awaits clinical testing using 
freeze-dried formulations of vaccine. A freeze-dried Hepatitis B vaccine recently 
underwent in vivo testing in mice. The objective of the testing was to observe vaccine 
efficacy following subcutaneous vaccine delivery through an implant made of 




Vaccine T ransport outside the Cold Chain  
Healthcare workers have also begun to take simple but creative approaches to 
reformulate the cold chain. The main method that researchers are investigating is the 
transportation and storage of vaccines out of the cold chain (OCC). According to 
Halm, et al., OCC transport can be defined as the absence of ice packs in the vaccine 
 (Halm et al., 2010). Many vaccine 
transportation routes already use OCC methods, especially as the vaccines get closer 
to the local dispensaries, quite simply because they do not have the appropriate 
equipment (ice boxes, vaccine carriers) to store the vaccines in. As such, OCC 
methods are often used out of necessity. 
As OCC methods continue to be used by healthcare workers, researchers have 
studied the effects of ambient temperature transportation on vaccine efficacy. A 
comprehensive literature review carried out by PATH found that Hepatitis B, a 
freeze-sensitive vaccine, is serologically effective even vaccines have been stored by 
OCC methods prior to administration. The review covered OCC methods in China, 
Indonesia, and Vietnam, among other countries. The authors found no difference in 
the immune response between children who received vaccines stored in the cold chain 
and children who received vaccines stored outside the cold chain. The study 
concluded that allowing storage through OCC methods would permit more children 
to be immunized in rural areas (Villadiego, 2008). 
Halm, et al. conducted a comprehensive study of the oral polio vaccine (OPV) 
in national immunization campaigns in Mali. This study aimed to show that storing 




no additional risk to the potency of the vaccine. The study was done in Mali during 
the third round of the 2009 inter-country West African National Immunization Days. 
Trivalent OPV, in a twenty dose vial presentation, was used to vaccinate the 
estimated target population of children under five years of age. All of the teams 
followed the same procedures by using the ice packs on two of the four days. On the 
remaining two days, OCC procedures were followed and ice packs were not used 
(Halm et al., 2010). 
As expected, the vaccine vial monitors (VVM) progressed through its stages 
slightly faster during OCC days, in which VVMs were exposed to a higher 
cumulative temperature. At the time the last dose was administered, however, no 
VVM had surpassed the VVM stage of 60% (90% is the point at which vaccines must 
be discarded) despite exposure to external temperatures between 25 °C and 40 °C 
during vaccination activities that lasted nearly seven hours on average. The OCC 
procedure demonstrated that it led to no vaccine wastage, and was easily understood 
by all vaccination teams that participated in the National Immunization Day. A study 
(L. Wang et al., 
2007). Overall, OCC methods worked in Mali because of the availability of VVMs 
and well-trained healthcare workers (Halm et al., 2010).  
A study by Ren, et al. investigated the effects of an inadequately trained 
healthcare workforce on success of OCC methods during a campaign for Hepatitis B 
and measles vaccines in rural Western China (Ren, Xiong, Li, Xu, & Zhu, 2009). 
Hepatitis B was chosen as a representative cold-sensitive vaccine, and measles as a 




two unsettling results: first, that consistent temperatures were not maintained, and 
second, that healthcare workers were uninformed about proper storage and delivery 
techniques. As a result, the efficacy of the vaccines was compromised. 
Ren et al., found that seven routes maintained a temperature above 8 ºC 18.5  
26.7% of time. In three of these routes, the temperature was above 8 ºC for more than 
80 hours. As a result, 3 out of 48 measles vaccines showed vaccine failure. The 
temperature was below -0.5 ºC for 2.9  12.9% of the time during OCC storage. 
Despite these temperatures, the hepatitis-B vaccines all passed the shake test. This 
discrepancy could be explained by vaccines being tested before they froze overnight, 
or by improper execution of the shake test (Ren et al., 2009). 
Using a survey to investigate the procedural knowledge of the healthcare 
workers, Ren et al. found that many healthcare workers at the district and local levels 
did not know that freezing temperatures were harmful for vaccines. The workers also 
had limited knowledge about the proper processes and techniques for keeping 
vaccines in the correct temperature range (Ren et al., 2009). 
As identified by Halm et al., as the number of vaccines administered through 
the EPI increases, and as the relative capacity of the cold chain decreases, OCC 
approaches may offer a promising alternative (Halm et al., 2010); however, it is 
essential to note that using vaccines outside of the cold chain can only be considered 
with the availability of VVMs as well as adequate OCC training protocols for 
healthcare workers. 
Another study by Nelson et al., 2004, demonstrated that an Indonesian cold 




delivery of HepB vaccine to infants born at home, midwives were permitted to store 
HB-Unijects without refrigeration in their homes until the endpoint of the vaccine vial 
monitor or expiry date was reached (C. M. Nelson, Wibisono, H., Purwanto, H., 
Mansyur, I., Moniaga, V., & Widjaya, A., 2004). The authors found that 75% of the 
shipments were exposed to freezing temperatures.  
The authors then led three interventions to observe the impact of taking away 
different aspects of the cold chain. During the first phase -
introduced in all transportation stages. HB-Unijects were transported in standard cold 
boxes and vaccine carriers but without any ice or ice packs. During the second phase, 
no-ice transport continued, and HB-Unijects were stored in air-conditioned rooms at 
the district level. During the third phase, in addition to no-ice transport and air-
conditioned district storage, HB-Unijects were stored at ambient temperatures in the 
health centers. Table 2 summarizes distribution conditions, and Table 3 states the 
Table 3: Freezing rates observed for interventions in Nelson, et al. 2004 study 




freezing rates observed (C. M. Nelson et al., 2004). 
The authors concluded that selective transport and storage of vaccines at 
ambient temperature would significantly reduce rates of vaccine freezing. Similar to 
previous studies, they also mentioned that policy changes that allow for limited 
storage of freeze-sensitive vaccines at temperatures outside of the 2 8 °C temperature 
range would enable flexible vaccine distribution strategies that could reduce overall 
vaccine freezing, reduce costs, and increase immunization capacity (C. M. Nelson, 
Wibisono, H., Purwanto, H., Mansyur, I., Moniaga, V., & Widjaya, A., 2004). 
Alternative Refr igeration T echnologies 
There are several promising refrigeration technologies that are currently in use 
or have potential to be used within the cold chain. Many are specific to particularly 
destinations with defined levels of resources that enable users to benefit from these 
technologies. Overall, however, refrigeration is not practical for the main method of 
transport and storage of temperature-sensitive vaccines through the cold chain. Here 
we examine compression, adsorption, and absorption refrigeration methods. 
Refrigeration: Vapor Compression Cycle 
Vapor compression cycle is the most widespread method for refrigeration and 
air conditioning. This technology is a system in which a liquid refrigerant undergoes 
numerous phase changes and processes in order to cool the items stored within the 
refrigeration compartment (Matsuoka, 2005). As the refrigerant passes through an 
expansion valve, the pressure is quickly dropped. As a result, the temperature of the 




mixture passes through an evaporator coil where it absorbs the heat in the air 
surrounding the coils. The warmed refrigerant gas then passes through a compressor 
in which it is bought back to a high pressure and temperature. After being 
compressed, the highly pressurized gas passes through a condenser where it is cooled 
back to its liquid form. The air in the condenser that absorbs the heat given up by the 
condensed liquid is discharged from the refrigerator at this stage. In an ideal system, 
the amount of heat energy absorbed by the system in the evaporator will equal both 
the amount of energy used to supply the compressor and the amount of waste heat 
energy discharged from the refrigerator in the condenser (Felder & Rousseau, 2005). 
 
Adsorption Refrigeration 
Adsorption refrigeration is a technology that provides active cooling of a 
refrigeration compartment with no mechanical or electrical energy required. This 
property has made adsorption a promising alternative to vapor compression 
refrigeration. The adsorption refrigeration cycle is similar to the common vapor 
compression refrigeration cycle with one key difference. Whereas the vapor 
compression cycle utilizes a compressor to cool the vapor refrigerant, the adsorption 
cycle uses the properties of adsorption/desorption (R. Z. Wang & Oliveira, 2005). 
The adsorbent bed, which is the main facet of any adsorption refrigerator, is 
composed of a solid material, such as activated carbon, which adsorbs the vapor 
refrigerant. Then, as an external heat source warms the adsorbent bed, desorption 
occurs, releasing the cooled vapor refrigerant into the condenser, where it reverts into 




available source, such as solar energy or waste heat from a nearby machine, making 
the adsorption refrigeration cycle attractive in situations where electricity is not 
readily available (R.Z. Wang, Ge, Chen, Ma, & Xiong, 2009). Furthermore, the 
liquids used as refrigerants are typically ammonia and water, which have zero ozone 
depletion potential (Yong & Wang, 2007). 
Unfortunately, adsorption refrigeration is rarely used as a primary cooling 
source due to its disadvantages. The main drawback of this system is the 
adsorption/desorption time (Yong & Wang, 2007). As the adsorbent bed requires a 
significant amount of time to heat up, the cooling cycle of these refrigerators is often 
not quickly available, making it an intermittent cooling source only. Furthermore, its 
specific cooling power (SCP) is lower compared to other refrigeration systems. SCP 
is a measure of the ratio between cooling production and cycle time per unit of 
adsorbent weight, showing that the required adsorbent bed significantly increases the 
size and weight of these refrigerators, while only providing a modest refrigerated 
storage compartment (Yong & Wang, 2007). Adsorption refrigerators also have a low 
coefficient of performance (COP), which is the main indicator of cooling efficiency 
of any refrigeration system (Li, Wang, & Wang, 2009). 
In their review of adsorption refrigeration technologies, Fan et al. (2009) note 
that adsorption refrigeration would be an attractive solution to current demands for 
less energy usage, as current compression refrigeration and air conditioning systems 
(Fan, Luo, & Souyri, 2007). 
Furthermore, adsorption technology is ideal for areas in LMICs that have limited or 




are pursuing many avenues to improve the cooling efficiency and address other 
disadvantages of adsorption refrigeration to meet these needs. Some areas include 
testing different adsorbent bed materials, using two or more adsorbent beds, and 
creating hybrid systems of compression and adsorption technologies (Yong & Wang, 
2007). 
While there are promising future directions for adsorption refrigeration, we 
determined that adsorption refrigeration would be impractical for transportation in the 
cold chain, as the adsorbent bed requires an external heat source and the SCP is 
relatively small. 
O ther Refrigeration Methods 
 Absorption refrigeration is very similar to adsorption refrigeration. The slight 
difference between these two technologies is in the conversion of the gas refrigerant 
back into a liquid. In absorption, the vapor refrigerant is absorbed, or dissolved into 
another liquid, usually a water and salt mixture (Fan et al., 2007). In adsorption, the 
vapor is adsorbed, meaning it does not completely dissolve in the adsorbent bed, but 
rather clings on to its surface. This difference means that absorption requires much 
more heat to release the refrigerant from the liquid. The main advantage of this type 
of system is that the liquid mixture is lighter and more portable than the adsorbent 
bed (Fan et al., 2007). 
The Score project, developed at the University of Nottingham in the United 
Kingdom, is working on a biomass-powered generator that could make electricity for 




is a Linear Alternator, which converts sound energy into electrical energy. It uses 
special configurations of magnets to convert sound into electricity (Rossi, Immovilli, 
Bianchini, Bellini, & Serra, 2009). The researchers say that the generator is very 
versatile in the type of fuel that it can burn to be used as heat energy for the Linear 
Alternator, making it attractive in a wide variety of developing areas. Their target is 
to make a device that costs about $20 and weighs between 10-20 kg (Rossi et al., 
2009). This generator could be an important source of electricity for health centers in 
LMIC regions of the world. 
 Another type of energy source used for powering refrigeration compressors is 
geothermal heat. Normally, compression refrigerators exchange heat with the 
surrounding air in order to remove heat from the interior compartment. However, this 
process is relatively inefficient, as the air changes temperature quickly and by a large 
amount with the seasons. In contrast, by exchanging heat with the surface of the 
earth, compressors can be made much more efficient, as the earth does not change 
temperature as quickly and stays about the same temperature all year round. The 
disadvantages to this system are that the refrigeration compartment cannot be 
transported and it must be rather large to accommodate the surface area needed for 
adequate heat exchange (Hepbasli & Akdemir, 2004). 
PC M T echnology  A Promising A lternative 
A phase change material (PCM) is a very effective means of temperature 




ambient heat energy, and as such has become used as a means of latent heat storage in 
a variety of different applications.  
One of the main features of PCM is its high heat of fusion (Pasupathy, Velraj, 
& Seeniraj, 2008). PCM is a passive cooling method, meaning that there is no power 
required for it to function. Each PCM melts and becomes solid at different 
temperatures, either absorbing or releasing heat when switching phases from solid to 
liquid, or vice versa. While there are other phase changes, such as liquid to gas, the 
phase change from solid to liquid are of interest because it is the most practical and 
widely available phase change (Pasupathy et al., 2008). This effect is best 
demonstrated by one of the most readily available PCMs - water. When changing 
from ice at 0 °C to liquid at 0 °C, water is absorbing heat from its surroundings. An 
example is ice cooling a drink. When the ice begins to melt, it absorbs the heat from 
the beverage, making it cold, while still maintaining its temperature. A PCM will 
continue to store heat at a consistent rate until completely turning into liquid form 
(Pasupathy et al., 2008). This gives PCM the ability to store and release large 
amounts of energy and giving it many thermodynamic applications.  
Since PCMs all have different melting points, a suitable PCM can be found to 
match a specific purpose. Thus, since most vaccines must be stored at 2-8 °C, PCMs 
that melt in this range would be able to keep the vaccines cool at a stable temperature. 
Therefore if a suitable PCM is used, the vaccines will stay in the desired temperature 
range, preventing them from losing potency. 
Other common applications include the cooling of homes, buildings, heat and 




of blood and other medical supplies, operating tables, and hot-cold therapies. PCMs 
are also used in many less common ways, such as the thermal storage of solar energy 
and in spacecraft thermal systems (Kenisarin & Mahkamov, 2007).  
Many PCMs are naturally occurring, and thus readily available at a low 
economic cost (Kenisarin & Mahkamov, 2007). This also means that a lot of PCMs 
are environmentally friendly and are safe to use (Pasupathy et al., 2008). 
There are a few different categories of PCM. Organic PCMs include paraffin 
and fatty acids. They are available in a large temperature range, melt congruently, are 
chemically stable, have a high heat of fusion, are safe, and are recyclable. However, 
they also have low thermal conductivity in their solid state and are flammable 
(Pasupathy et al., 2008). Inorganic PCMs are usually salt hydrates, and they are easily 
available at a low cost, with sharp melting points, high conductivity, high heat of 
fusion, and inflammability. Some disadvantages of inorganic PCMs are that their 
change in volume is high and that they need nucleating agents, especially after 
repeated use (Pasupathy et al., 2008). 
A third kind of PCM called eutectics is a mixture of organic and inorganic 
PCMs. They have a sharp melting point and a slightly higher storage than organic. 
Eutectics are relatively new to the field, and thus little information is known on their 
performance and characteristics (Pasupathy et al., 2008). 
For all the reasons listed above, we decided to use this technology in 





As can be seen throughout the exhaustive literature review, many gaps and 
weaknesses are present at every stage of the cold chain such as improperly trained 
health workers, frequent electricity outages, and mismanaged equipment.  Studies 
from across the field also bring to light region- and disease-specific issues, such as 
non-existent transportation infrastructure in the Peruvian Amazon. Despite these 
pitfalls, the cold chain is strengthening due to an increased focus on immunization 
programs and due to the diligence of public-private partnerships across the world.  
Should the momentum from these partnerships and programs continue, immunization 
rates will continue to increase.  
The goal of this literature review was to provide our team with a foundation of 
cold chain knowledge and a focus to our multi-year research problem.  As such, while 
problems manifest the cold chain, every issue could not be addressed by our team.  
As we tried to formulate responses to weaknesses in the cold chain, the issues that 
stood out to us the most were the prevalence of vaccine-freezing, mismanagement of 
current complicated equipment, and the promise of simpler technologies like PCM. 
 As can be seen through our research objectives and methods, we used the 




Chapter 3: Methodology 
Characterization of Phase Change Materials 
PCMs are highly relevant solutions to vaccine storage problems with an 
ability to act as thermal buffers and stabilizers. Therefore, one of the goals of our 
methodology was to select, characterize, and implement the most applicable and high 
performing PCM into our prototype design. The first step in preliminary 
characterization was to select candidate PCMs for by examining the exact melting 
point and heats of fusion and costs associated with each. PCMs listed in the literature 
with relevant melting points are included in Table 4, along with pricing information, 





Table 4: PCM names and characteristics 
PC M Name 
T emp 
(°C) 




(kg/m3) Type Price 
Water 0 333 
1000 (l), 
917 (s) N/A N/A 
Climsel C7 7 130 N/A Eutectic N/A 
RT5 b9 205 N/A Paraffin $25/L 
RT6 6 175 N/A Paraffin $25/L 
Propyl Palmitate 11 186 N/A 
Fatty 
Acid $10/L 
Paraffin C14 4.5 165 N/A Paraffin $25/L 
Paraffin C15-16 8 153 N/A Paraffin $30/L 
Lithium Chlorate 




Clathrate (Tombari et. 
al. 2006) 5 280 970 Clathrate $110/L 
Polyethylene Glycol 
MW400 8 100 N/A Glycol $130/L 
 5 unknown N/A organic  
AcuTemp unknown unknown N/A organic  
PureTemp4 unknown unknown N/A organic  
 
          The variance between candidate PCMs suggested that an optimal PCM could 
be found based on a specific selection criteria. Of the above PCMs, the following 
were deemed unattainable due to manufacturing issues: Climsel 7, Lithium Chlorate 
Trihydrate and both RT5 and RT6 substances. These PCMs were not tested and 
excluded from selection. The PCMs with very high prices, such as Polyethylene 




strong, their economic viability was too low to consider for measurement.  Beyond 
PCMs reported in the literature, we also evaluated several commercially available 
PCMs. For most of these materials, the heat of fusion was inaccessible in the 
scientific or company literature. One of these PCMs was (TCP Reliable, 
to test it for melting temperature and heat of fusion. We also characterized PureTemp 
4 (Entropy Solutions, Minneapolis, MN), which is a biologically produced paraffin 
and was therefore more economical than the paraffins in Table 4 (Rodie, 2009) and 
AcuTemp, another commercial PCM with minimal existing literature. 
 Characterization was performed using a Differential Scanning Calorimeter 
(DSC), and analysis was performed with the program Universal Analysis V4.7A by 
TA instruments for use in conjunction with a DSC. The goals of characterization and 
analysis were to determine the heat of fusion and melting temperature of each PCM. 
The heat of fusion is the energy storage capacity of the crystallized solid structure 
while the melting temperature can be considered the peak of energy storage. The DSC 
utilized was a TA instruments q100 V9.9 build 303 system certified from -80 ºC to 
300 ºC (Figure 5).  
Characterization involved isolating small samples of a well shaken mixture of 
PCM provided by the company and placing it in a small vial. Hermetically sealed 
alodized aluminum pans served as the nonreactive containment vessel during 
measurement. The mass of each pan was measured on a balance accurate to a tenth of 




seal, each sample was massed again and then stored in a highly ventilated fume hood 
for half an hour. Each sample was massed once again and the process was repeated if 
the sample mass changed by more than 3-4 µg. Once the sample was prepared, the 
instrument was turned on and allowed to reach the operating flange temperature of -
80ºC. The sample was placed on one of the heating sources as seen below. On the 
other source a comparison pan (an empty pan) was placed. 
 
Figure 5: Image of sample containment in q100 series DSC 
The instrument was instructed to seal the sampling stage and begin the 
inputted experimental procedure. The procedure consisted of three steps: step one was 
to cool to -10 ºC, isothermal for two minutes to ensure the sample is frozen, followed 
by heating it at a specified ramp rate to room temperature. Different ramp rates will 
be utilized. Although more accurate measurements could have been garnered from 
slower ramp rates, system constraints limited the usable rates, thus a series of rate 
were used. Water served as a standard for these rates to determine if measures were 
accurate when compared to the literature value for the heat of fusion. As the system 
heated up, given the relative stability of the heat capacities of solid and liquids, it was 




curve was theoretically assumed to be linear until the melting point was reached. At 
the melting point, the deviation of the system from the extrapolated line represented 
energy input used to melt the sample at a constant temperature. The energy absorbed 
by the system was geared towards melting from solid to liquid, as opposed to raising 
the temperature of the sample. The program TA universal analysis was able to 
integrate the area where the limits of the deviation of the curve were inputted. The 
result was a series of measurements of the freezing point and heat of fusion for each 
sample. 
CAD and F E A Theoretical Modeling 
           The goal of the modeling team was to simulate the heat transfer phenomenon 
in passively refrigerated containers in order to gain a sense of how to design an 
optimally shaped cold box. The starting point for any analysis of heat transfer is the 




The first term of this equation is the partial derivative with respect to time. The 
second term represents convective heat transfer, with u representing a velocity vector 
which is multiplied by the temperature gradient ( ). ,  are the density, 
mass heat capacity and thermal conductivity of the fluid under consideration 
respectively. The first term on the right side of the equals sign is the conductivity 
. The final term is a volumetric heat source 




generation term which can represent electrical heating or heat generated from 
radioactive decay.  
 For our analysis of phase change, we ignore the convection and generation 
terms. (Though the temperature inside the box will probably exhibit natural 
convection, this requires coupling the heat equation with partial differential equations 
for fluid flow.)  
 A computer model was generated to serve as a theoretical control for our 
experiments using Finite Element Analysis (FEA) software. In this type of program, a 
geometric model may be created with defined material properties and then stressed 
with physical conditions, like forced loads or thermal conditions. This is done by 
meshing the modeled geometry, i.e., dividing the model into a grid of polygons, 
where the points of intersection between the polygons are called nodes. The size of 
the mesh regulates the node density (coarse to fine). The program solves a series of 
partial differential equations, dependent on what loading conditions were applied, at 
each node in the defined mesh. The solution is generated through iterations over a 
user-specified time increment and duration.  
   




 Using an FEA program, simulation of any physical experiments was possible 
by adding thermodynamic conditions as the model physics. After running the 
simulation, the program may output a variety of useful information, including a time-
temperature graph. This data was compared with those taken from the thermocouples 
in the icebox experiments to determine errors and accuracy in our findings. 
 At first, we were able to generate a preliminary thermal model without phase 
change to demonstrate the use of the FEA software COMSOL Multiphysics. We 
simulated a three-dimensional cubic cold box, encompassing an outside layer of 
insulation, a plastic-bounded layer of PCM, and an air-filled vaccine storage 
compartment at the core. The dimensions were arbitrarily chosen. A thermodynamic 
condition was placed on the boundary of the box to keep it at a constant ambient 
temperature. Thus, the insulation and vaccine storage compartment are initially at the 




           
 
Figure 7: COMSOL model demonstrating the initial heat transfer at the onset of the 
melting. Output of temperature within horizontal and vertical sectional cut of model, 
showing the melted phase change material rising in temperature. The images are 
taken at times: a) 0, b) 5 hours, c) 10 hours, d) 1 day, and e) 2 days. The temperature 
scale is given in Kelvin, with blue signifying the freezing point and the red signifying 
the ambient temperature. Figure 7f displays the Time-Temperature graph at a point 








The model was run in two stages: the first, demonstrating the initial heat transfer at 
the onset of the melting period (Figure 7), and the second, demonstrating the box 
heating up after the melting phase (Figure 8). In this simulation, ice/water was used 
for the PCM, and the ambient temperature was set at 30 °C.  
 
Figure 8: COMSOL model of the box heating up after the melting phase. 
Output of temperature within horizontal and vertical sectional cut of model, showing 
the melted phase change material rising in temperature. The images are taken at 
times: a) 0, b) 5 hours, c) 10 hours, d) 1 day, and e) 2 days. The temperature scale is 
given in Kelvin, with blue signifying the freezing point and the red signifying the 
ambient temperature. Figure 8f displays the Time-Temperature graph at a point 








           One difficulty we experienced was that the COMSOL software (and other 
Finite Element Analysis programs) does not have an inherent function to address the 
discontinuous but natural behavior of the melting and freezing of substances. To 
accommodate this, we implemented the effective heat capacity method as suggested 
by the COMSOL documentation (Phase Change: Solved with COMSOL 
Multiphysics 3.5a, 2008). The program ran but gave inaccurate results. A simple 
implementation of the level set method also ran in 2-D axisymmetric coordinates, but 
was not easily adaptable to a 2-D rectangular PCM- panel geometry (Zimmerman, 
2006). We also tried to implement the effective heat-capacity method in another FEM 
software suite, Elmer, as well as the enthalpy method using data from the DSC 
curves. 
           We finally settled upon a method of approximation for the phase change 
simulation. Although the real process occurs over a constant temperature, it may be 
approximated to occur over a very small temperature range (~0.5 °C) about the 
material's melting point. The energy required to change phase may then be 
approximated using the specific heat capacity over this small temperature range. The 
relation is outlined in Equations 1-3. 
For a known mass (m) and material with latent heat of fusion, L, and specific heat 










material is given 
by: 
  (3) 
G 0), an setting the energies in equations (2) and (3) equal 
to each other yields the relation:  
  (4) 
This concept of approximated phase change is graphically illustrated in Figure 9 
below. 
 
Figure 9: Graphical illustration of the approximated phase change material behavior, 
in taking the melting regime to occur over a very small change in temperature (slope 
is exaggerated for visual aid). In the true behavior, this occurs at a constant 
temperature for the duration of melting. 
 Using this relationship, we defined the specific heat coefficient of the phase 
change material for the melting transition (Tmelting 
properties were defined: one for temperatures below the material's melting point, and 
one above. The model would then give an estimated simulation of the phase change 
process.  
 We began to implement this method in COMSOL Multiphysics with limited 
success. Many of the models resulted in failed computing executions or in 







receiving formal course instruction in FEA software, we began to use the program 
ANSYS 13.0 to run our simulations because of its wide application and advanced 
capabilities. 
 To verify an accurate execution of the phase change simulation, we began 
with a simple model of a melting cube of ice (side dimensions of 10 cm). The block 
started at a temperature of -5 °C and was subjected to a constant boundary 
temperature of 40 °C to imitate an ambient environment. Conventional material 
values for water and ice were used, and the melting temperature range was set 
between -0.50 and 0.50 °C. For this range, the specific heat capacity was given to be 
334000 J/K (=334 kJ / 1K). A transient analysis yielded the following results in 
Figure 10 below. 
 





Figure 11: Time history plot of a nodal temperature within a melting ice cube. The 
time is given in seconds and the temperature in °C. 
 As demonstrated in the time-temperature graph in Figure 11, the model does 
exhibits phase change behavior. The temperature rises from its initial temperature for 
about 125 seconds until it reaches the minimum end of the melting regime (-0.5 °C). 
The temperature rises minimally for the melting regime, where a change in the slope 
is observed around 0 °C, when the material properties change from water to ice. The 
temperature then rises as normal for the fully melted volume, when the water absorbs 
heat through its natural specific heat capacity.  
 Given this proof of modeling concept, we then wanted to use this method to 
simulate the ice box experiments and other models to verify our experimental 
findings and to determine the optimal configuration of PCM geometry. This was also 
done in the ANSYS finite element analysis software. 
 To begin this, we created a base file to store the fundamental model settings 
for uniformity through all variations of the model. The model preference was set to 




Celsius temperature units. The element used was SOLID70, an 8-node element with 
temperature degree of freedom, given application in 3-D steady state or transient 
thermal conduction analyses.  
 Next the material properties were to be defined. The manufacturer 
specifications for the polystyrene insulation from the icebox experiments were 
translated into SI values, while a conventional value for the specific heat capacity of 
polystyrene was not manufacturer-defined and thus chosen from outside literature. 
 Given the weight and volume of the insulation product, the density was found 
by: 
 
    
 
The insulating property was given at R5. This is related to the thermal conductivity 
property, k, by its thickness, L. The units were further converted to the SI system. 
 
 The materials for the PCM (ice) were defined using a piecewise functionality, 
where different values could be assigned to different temperatures. Specifically, two 
different densities and thermal conductivities were defined for ice (when the 
substance was at 0 C or below), and one for water (when the substance was above 0 
C). The specific heat capacity was further defined in three segments - one for ice 
(less than -0.25 C), one for the melting regime (between -2.5 and 2.5 C), and one 




through a 0.5 C temperature change about the melting temperature of 0 C. It was 
reasoned that this temperature change was small enough to ensure relative model 
accuracy but large enough for the program to solve the system of equations 
throughout the model without error or storing huge amounts of data. 
 It is worth noting why air was selected to fill the vaccine storage compartment 
at the center, instead of a denser substance like water that is comparable to actual 
vaccine vials or fluids. First, using an air-filled ice box was also done in our 
experiments, and we wanted to match the data between the physical experiment and 
the theoretical model. Second, the solving time would be significantly decreased, and 
the output data would be minimized, if the inside was filled with a negligible 
substance. We could thus use a coarser mesh on the air volume to reduce node 
density. Finally, we reasoned that using air would be the worst-case scenario for 
temperature distribution, in that in this case, any thermal load placed on the box 
would quickly affect the vaccine volume and cause a significant temperature gradient. 
If filled with a more dense material, the vaccine compartment would better resist a 
change in temperature at the onset, but would likely still eventually develop the 
temperature gradient observed in the air-filled case.  
 Although in reality air would be subject to some convective conditions within 
the box, it was instead treated as a conducting material for simplicity of the model. 
This would also coincide with the conditions for when the vaccine compartment was 
fully loaded, where the vials and liquids within would disrupt any form of circulation 





Table 5: Default Material Properties for FEA ice box model 
Ice/Water Temperature ( C) 
 
 -100 0 0.001 100 
  Density (kg/m3) 916.2 916.2 1000 1000 
  Thermal Conductivity (W/m-K) 2.22 2.22 0.58 0.58 
 -100 -0.251 -0.25 0.25 0.251 100 
  Specific Heat Capacity (J/ C) 2050 2050 6.68E5 6.68E5 4210 4210 
 Polystyrene A ir 
  Density (kg/m3)  37.24   1.293  
  Thermal Conductivity (W/m-K)  0.0288   0.0243  
  Specific Heat Capacity (J/ C)  1300   1005  
 
 Assigning these values to set material profiles completed the base settings file. 
A log file was then created so that input from these base settings could be read 
directly into any new model file, saving the effort required to set up each different 
model geometry. The code for this log file may be found at the end of this volume in 
Appendix A. 
 Two sets of models were then created. One set mimicked one size box of the 
physical experiments with outside dimensions of 9.5 in. The other set followed the 
larger sized box with 13-in dimensions. Each ice box experiment (ice geometry on all 
sides, with a horizontal shelf, and with a vertical shelf) for both sized boxes was to be 
executed as an FEA model. Furthermore, other geometries not physically tested were 
also investigated with the FEA models, as it was easier, faster, and more efficient to 
create a computer model, in comparison to setting up, running, and analyzing 




 The geometry for each model variation was drawn out on paper and inputted 
into the software. Separate volumes were created for each differing material in the 
icebox - the insulation layer, ice, and air at the vaccine storage compartment. Simple 
rectangular geometry was used to construct the model, where subtracting volumes 
was utilized to create each layer or unique geometry. To complete the model, all 
volumes were glued together to ensure that the areas between volumes were joined as 
one. Failing to do so resulted in no interaction between the volumes when solved, as 
each was considered its own entity without cross-interaction. 
 Each volume was then meshed using the smart size option with tetrahedral 
polygons. The appropriate material was assigned to each volume, and the mesh size 
for each volume was varied between 3 and 8 (on a scale of 1-12 [Fine to Coarse]), 
depending on the size constraints and maximum number of elements allowed in the 
model. In most instances, size 3 was considered the default value, having enough 
nodes to satisfy requirements and to be relatively fine without extending solving time. 
In some instances, volumes had to be assigned coarser meshes to cut down on the 
number of elements. 
 Following the mesh, thermal loading conditions were then applied to the 
model. First, a new transient analysis was created, where these loading conditions 
would apply. Second, the initial temperature conditions for all of the nodes were 
assigned. The ice layer temperature was set at an initial -10 C to ensure proper phase 
change behavior prior to reaching the melting regime at -0.25 C. All other nodes, in 
both the insulation and air volumes, were given an initial temperature of 22.5 C. This 




the ice box experiments. Instead of adding active heat loads like conduction or 
convection to the outside areas of the box, a temperature condition of this ambient 
22.5 C was applied on all six outside areas of the box. This was deemed a reasonable 
estimate of the loading condition, in considering that the box would not likely be 
subject to fluctuating conditions. We considered using a convection condition but 
decided that a constant temperature was easier to manage in the model and that it 
would be difficult to find the convection coefficient for the insulation used that would 
fit all scenarios. 
 Solving constraints were then defined. Data was restricted to nodal degree of 
freedom data, i.e., recording the temperature data from the model. A time duration of 
300,000 seconds (about 3.5 days) was sufficient for most models to go through the 
melting phase and reach the equilibrium ambient temperature, though some required 
adjustment for a longer time. The time step size was set to 60 seconds, with a 
minimum of 0.01 seconds and maximum of 300 seconds. Temperature solutions were 
recorded at every three or five sub steps to cut down on the amount of data, and 
automatic time increments was enabled to be chosen by the program. That is, if the 
differential equations could not be solved at a higher time increment, then the 
program would try to solve for smaller time increases, and vice versa if the 
differential equations converged to a solution at larger time increments. Average 
solving time was about two to three hours for each model, depending on the element 
density. Sample code for this simulation log file may be found in Appendix B. 
 After running a few models, we began to compare the data to the ice box 




the thermal couples in the ice box experiments. In an ideal case, the time-temperature 
graphs from the experimental and theoretical would be near identical. In analyzing 
the data, we noticed similar patterns of temperature distribution. Then, to determine 
some quantitative analysis for duration of cold storage, we then considered the 
average time for the temperature probes to go from the melting state (-0.25 C) up to 
the high end of the optimal vaccine temperature zone of 8 C.  
 We noticed that this duration in the ice box experiments was significantly 
longer than the time seen in the model - the heat transfer in the model was greater 
than in real life. We reasoned that this might have been because of the unrealistic 
temperature loading condition subject to the model, where we defined the outside of 
the box as being subject to one constant ambient temperature. In reality, the air 
surrounding the box would be cooler than the ambient temperature if the box itself 
were colder. The box would also be subject instead to convection effects, which 
would lend to a slower rate of heat transfer. Another factor could have been that the 
experimental ice box was resting on some surface, making the bottom additionally 
insulated and not subject to any particular heat load. The grounding surface and the 
box would have come to an equilibrium temperature lower than the ambient 
temperature, thus having a lower heat flux. There would also be no heat loss to 
convection conditions along the bottom, unexposed surface. 
 In order to counter this disconnect between the model and the ice box 
experimental findings, we considered adjusting the thermal conductivity of the 
insulation layer to better match the model data to the experimental data. The thermal 




more specifically, a higher insulation thermal conductivity increases the rate at which 
heat can enter the system, where the ice is to be melted. By lowering the thermal 
conductivity of the insulation from its manufacturer-claimed value, we could decrease 
the heat flux into the box, and increase the time of the melting period. Thus we could 
create a more accurate model to the physical experiments, while using the same 
loading conditions and other material properties already defined. 
 To go about this, we analyzed the data from two distinctly different models. 
The first was the 9.5-in sided model with ice surrounding all sides of the box interior 
and a horizontal shelf. We then chose the 13-in sided model with ice surrounding all 
sides of the box interior (no shelf) as a comparative set of data. The objective was to 
find a value of insulation conductivity to match both sets of data to their respective 
counterpart data set from the physical experiments. 
 Initial conductivity variations for each model were calculated through a 
simple ratio of the measured time over the model time. The conductivity was further 
adjusted to attempt to pinpoint a matching conductivity. After three different 
variations, a mutual conductivity value of 0.0227 W/m-K was determined to be an 
accurate adjustment. This matched the 9.5-in side horizontal shelf model to 99.14% 
of the measured physical value, while the 13-in side all sides model was 100.25% of 
the measured physical value. Given this highly accurate correlation, we determined 
that this was a valid means to adjust the model. Graphical findings may be found in 





Table 6: Summary of results in finding the insulation thermal conductivity (W/m-K) 
for the FEA model. 
 9.5-in horizontal  13-in all sides 
measure 1647  3473.1 
original model 1270  2624.8 
% difference 77.1   132.3 
k=0.0210 1856.0 k=0.0207 3816.3 
% difference 88.7   91.0 
k=0.0236 1584.6 k=0.0215 3673 
% difference 103.9   94.6 
k=0.0227 1632.9 k=0.0227 3481.778571 
% difference 99.1   100.2 
  
Given this verification of method and matched correlation between physical 
and theoretical data, the models were then completed using the newly found value of 
thermal conductivity. Models were created for both sets of box sizes, including an all 
sides model, a horizontal shelf model, a vertical shelf model, a top and bottom slabs 
model, a bottom slab only model, and an all sides model without a bottom slab (not 
solved for the 13-in model). In total, this became eleven different FEA models to 
compare and analyze. 
Ice Box Experiments 
In accordance with our experimental plan  
how the PCM acts inside of a vaccine box over time. This ice box is a simplified 
model, constructed out of 6 sides of polystyrene, and replacing PCM with ice packs. 
Using an 8-lead thermocouple data logger, we obtained experimental results detailing 
how the internal temperature gradient shifts over time. This experimental model 
should be matched to a theoretical computer simulation of the same materials and 




results, we will be able to run an optimization algorithm to determine the geometry 
that best matches our priorities.  
In a typical cold box, there are many possible ways to distribute the same 
volume of ice. While panels on one or two sides are the simplest designs, it is likely 
that the efficacy of our box can be improved with minimal increases in complexity of 
panel placement. For our design, we must consider the effects of gravity, direction of 
heat source, the distance of the vaccines from the PCM panels, and the total volume 
of PCM in each panel. As ice floats, a melting ice panel will form an internal gradient 
with the coldest portion being the highest point. Additionally, heat rises inside of a 
cold box, so a good design should take advantage of these nuances created by 
gravitation. As the ice box travels, the sun typically will affect the top side the most 
and the bottom side the least. As the distance from the vaccines to the ice pack 
increases, there is a higher likelihood that the effective phase change temperature may 
be above 8 C, especially for larger boxes. To this end, we will investigate if 
rearranging some of the PCM to the center of the box can counteract this effect. 
Finally, as rearranging the PCM distribution changes the thickness of the panels, we 
must investigate how much PCM is necessary to ensure the longest effective phase 
change time.  
We predict that for same total volume of PCM, the smaller size box will be 
able to hold the temperature for longer, but have less storage volume than the larger 
box. The 6 -sided box will have the longer average time, but the center temperatures 
will pass 8 C much sooner than the edges. For the geometries with shelves, the total 




panel to melt. Consequently, the temperatures should be more evenly balanced 
throughout the total time span.  
To design the experimental setup, we wanted to create a simplified model of 
the PCM-cold box interaction. To this end, we created polystyrene boxes of varying 
sizes. We used ice as a PCM due to its ubiquity and safety in case of spills and 
leakages during testing. We also created different configurations of PCM placement 
to explore possible geometries. Using an 8-lead thermocouple, we can measure 
various important points inside and outside of the box to monitor the temperature 
changes over time. The data collection mechanism in the laboratory was a 
thermocouple operating with the DT300 collection software, accurate to 0.1 °C 
(Apollo IV DT300 Multi-component Thermocouple, 2010). The locations of 
important leads include a lead outside of the box to monitor the ambient air 
temperature of the room, a lead in the center of box, a lead in the center of bottom 
panel, a lead in the center of the top panel, a lead in the center of top corner quadrant, 
a lead in the very top corner, a lead between the panel and the polystyrene, and a lead 
halfway between center of box and center of side panel. The placement was created to 
measure gradient lines extending from the center of the box to the center of the side, 
the center of the box to the corner, and the bottom of the box to the top of the box. 
We planned a total of 6 full box experiments and 1 gradient measurement experiment. 
Our six tests consisted of three geometries and two box sizes. We used an 8 in.3 box 
and a 13 in.3 box, with a 6 panel setup, a 6 panel and horizontal shelf setup, and a 6 




To conduct the gradient measurement, we kept one panel on the bottom of the 
box, and equally spaced leads vertically through the box to measure the formation of 
a temperature gradient over time. This allows us to understand how close to the 
panels the vaccines can stay, as well if we can create a geometry that extends the 
lifetime of the most distant point from all sides (center).  
All experiments were conducted in a temperature-stabilized room held at 24 
ºC. For ease of matching theoretical results, there was no external heat source and no 
extra layers of insulation or support besides the polystyrene box. All thermocouple 
leads were arranged as identically as possible between trials, with obvious 
accommodations for trials with shelves. In order to create our ice packs, we created 6 
packets with identical volumes of water and froze them flat. These were placed inside 
metal holders to maintain the shape of the pack once melting started. For geometries 
with a shelf, 7 packets were created with the same volume of water, with the total 
sum of individual volumes equaling the total of the six packets from the previous 
arrangement. The thermocouple leads were held in place with masking tape, and the 
lid was closed as tightly as possible. Since the presence of the thermocouple wires 
offset the lid slightly, additional weight was added on top of the box to ensure a tight 
seal with minimal air leakage.  
The ice packs were taken from a freezer at -10 ºC and, correspondingly, this 
was the starting point of the temperature graph. After the ice box stabilized at ~0 ºC, 
the phase change period began, and was considered reasonable for transport until the 
average temperature reached 8 ºC. The box was allowed to stabilize with the ambient 




The data strongly supports the concept that the latent heat of the PCM is the 
key factor in the longevity of cool temperatures within the cold box. The curves also 
indicate that a temperature gradient exists within the system. The internal temperature 
of the box settles at 0 °C for a very short duration before gradually increasing towards 
room temperature. In contrast, the temperature at the periphery of the box is stable for 
a longer time before approaching ambient temperature following the phase change. 
From a methodological standpoint, the consistency in the length of time each 
experiment took to reach two important points across all experiments (the equilibrium 
temperature and the point at which the ice is melted) all lend support for the 
repeatability of the experiment. 
Prototyping and F abrication 
Prototype 1.0 
In order to test our concept, the team designed a prototype using durable, 
inexpensive materials. The materials used for the prototype were decided upon based 
on their ability to insulate the cold box as best as possible. Five materials are 
necessary for our design. The outer shell will be constructed out of corrugated plastic. 
Corrugated plastic is a heavy-duty material that will provide stability and endurance 
to the prototype. These properties are necessary for the outer shell of the box. 
Corrugated plastic, although heavy-duty and stable, is actually quite light and 
relatively cheap. This helps the appeal to the ease of use and handling of the box, as 




The next layer inside the outer shell is a one inch layer of foam insulation. 
There were two types of foam insulation used for this layer. Extruded polystyrene is 
the foam insulation that is used to cover all four walls and the top lid. It has a lower 
R-value than Polyisocyanurate, which is the foam insulation used for the base of the 
box. It was believed that the bottom of the box would be exposed to warmer 
temperatures than the rest of the walls, and thus demanded stronger foam insulation. 
As stated earlier, Polyisocyanurate was used as the insulation for the bottom panel. 
The bottom panel also doubles as a mount, to which the side panels and other features 
of the prototype are fixed. Polyisocyanurate provides the necessary insulation and 
thickness to serve this dual function. 
Inside of the foam insulation is an inner box made of polycarbonate. We used 
a brand called Lexan, which is shatter resistant. The payload of vaccines rests within 
this box, allowing the polycarbonate to act as a thin buffer between the PCM slabs 
and the vaccines. The layer of polycarbonate is placed along four walls and the top lid 
of the box. A small gap was left between the polycarbonate and foam insulation in 
order for the PCM slabs to be strategically placed. The PCM slabs are the third layer 
of the cold box. There are five panels of PCM. A panel of PCM is used to cover each 
of the four walls as well as the lid of the box. These slabs are removable, and contain 
2 sections: an outer panel of water, and an inner panel of our chosen PCM. This 
allows the cheaper, colder water to be used as a cold source, while our 5 °C PCM is 
used as a buffer to ensure the vaccines themselves never reach freezing temperatures. 
As described earlier in the methodology section, the cold box functions through the 




capability, the lid of the box is opened and the panels are removed and refrozen. The 
inner separate compartments for PCM and the payload allow the payload to remain in 
the box while the PCM slabs are recharged. 
The structural integrity and thermal capacity of the box will be insured 
through the use of thermal adhesive. Joints between the polystyrene panels are sealed 
with a specialized adhesive that prevents heat from entering as well as provide 
structural strength. The inner polycarbonate and insulation panels will be glued in 
place, and then surrounded on all sides by the corrugated plastic. Figure 12 below is a 
CAD drawing of the prototype box, while Figure 13 demonstrates the three major 
structural components of the box: a) Inner Lexan layer b) middle polystyrene layer 
and c) outer corrugated plastic layer. 
  
Figure 12: CAD drawing of Prototype 1.0 
 




was inexpensive, yet durable. The separated design will allow for easy operating 
procedures, and will prevent significant damage to the actual vaccines. Our PCM 
slabs will have a simple color change temperature sensor attached, which allows the 
user to check if the slabs are completely melted. If the PCM slabs are completely 
melted, the temperature will start to rise, the color will change, and the sensor will 
read 6 °C or higher (Figure 14). This notifies the user that 
the slab must be recharged in the freezer. While the PCM 
only requires around 6 hours to fully freeze, there is no 
harm if the panel is left in longer. If the PCM is removed 
after 24 hours, it will likely be the temperature of the 
freezer, which is usually around -10 °C. This is shown on 
the sensor, which will read temperatures below 5 °C. 
Since our material has a high heat of fusion, but not high 
heat capacity, leaving the PCM slabs in room 
temperature for 10 minutes will raise the temperature of 
the solid PCM to 5 °C, which is the phase change point. 
Using the sensors, the user will be able to insert the PCM 
Figure 14: Color change 
temperature sensor 





slabs are the correct temperature. Ideally, this could be 2 °C. This design will prevent 
any exposure to freezing temperatures as well provide simple operating instructions 
for the users. 
Every layer used to construct the prototype was focused around the goal of 
maintaining a constant, cool temperature for the vaccines contained within the box. 
Each material used acts as some form of insulation that will reduce the rise of the 
internal temperature of the box, allowing for maximum use of the PCM panels before 
they have to be removed and refrozen. The exterior shell of corrugated plastic 
provides the cheap, durable material necessary for the prototype, while the remaining 
materials provide significant insulation for an inexpensive price. With regards to a 
user-friendly device, the easy removal of PCM panels and the sensors add value to 
 
Prototype 1.0 construction parameters were chosen relatively blindly. That is, 
the dimensions of the box, thickness of insulation and other design parameters were 
chose intelligently, yet ultimately arbitrarily. The methodology consisted of matching 
CAD and FEA results with observable results from something more complex than a 
simple ice box and closer to a working prototype. The compiled results of the many 
ice box experiments, CAD and FEA modeling, and prototype testing were then used 
to influence and define the design parameters of Prototype 2.0, detailed later within 





Construction of Prototype 1.0 
Before construction of the original prototype began, the following materials 
were purchased online and from the Home Depot: 
Table 7: Bill of Materials for Prototype 1.0 
Part Descr iption    Cost Qty Total 
     $9.90 2 $19.80 
    $29.60 1 $29.60 
 Corrugated Plastic (size??)   $36.90 1 $36.90 
 Lexan (Polycarbonate -   $19.98 2 $19.98 
 - Lexan is shatter resistant Brand of Polycarbonate. We cut the sheets with a jigsaw, hence shatter 
resistance was necessary. Also, it adds resiliency to the box. 
 Construction Strength Liquid Nails   $4.97 1 $4.97 
 Caulk Gun     $13.97 1 $13.97 
 
      $115.32  $145.20 
 
The construction proceeded as follows (Images of the team constructing prototype 1.0 
can be seen in Appendix C at the end of this volume):  
1. A corded jig-saw (Black and Decker 4.5 amp, variable speed) was used to cut the 
Lexan into the panels that would comprise the inner payload chamber. Panels 
as cut at the lower left of each 
panel. Four panels were cut as such and then fitted together by placing one 




3. The Lexan cube was then centered on the Polyisocyanurate square, and pressure 




Polyisocyanurate on each side of the cube. This formed the main frame of the 
prototype. 
4. 
sheets. The sheets, each an inch in width, were then glued vertically along the one 
(1) inch border on the base Polyisocyanurate, to create walls. 
5. At this point, all inner and outer joints of the box were sealed with a bead of glue 
smoothed by a finger. This created a thermal seal in each joint gap and also added 
structural integrity to the box. 
6. The lid was created from a second similarly dimensioned piece of 
The chamber was closed on five sides; one side was left open to be able to slot 
PCM slabs in and out. When inverted, this lid fit snugly into the top of the box 
created in steps 1-4. 
7. Lastly, the corrugated plastic was cut and folded to encompass the box. The 
plastic was glued onto the box, and held in place through a combination of 
butterfly clips, and mechanical clamps until dry. The finished box (lid in bottom 
left) can be seen below in Figure 15.  




Chapter 4: Results 
Characterization of Phase Change Materials 
The analysis was performed with high initial ramp rates on water. The high 
ramp rates led to large initial values of error for the measured melting temperature. 
To investigate the discrepancy between the literature value of 0 ºC and the measured 
values, slower ramp rates were used. A similar analysis technique was used to 
elucidate the melting temperature of , cited as 5 ºC. Data describing our 
characterization of and deionized water is displayed below in Figure 16. 
The results indicated that the melting temperature accuracy was significantly affected 
by the rate at which the material was heated (ramp rate). The temperature readouts for 
the melting point were plotted against the ramp rate to predict the melting 
temperature; it appears that the regression lines fit this data (R2 values of 0.79 and 
0.77 for and water, respectively), and the y-intercepts of regression lines 
accurately predict the theoretical melting temperature, based on comparison with 





Figure 16: Characterization of water and . Melting temperatures vs. heating 
rate for water (blue diamonds) and (red squares). Lower heating rates 
resulted in more accurate melting temperatures compared to literature values of 0 ºC 
and 5 ºC for water and Phas , respectively. 
 
The insights into the higher accuracy at lower ramp rates guided our proposed 
characterization of new materials. Other materials that were characterized include: 
Pure temp, AcuTemp and Tetrahydrofuran clathrate of various concentrations. 
Tetrahydrofuran clathrate showed promise in the literature as it is mixed into 1:17 
molar ratio with water (Tombari, 2006). However, when prepared as prescribed in the 
literature, and additional solutions of 1:17.5 and 1:16.5, the resulting solution 
exhibited none of the predicted phase change properties observed in the literature 
values as evident by Figure 17 through Figure 19. The peak energy inputs were at 
temperatures close to zero instead of the cited 2-8 ºC; thus, it was disregarded as a 
candidate.  
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Figure 17: Tetrahydrofuran clathrate 17:1 ramp rate versus temperature 
 







































Figure 19: Tetrahydrofuran clathrate 16.5:1 ramp rate versus temperature 
Heats of fusion were calculated to be 333 J/g for water and 178 J/g for Phase 5 
, not taking into account the incomplete 20 ºC/min runs. The experimental 
procedure was applied to Pure temp and AcuTemp to calculate the heats of fusion as 
well. PureTemp was measured to be 154 J/g with a melting temperature of 2.1 ºC. 
AcuTemp however was discovered to be a pulp substance soaked in a fluid. When the 
fluid was tested for thermal properties the resulting curve was detected, Figure 20. 
The data indicates a strange melting profile in which there is one large peak at 7 ºC 






















Figure 20: AcuTemp ramp rate versus temperature 
The calculated latent heat for the entire melting curve was 124 J/g. Melting 
temperatures and heats of fusion calculated from these experiments were then input 
into theoretical models described below. This indicates that water as expected has the 
highest latent heat, followed by  then PureTemp and finally AcuTemp. The 
results show that  is the most desirable PCM because it has a high enough 
melting point 5 ºC and the highest heat of fusion of the PCMs tested as seen in Table 
8. 
Table 8: Table of measured PCMs 
PCM measured Latent heat (J/g) Melting Temperature (ºC) 
Tetrahydrofuran clathrate No Result No Result 
Water 333 0 
 178 5 
PureTemp 154 2.1 























Ice Box Experiments 
The first six sets of measurements for the ice box system are displayed in the 
following series of figures ( 
 Figure 21 through Figure 26). The data represents two cubes sizes with side 
lengths of ith 1.4 kg and 6 kg respectively of ice as the PCM. The 
three experiments performed on each are the ones in which all sides are evenly 
covered in ice or evenly covered in ice with a PCM shelf that is either horizontal or 
vertical. The following diagrams illustrate the probe and PCM configurations. The 
 shown in Table 9: 
Table 9: Probe and PCM configurations for ice box experiments 
 
 
Data Set Label Location in Ice Box Model 
Channel 1 Center of bottom of storage, above the ice layer (next to shelf if present) 
Channel 2 Center of top, between the insulation and ice layers 
Channel 3 Top corner of storage 
Channel 4 Center of storage space (air), (on top of ice she lf if present) 
Channel 5 Center of upper quadrant of storage 
Channel 6 Midpoint of side along bottom of storage, above the ice layer 
Channel 7 Center of side panel, between the insulation and ice layers 
Channel 8 External Probe 
Data Set Label Location in Ice Box Model 
Channel 1 Center of bottom of storage, above the ice layer (next to shelf if present) 
Channel 2 Center of top, between the insulation and ice layers 
Channel 3 Top corner of storage 
Channel 4 Center of storage space (air), (on top of ice she lf if present) 
Channel 5 Center of upper quadrant of storage 
Channel 6 Midpoint of side along bottom of storage, above the ice layer 
Channel 7 Center of side panel, between the insulation and ice layers 





Figure 21: Ice Box Experiments  All sides with even layer of ice
 
Figure 22: Ice Box Experiments - All sides with even layer of ice and vertical shelf  

















9.5 inch All Sides Exp





















Figure 23: Ice Box Experiments - All sides with even layer of ice and horizontal shelf  
 
Figure 24: Ice Box Experiments - All sides with even layer of ice 

















9.5 inch Horizontal Exp





















Figure 25: Ice Box Experiments - All sides with even layer of ice and vertical shelf 
 
Figure 26: Ice Box Experiments - All sides with even layer of ice and vertical shelf 

















13 inch Vertical Exp





















Although it is difficult to follow the results initially, a few key pieces of 
physical insight can be extracted from the data. Each graph exhibits some of the 
expected behaviors. The room temperature probes (Channel 8) were similar in 
behavior, holding steady at temperatures ranging from 24-27 C. For all of the 
hannels 1-7), the data recording began at a 
temperature below zero. Initial sampling indicates a rapid increase in temperature 
represented by a steep curve on the graph. Each probe then settles at a quasi-steady 
state value for an extended period of time. In some of the experiments, the 
temperature rises more quickly to reach a second quasi-steady state value. Finally, all 
of the internal probes rise in temperature towards the ambient value. The steepness of 
the approach varies, but it is flatter than the slope of the early temperature increase.  
 The first major feature in the graph is the rise to the initial steady state. The 
slope is steep and levels rapidly as evident by the graphs. This validates several 
theories regarding the operation of an icebox system. The steepness indicates that the 
driving force, the higher ambient temperature, is far away. Additionally, this signals 
that the physical properties which make energy storage per degree change of ice is 
low compared to the energy of storage for melting the same mass of ice or heating the 
same mass of ice once in liquid form may play a role in the rapid heating. This is 





Figure 27: Energy Comparison for H2O as PCM 
 It is very clear that the energy adsorption for changing similar temperatures 
quantities varies vastly between a sample of ice and sample of water. It takes 
significantly more energy to heat the water from 0 C to 25 C than ice from -20 C to 
0 C. The chart shows that the temperature flattens out for a significant time period, 
during which we predict that the ice is melting. The energy to melt the ice is much 
greater than the energy to change the temperature of the system. Ice melts at a 
constant temperature of 0 C, which would show up on the data as prolonged flat 
portions at or near 0 C. We believe that the system is of the following pattern; 
initially rapid heat exchange as the inserted ice moves to its melting temperature, a 
melting phase during which the temperature holds near 0 ºC, and finally a heating 
phase as the system climbs towards room temperature.  
With the basic form of the probe measurements understood, an analysis 
between individual and group trends can be performed. The most obvious difference 
is in the 0.241 meter box versus 0.330 meter operating conditions. The smaller size 
PCM  Energy  (H2O)  
Energy  to  heat  liquid  water  from  
0°C  to  25°C  
Energy  to  heat  ice  from  -­‐20°C  to  
0°C  
Energy  to  melt  Ice  at  0°C  to  




lasted a considerably shorter time period where approximately 2000 minutes elapsed 
before the system was above 8 ºC, whereas for the 0.330 meter box, nearly 4000 
minutes on average elapsed before all the probes were above 8 C. Because the 
systems are different sizes and different relative compositions by volume of 
insulation storage space and water, we cannot use relative values to compare the 
results. Qualitative differences are the only data that can be extracted directly. 
However the two box systems behave almost entirely the same with similar trends 
developing in each. This is likely due to the extent of the similarity between the two. 
Within the sets of different geometries, overall certain trends can be observed. 
The external probe, channel 8, measured temperature consistently within a 0.2 C 
range with few major fluctuations; this allows for a simple assumption to be made, 
that the driving force was relatively constant throughout experimentation. The 
remaining probes show typical trends throughout different geometries and box sizes. 
Channel 2, the probe outside of the topmost ice pack, was consistently higher in 
temperature than the other probes, rising more quickly during the phase transition. It 
mirrored the other probes  temperature profiles but was a few degrees higher in 
temperature. This is likely due to its placement outside the ice surrounding the storage 
area. Outside was only shielded by insulation, and thus at the edge of the temperature 
gradient developed between the ice and the air. Channel 7, the probe which was 
placed on a side ice pack, represents a good gauge of how quickly the side ice packs 
have fully melted. It should therefore be noted that the probe typically lasted longer at 
low temperatures than the other probes on all sides of the experiments. In the 




temperature more closely to the other probes located in the storage chamber and 
elsewhere, indicating the center ice pack plays a role in cooling the system after the 
outside ice packs have fully or partially melted. The probes located in the storage 
chamber, channels 6, 5, 1, and 3, all exhibited similar behavior. Their temperatures 
were typically within a few degrees of each other, dictated by the proximity to an ice 
pack, and followed identical trends. It should be noted that the warmest one, channel 
3, is located in the top corner of the vaccine storage chamber. The temperature 
separation from other similar probes was larger in the experiments with a shelf. This 
is most likely generated because it is the furthest probe from the shelf in either 
configuration and is thus the warmest of the probes once the outer shell of ice has 
melted.  
Geometry plays a key role in creating the largest differences from prediction. 
These can be observed when the steady state temperature is above 0 C and the 
smaller shorter quasi-steady states occurring at even higher temperatures. This can be 
seen in the differences between the even covering of ice and the horizontal and 
vertical shelf configurations. The comparison is consistent for both small and large 
box sizes. All sides of the experiment acted as expected. The vertical shelf, however, 
leaves the steady state quickly to reach a second quasi-steady state which can be 
observed as the large shoulder on the graph. After this short halt, the temperature 
begins to rise again. However, the probe corresponding to the side locations away 
from the vertical ice pack begins to rise in temperature faster. Probes 4 and 5 become 
the coolest in the system as they are closest to the center ice pack. For the horizontal 




the probes is less pronounced. The system experiences two quasi-steady states instead 
of the one observed with the vertical configuration. The result of these differences is 
that although the time spent from 0-8 C on average is the same between each 
configuration, the average temperature experienced is much higher for the systems 
with shelves. This is due to the prolonged rise in temperature caused by the shoulders, 
which cut short the main steady state near 0 C. These differences are key features to 
try to capture with the model: the similar time of steady state between configurations, 
the time spent from 0-8 C, and the different rate or times at which various probes 
leave the steady state to rise towards room temperature. 
CAD and F E A Modeling 
3-Dimensial Modeling 
Upon solving each FEA model, time-temperature data was generated using 
time-history post processing. For select nodes that corresponded to thermocouple lead 
locations in the ice box experiments, we could extract the degree of freedom solution 
and the nodal temperature, at each recorded sub step. From this, we could either 
graph the data directly in the FEA software, or export the data into a text file to be 
converted into an Excel spreadsheet and graph.  
In attempting to refine the thermal conductivity (k) value for the models, 
Figure 28 through Figure 31 were generated from the 9.5-in sided box with horizontal 
ice shelf, and Figure 32 through Figure 35 were generated from the 13-in sided box 





Table 10: Data set label denotation for the 9.5-in sided box with horizontal ice shelf 
model.  
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 























9.5 inch Horizontal k=.0210





























9.5 inch Horizontal k=.0288

















9.5 inch Horizontal k=.0227
Figure 29: k-value refinement: 9.5-in sided box, horizontal ice shelf, k = 0.0288 
W/m-K 
 






























9.5 inch Horizontal k=.0236





Table 11: Data set label denotation for the 13-in sided box with ice perimeter model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 






















13 inch All Sides k=.0288




























13 inch All Sides k=.0207

















13 inch All Sides k=.0227
Figure 33: k-value refinement: 13-in sided box, all sides ice, k = 0.0207 W/m-K 
 







As can be seen from each graph set of varying thermal conductivity, the 
temperature distribution through the box remains the same, but the duration of cold 
storage decreased as the k-value increased.  
The following pages detail the results from the various PCM geometries in the 
9.5-in and 13-in sided ice box models with the modified thermal conductivity, k = 
0.0227 W/m-K. The volume of ice for the 9.5-in models was 85.8 in3 (0.001406 m3) 
with vaccine compartment side length of 7.5 in (0.1905 m). The volume of ice for the 
13-in models was 393.4 in3 (0.006447 m3) with vaccine compartment side length of 
11 in (0.2794 m). The cold duration of storage was defined as the average amount of 
time from the data sets for temperature to go from the lower bound of melting (-0.25 
C) to the upper bound of ideal vaccine storage (8 C). 

















13 inch All Sides k=.0215






 9.5-in Sided Model: All Sides 
Table 12: Data set label denotation for the 9.5-in sided box with ice perimeter model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 




Cold duration of storage: 1640 min  27.33 hr 





















Analysis: This model maintained an even temperature distribution throughout the box 
for the duration of melting, while the box was quickly brought to thermal equilibrium 
after the melting. The first point to reach 8 C was the corner probe, which was the 




 9.5-in Sided Model: All Sides, No Bottom 
Table 13: Data set label denotation for the 9.5-in sided box with all sides ice except 
the bottom model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 
 
Figure 37: 9.5-in sided box, all sides ice except bottom. Inset: Cutaway of experiment 
(blue = ice locations) 
Ice thickness:  
 
Cold duration of storage: 1397 min  23.3 hr 





















Analysis: The points not along the bottom maintained temperature stability for the 
relatively same duration as the all sides model. There is a drastic difference in 
temperature for the points along the bottom, though this is assumed to be an extreme 




 9.5-in Sided Model: Horizontal Shelf 
Table 14: Data set label denotation for the 9.5-in sided box with horizontal ice shelf 
model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 
 
Figure 38: 9.5-in sided box, all sides ice with horizontal shelf. Inset: Cutaway of 
experiment (blue = ice locations) 
Ice thickness:  
 
Cold duration of storage: 1633 min  27.2 hr 





















Analysis: An uneven duration of melting is observed in this model, where the outer 
ice panels melt much faster than the central shelf (skewing the cold duration to be 





 9.5-in Sided Model: Vertical Shelf 
Table 15: Data set label denotation for the 9.5-in sided box with all sides and vertical 
ice shelf model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 
Figure 39: 9.5-in sided box, all sides ice w/ vertical shelf. Inset: Cutaway of 
experiment (blue = ice locations) 
Ice thickness: 
 
Cold duration of storage: 1697 min  28.3 hr 





















Analysis: Parallels are drawn between this model and the horizontal shelf model. The 
same uneven duration of cold storage is observed throughout the box, with the 
average here being slightly longer than in the horizontal shelf model. The vertical 
shelf fully melts much quicker (data set T1), but it does not increase in temperature as 




 9.5-in Sided Model: Bottom and Top Slabs 
Table 16: Data set label denotation for the 9.5-in sided box with bottom and top ice 
slabs model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 
Figure 40: 9.5-in sided box, bottom and top ice slabs. Inset: Cutaway of experiment 
(blue = ice locations) 
Ice thickness:   
 
Cold duration of storage: 2308 min  38.5 hr 
Analysis: An obvious temperature distribution is observed in this model, though for 
the majority of the simulation, the temperature remains within the optimal vaccine 





















temperature conditions. The cold duration of storage here is by far the longest of all 




 9.5-in Sided Model: Bottom Slab 
Table 17: Data set label denotation for the 9.5-in sided box with bottom ice slab 
model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 
Figure 41: 9.5-in sided box, bottom ice slab 
Ice thickness:  
 
Cold duration of storage: 1157 min  19.3 hrs 
Analysis: This model demonstrated the temperature distribution in a linear sense 
throughout the box. The ice takes the longest to melt here (  70 hrs), given that it is 
all concentrated in one block. However at halfway in the storage compartment, the 





















temperature is already above the desired mark through the whole melting duration. 




 13-in Sided Model: All Sides 
Table 18: Data set label denotation for the 13-in sided box with ice perimeter model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
Figure 42: k-value refinement: 13-in sided box, all sides ice, k = 0.0227 W/m-K 
Ice thickness:  
 
Cold duration of storage: 3816 min 63.6 hr 
Analysis: The temperature distribution in this model mirrors that of the 9.5-in sided 
model. The cold duration of storage was over twice as long as in the other model, 





















though the volume of ice was over four and a half times more than in the other model, 
verifying a nonlinear relationship between ice volume and duration of storage. 
 
 
 13-in Sided Model: Horizontal Shelf 
Table 19: Data set label denotation for the 13-in sided box with all sides and 
horizontal ice shelf model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 
Figure 43: 13-in sided box, all sides ice with horizontal shelf 
Ice thickness:  
 
Cold duration of storage: 3572 min  59.5 hr 





















Analysis: This model exhibited the same findings as in the previous model, in that 
the temperature distribution was mirrored from the smaller box. The duration of 




 13-in Sided Model: Vertical Shelf 
Table 20: Data set label denotation for the 9.5-in sided box with all sides and vertical 
ice shelf model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 
Figure 44: 13-in sided box, all sides ice with vertical shelf 
Ice thickness:   
 
Cold duration of storage: 3852 min  64.2 hr 
Analysis: This model differed from the 9-in sided counterpart in that the vertical slab 
exhibited an even melting regime and subsequent sharp temperature increase to 





















equilibrium, where previously the melted slab experienced a longer regime of cooling 
after melting. The overall cold duration of storage was still about twice as long, in 
line with the other 13-in sided models. 
 13-in Sided Model: Bottom and Top Slabs 
Table 21: Data set label denotation for the 13-in sided box with bottom and top ice 
slabs model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 
T7 Center of side panel, between the insulation and ice layers 
 
 
Figure 45: 13-in sided box, bottom and top ice slabs 
Ice thickness:     






















Cold duration of storage: 3049 min  50.8 hr 
Analysis: In comparison to the 9-in sided model, this temperature distribution is 
almost identical, in that the relative locations in the box were stabilized at the same 
temperature through the melting period. The cold duration of storage here is a bit less 
than half of the previous model (38.5 hrs), but the time for the actual slabs to melt 
here (about 3.5E6 sec.) is well over twice that of the other model (about 1.5E6 sec.). 
 13-in Sided Model: Bottom Slab 
Table 22: Data set label denotation for the 13-in sided box with bottom ice slab 
model. 
Data Set Label Location in Ice Box Model 
T1 Center of storage space (air), on top of ice shelf 
T2 Center of bottom of storage, above the ice layer 
T3 Center of top, between the insulation and ice layers 
T4 Center of upper quadrant of storage 
T5 Top corner of storage 
T6 Midpoint of side along bottom of storage, above the ice layer 






Figure 46: 13-in sided box, bottom ice slab 
Ice thickness:  
 
Cold duration of storage: 3342 min  55.7 hrs 
Analysis: The temperature distribution seen here is slightly more spread than in the 
9.5-in model, but it is still far from ideal for cold storage. The time for the slab to 
melt here is over twice that of the smaller box model.  
 
  





















Each model exhibited distinctly different behavior in terms of temperature 
stratification and duration of melting. The all sides model had the most even 
temperature distribution and rate of melting in the box matching the experimental 
model. The five sides, no bottom model had a fairly even temperature distribution, 
except at the points along the bottom of the box where little cooling with prevalent. 
Both the horizontal and vertical shelf models exhibited longer melting times for the 
shelf slab, with the outer panels reaching warmer temperature much quicker. The 
bottom and top slab model showed an obvious temperature gradient throughout the 
box that mostly fell below the 8 C mark for the melting regime, and the duration of 
cold storage was also the longest here, in comparison to the ice perimeter models 
however, the location of measurement points may not have been conducive to 
accurate measurement. Finally, the single bottom slab model was ruled out as a viable 
geometry, given the gross temperature distribution in the box, where little to no 
cooling was observed at the extremities away from the ice. We concluded that the 
FEA modeling provides a good basis for eventual prototype construction and that the 
different geometries, typically not considered in design, play an important role in ice 
box performance. 
1-Dimensional Model Results 
In order to identify proper thicknesses for ice, insulation, and PCM a 1-
dimensional model was created in COMSOL as shown in Figure 47. This model had 
a run time of ~120s which allowed for rapid comparison of different combinations of 





Figure 47: Comsol 1-D model 
Region 1 has the material properties of insulation, Region 2 is the ice, and region 3 is 
the air. In all of the 1-D experiments the size of the air region was the same. The left 
most boundary point is held at 22.5 °C and the right most boundary point is 
considered symmetric, which means the heat flux is equal to 0. The initial 
temperatures for regions 1 and 3 were 22.5 °C and the initial value for the ice was -10 
°C for all of the models.  
Model Validation 
The 1-D model with an insulation thickness of 1 inch and ice thickness of 0.56 
inches took 76 hours to reach 8 °C, which is within 10% of both the 3-D model and 










T ime (sec x 105) 
Figure 48:  Dynamic temperature profile of a point in the air of the 1-D model. This 
profile matches qualitatively with the profiles as seen in the ice-box experiments 





shown in Figure 48 had a similar shape to both of those experiments as well.  
A series of experiments was run with varying thicknesses of insulation and ice 
in the model. The results are shown below in Figure 49 below.  
 
Figure 49: The time in hours that it takes the air in the 1-D model to warm up to 8 ºC 
versus insulation thickness plotted for different series of ice thickness. 
For each thickness of ice, an increase in insulation thickness directly increases 
the amount of time until the temperature reaches 8 °C. For each series the residual 
squared is above 0.99 indicating that the data is in fact linear. The slopes and 
intercepts of the linear regressions were plotted against the ice thickness for each 
series resulting in the Figure 50 below.  
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Figure 50: For each thickness of ice, the slope of the time to warm to 8 °C vs. 
insulation thickness graph was determined. These slopes are plotted against ice 
thickness, again giving a linear series.  
y  =  143.32x  -­‐  2.4513  























Ice thickness (in.) 
With these correlations, the time until the box is above 8 °C can be estimated 
generally for any combination of ice and insulation. This is shown below in the 
contour plot in Figure 51. 
Increasing the ice and insulation to 25 inches gives 1,900 hours of cold time, 
and this number increases indefinitely. The curve appears to be symmetric about the 
y=x line (white). This result means that if the interest is maximizing cold time while 







Figure 51: 2-D color contour plot of time until the air in the model is greater than 8 -
°C in hours shown as a function of ice thickness vs. insulation thickness. 
 
Cost Model  
To develop an optimized cold box, the cost of materials as well as the weight 
of the box needed to be considered to develop an idea of the cost efficiency of the 
design. A previous work on optimization of an insulated shipping container for use in 
the U.S. developed a cost model that accounted for the cost of materials and the cost 













































(East & Smale, 2008)  The model requires volumetric costs for insulation and ice 
which were assumed to be $900/m3 for polystyrene insulation (East & Smale, 2008) 
and $0.50/gallon for deionized water. These costs were converted to dollars per cubic 
inch for use in the program. 
was adapted. The equations for the costing model are shown in equations 5 through 8. 
This shows that the boxes with more ice are more expensive, due to the ice adding 
weight to the design. The full cost model can be found at the end of this volume in 
Appendix G. 
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To optimize the design, we divided the time to melt by the cost for the box, 
and found a global optimum. This is shown below in Figure 53. The optimum point, 
the center of the green ellipse, is 6 inches of ice and 11 inches of insulation. This box 
is much too large for a vaccine carrier and it would cost ~$1,000 to build and ship. 
However for every total box size below that there is an optimum distribution of ice 
and insulation that lies along the white power law curve. These optimums are 
relatively insenstive to the price per shipping. Increasing or decreasing the price of 
shipping by an order of magnitude results in 30% change in the optimum insulation 
and ice thicknesses.  
 














































Theoretical Integration of PCM as Buffer  
The novelty of our design is in the integration of PCM as a buffer to prevent 
the inner storage compartment of the vaccine carrier from ever dipping below zero.  
The quantitative question to answer is this: what is the proper ratio of PCM to ice? 
Consider the case in which there is exactly enough unfrozen phase change 
material inside of a shell of frozen ice such that the latent heat of the bulk PCM is 
exactly that of the latent heat of the ice, that is to say in 3-Dimensions: 
      (9)  
 
In one dimension, the cross sectional areas can cancel out on both sides out of the 
volumes, to give a critical thickness of PCM, x*, where the melting ice would exactly 
freeze the PCM slab while melting.  x* can be found quite simply by arranging 
equation (9).   
  
   (10)  
 
 Of course, using an x* thickness of PCM is too much buffer for the inner 
compartment, which 
then to consider what minimum fraction of x* gives the desired temperature stability, 
but minimizes the total volume of PCM in the system.  




Prototyping and F abrication 
A variety of experimental results and practical constraints have influenced our 
final prototype design. These results were drawn from physical ice box 
experimentation, PCM characterization, 1-D modeling and 3-D modeling of boxes in 
cold chain conditions. The practical constraints stemmed from data unearthed while 
investigating the cold chain, such as desirable storage conditions and common 
equipment dimensions and practical constraints for building these cold boxes. 
Our research into the cold chain elucidated a variety of constraints for the 
design based on environmental conditions and human factors. The most obvious 
constraints stem from the purpose of a cold box. The goal is to keep vaccines in a 
temperature range of 2-8 ºC for the longest time possible; this was weighted to be the 
most important design parameters. Making this constraint, the priority of our design 
distinguishes us from previous research.  
Using WHO constraints of 5-25 liters and their suggestion that vaccine vials 
are stored in boxes of the size of 100mm x 100mm x 50mm, we determined the inside 
dimension of our prototype to be 250 mm (9.84 inches). This results in a storage 
volume of approximately 15 L, which is mid-range for a cold box and fits the vaccine 
boxes with minimal wasted space. 
 To alleviate freezing of vaccine vials, our prototype is designed to have no 
contact of the ice with vaccines and additionally designed to be simple and full proof 
from possible misuse. This may seem an extensive measure, but ice lined refrigerators 
have extensive manuals that indicate that the vaccines stored within should never 




is aimed to be mass produced for distribution across the globe, so the box needs to be 
both simple to construct, and easy to use. Our final prototype design does not use 
nonstandard material sizes, and has a simple removable lid to allow access to the 
vaccines.  
Initial experimental investigations were into PCM characterization. The 
results indicate that Phase 5 would be the strongest performing material for energy 
storage within the ice box. However the results indicate even though the melting 
temperature is ideal at 5 ºC, the latent heat is significantly less than that of water. To 
store enough energy to keep 
be required than ice, adding volume, weight and expense to the design. There is also a 
possibility of the PCM s sensible heat freezing vaccines if it is placed directly in the 
box out of the freezer. We concluded that unfrozen PCM would best serve as a 
temperature stable barrier to keep vaccines at 5 ºC. External energy melts the ice at a 
temperature of 0 ºC, and the ice freezes the PCM at 5 ºC, which keeps the storage 
container at 5 ºC. When the ice is fully melted, the now frozen PCM melts at 5 ºC. 
This design has the disadvantage of being somewhat bulkier and heavier than current 
cold boxes, but it is not as expensive as solely using PCM as the refrigerant and does 
more to prevent freezing than current cold boxes. Additionally water in the form of 
ice packs is highly integrated into the current cold chain maximizing accessibility.  
The icebox experiments provided an excellent starting point for the eventual 
prototype design. The variety of designs allowed us to focus on the actual temperature 
profiles exhibited by different special arrangements of ice boxes. The experiments 




prevalence of freezing close to ice (PATH, 2008). The two most influential features 
on final prototype design we found from the ice box experimentation are as follows:  
the internal temperature uniformity or extent of mixing within the air of the vaccine 
storage chamber, and the gradient formed moving away from an ice pack. The mixing 
of the air allows us to create a prototype without complete circulation of vaccine 
storage chamber in frozen materials. The gradient starting with 0 ºC on an ice pack 
confirms the research that vaccine containers need to be separated from direct contact 
from ice and can be shielded with a barrier such as air. Thus our final prototype was 
designed  with a barrier of PCM between the ice and the vaccines in the vaccine 
storage chamber, additionally concluded that at least one side of the vaccine storage 
chamber does not necessarily need to be covered with ice. 
FEA modeling was developed utilized on two scales, modeling of 1-D trends 
based on ratios of ice, PCM, vaccine storage and insulation thickness, and 3-D 
modeling which focus on the effects of different geometries and melting trends. The 
1-D model was first used to determine the optimum ice to insulation parameters. This 
relationship was used to map a 2-D space between increasing ice and increasing 
insulation, and coupled with a costing model that found an optimum thickness for the 
ice and insulation that maximizes hours the box is cold per dollar spent. The most 
feasible dimensions were carried on for further refinement. PCM was added into the 
model to see the optimum ratio of PCM to ice to insulation at which the internal 
temperature was maintained at 5 ºC was performed. However no direct pattern could 
be observed, so only the ratio of ice to PCM could be optimized and was assumed to 




amounts of insulation is not easy, 1.5 inches was chosen as the insulation size for the 
final prototype, and the ice and PCM thicknesses were derived backwards from that 
using the power law derived from an updated version of the optimal costing model. 
The final thicknesses for the prototype box were 1.5 inches of insulation, 0.45 inches 
of ice, and 0.42 inches of PCM.  
 The 3-D modeling helped develop the final constraints setting our boxes 
geometry, which when combined with the data gathered from a variety of other 
sources served as our prototype design. The model was used to generate a variety of 
3-D shapes with the hopes of finding a simple design. The geometry with five sides, 
everything except the bottom covered was discovered to be able to maintain low 
temperatures but above 0 ºC while providing a design that is simple to construct and 
refill with ice. This was translated to the final shape and structure of the box. 
Construction of Prototype 2.0 
The same materials used in prototype 1.0, detailed in Table 7, were used to 
construct prototype 2.0. Similarly, the general construction process and order of 
materials was similar to prototype 1.0. The exception is that in prototype 1.0 there 
was one inner slot along each wall for a slab of PCM. However, for reasons detailed 
above, we decided to incorporate a dual inner slot along each wall that would house 
slabs of PCM that would be sealed in a chamber and ice packs that could be easily 
removed. Hence in prototype 2.0 (Figure 54) the layers of the box moving from the 




capacity of 15.625 liters (a cube with side length 9.84 inches). The inner 
resistant brand of polycarbonate (Plexiglas). 
 
Figure 54: CAD drawings and dimensions of prototype 2.0. 
a) Prototype 2.0 b) Birds-eye view with component dimensions c) 
plastic as outer layer d) e) 




The box also features a removable lid of the same layer based dimensions. 
Details of the dimensions and fabrication of the individual parts are given below. 
One of the novel features of our box is that the vaccines are packed inside initially at 
the beginning of transport, and are not removed until the final destination. However, 
the lid of the box will need to be removed in order to swap out ice packs. Therefore, 
we fabricated a clear plastic lid that covers the vaccine compartment even when the 
lid of the box is removed (Figure 55). This serves the dual purpose of allowing the 
healthcare worker who is changing the ice packs to view the vaccine compartment 
and ensure that they are all intact, while maintaining a minimal barrier between the 
cool vaccines and the ambient air while the ice packs are changed.  
 





The construction proceeded as follows (images of the construction of 
prototype 2.0 can be seen in Appendix D at the end of this volume): 
1. A corded jig-saw (Black and Decker 4.5 amp, variable speed) was used to cut 
the Lexan into the panels that would comprise the inner payload chamber. 
Four panels were cut to form the inner walls of the vaccine payload space, and 
an additional four panels were cut to form the walls of the PCM and ice slots. 
The panels were notched (Figure 56) so that they could be fitted together by 
anels slot at a right angle. The 
smaller panels were fitted together to form the inner payload chamber, and the 
outer panels were fitted around the chamber to form the walls of the PCM and 
ice slots. 
 
Figure 56: Lexan panels with notches and slots for assembly of a) the inner 
chamber and b) the PCM and ice slots. 
2. The jig-saw was used to cut the 
to serve as the insulation at the base of the box. The Lexan frame was centered 





vertically along the border on the base Polyisocyanurate, enclosing the Lexan 
frame, creating sturdy walls. 
4. At this point, all inner and outer joints of the box were sealed with a bead of 
glue smoothed by a finger. This created a thermal seal in each joint gap and 
also added structural integrity to the box. 
5. A rectangular annulus of Lexan was fabricated to sit atop the PCM slots, 
allowing the slots to be sealed once the PCM is added. The center of the 
annulus was saved and serves as the clear plastic lid to the vaccine 
compartment that will remain closed even when the lid of the box is removed. 
6. 
that, an 11
slot for ice packs on the top of the cold box. 
was fabricated from Lexan on top of the ice pack chamber to serve as the 
PCM chamber. When inverted, this lid fit snugly into the top of the box 
created in steps 1-4. 
7. Lastly, the corrugated plastic was cut and folded to encompass the box. The 
plastic was glued onto the box, and held in place through a combination of 
butterfly clips, and mechanical clamps until dry. 






Figure 57: Prototype 2.0 fully assembled 
Instructions for Using the Cold Box 
In the current cold chain system, the cold box used for vaccine transport 
passes through country centers, regional centers, and local health centers 
continuously. Our box will replace the current cold box while maintaining a similar 
level of low-maintenance care. At the primary vaccine store, the vaccines can be 
placed in our PCM cold box when ready for transport. The interior section of our 
PCM cold box has a removable plastic lid, which covers the vaccine storage 
compartment. After the vaccines are stacked inside, the internal compartment is 
closed, and should not be opened until the shipment has reached the final destination. 
The ice packs should be removed from our PCM cold box and placed in the freezer 




placed in the appropriate slots and the lid closed. Our PCM cold box is now ready for 
deployment. 
 After a travel time of 48 hours, during which the PCM component of our 
system functions by absorbing heat from the internal environment and disposing it 
into the ice packs, keeping a steady temperature of 5 °C, the ice packs will have fully 
melted. After the trip, the cold chain worker can observe the state of the system by 
looking at the color temperature labels on the PCM panels. If the temperature is 
above 8 °C, then the system needs to be recharged by removing all the ice packs and 
placing them in a freezer, and reclosing the lid of the box. The box should be kept at 
room temperature; the insulation and the covered internal compartment will prevent 
high heat from destroying the vaccines. The ice packs should be in the freezer for 48 
hours to ensure they freeze thoroughly, at which time they can be replaced into the 
PCM cold box in their respective locations without risk of freeze damage. Because 
there is a layer of PCM between the ice pack and the vaccine compartment, the 0 °C 
ice packs never touch the vaccine compartment. This process of refreezing the ice 
packs can occur any time when the traveling delivery truck makes a stop at a center 
with a freezer. Additionally, as ice packs are very cheap and simple to make and 
store, health centers along the way may have extra frozen ice for a quick exchange 
during a short stop. This way, when a shipment comes along with long distance goals, 
the deliverer can stop, replace the ice packs with frozen ones, and continue on his 
way for another 48 hours.  
 At the final destination, the vaccines can be removed from the PCM cold box 




the provincial center through the same distributor that brought the box. Our box will 
allow for less vaccine freezing along the cold chain, and create a more systematic and 
reproducible chain of events for shipments. The materials of our box can vary 
depending on the specific resources available to each country, but the general design 
and integration of PCM and ice packs is vital for preventing both freezing and 






Chapter 5:  Interpretation and Discussion 
What the Results Mean 
The main information that can be drawn from our research is as follows. A 
on with 
. Rapid prototyping of various box geometries 
illustrated difference in the time until the box was warm and the temperature 
distribution of the box. The method of FEA modeling with the phase change as a 
large energy heat capacity has been observed to be an effective tool for design of 
iceboxes or thermal systems provided unique geometries can be generated and 
convection is not the dominating factor in the thermal movement. Furthermore 
convection plays a small but noticeable role in cold box storage. A 1-D model 
illustrated the economic optimum ratio of ice to insulation and was further evaluated 
to find the required thickness of PCM needed to maintain the air above freezing 
temperature in a cold box. This data can play a role in future investigations into cold 
box technology. 
melting temperature and latent heat of substances. Our group used a DSC to 
determine both. We found a variety of latent heats and melting temperatures for 
proprietary PCMs such as  AcuTemp and PureTemp 4. Additionally we 
determined that the clathrate mixture of tetrahydrofuran and water proposed in the 
literature is very difficult to achieve and was not repeatable. Our conclusion indicates 




enough melting point 5 ºC and the highest heat of fusion of the PCMs tested and 
easily attainable in the literature. 
The ice box experiments performed used a variety of designs at two different 
box sizes, 9.5 in and 13 in and one experiment with a large ice pack on the bottom. 
The results gave a few different physical understandings of the melting process within 
a cold box which can help future investigations and guided our prototype design. It 
was observed that although a gradient was developed moving away from an ice pack 
into air or foam, the gradient was less than predicted by the model. This is attributed 
to the lack of convection in the computational mode.  
The geometry of the ice packs affects the temperature distribution the air. For 
those designs with an ice pack in the middle, we observed the center icepack plays a 
role in cooling the system after the outside icepacks have partially melted at which 
point the outside packs act as secondary insulation. Furthermore the result of 
geometries with an icepack in the center is an average temperature of the system 
much higher when shelves are integrated. The higher average temperature can be 
used to the advantage of a cold box designer as PCM can be used as a sort of 
insulation by placing it inside the cooling source for the cold box, such as ice. 
We were able to further study geometry using 3-D FEA models by creating a 
theoretical simulation that accurately exhibited phase change behavior using the 
approximated specific heat method. Further refinement to the model, by adjusting the 
thermal conductivity of the insulation, yielded results more accurate to experimental 




and cons of different ice box geometries in terms of equal temperature distribution 
within the cold box and duration of cold storage and a variety of other factors.  
Six different geometries were simulated corresponding: all six sides of ice, 
five sides of ice (not the bottom), six sides of ice with a central, horizontal ice shelf, 
six sides of ice with a central, vertical ice shelf, two sides of ice at the top and bottom, 
and one side of ice at the bottom. The all sides model had the most even temperature 
distribution and rate of melting in the box matching the experimental model. The five 
sides, no bottom model had a fairly even temperature distribution, except at the points 
along the bottom of the box where little cooling with prevalent. Both the horizontal 
and vertical shelf models exhibited longer melting times for the shelf slab, with the 
outer panels reaching warmer temperature much quicker. The bottom and top slab 
model showed an obvious temperature gradient throughout the box that mostly fell 
below the 8 C mark for the melting regime, and the duration of cold storage was also 
the longest here, in comparison to the ice perimeter models however, the location of 
measurement points may not have been conducive to accurate measurement. Finally, 
the single bottom slab model was ruled out as a viable geometry, given the gross 
temperature distribution in the box, where little to no cooling was observed at the 
extremities away from the ice. We concluded that the FEA modeling provides a good 
basis for eventual prototype construction and that the different geometries, typically 
not considered in design, play an important role in ice box performance. 
We were also able to verify these results using two different size boxes - one 
with 9.5-in sides and one with 13-in sides. Similar temperature distributions were 




storage was about twice as long in the larger box models; however there was over 
four times the volume of ice in the larger box model. This verified that there was a 
nonlinear relationship between duration of cold storage and volume of PCM, and that 
other factors (overall size, insulation thickness, insulation quality, etc.) would need to 
be adjusted to find the optimal cold box and cooling conditions.  
Another FEA model was created in 1-D to study the thicknesses of ice and 
insulation and their effect on the cold time of the box. In the model, where ice, 
insulation and air were changed iteratively showed the relationship between changing 
the ice to insulation ratio, as well as increasing the amount of either. This relationship 
was used to map the relationship between increasing ice or increasing insulation the 
result is a curve which can determine the optimal ratio of ice to insulation given a 
designed box size. The true optimum was outside of a realistic box size. The problem 
with just using ice and insulation is that the air spends a significant time at 0 ºC and 
this presents an opportunity for vaccines to freeze. To alleviate freezing, P  
PCM was included in the model between the air and the ice. It was found that PCM 
needs to absorb roughly half of the latent heat of the ice to maintain the temperature 
of the air at 5 ºC, and that this causes a reduction in the time the box spends below 8 
ºC, but protects the vaccines from freezing which increases value. However, a pattern 
in how long the box would last was not immediately noticeable with the 1-D model 
with PCM. The model was still usable to find an economic optimum in the ratio of 




Contribution to World Vaccination 
The needs presented by the cold chain studies cited above represent an 
opportunity for a novel icebox design that would address these issues in a cost-
effective manner. There are a few possible refrigeration methods that can help 
minimize vaccine freezing. Vapor compression refrigeration, as is found in common 
household refrigerators, is the most used method of active cooling; however, it has 
significant drawbacks that prevent it from being practical for vaccine storage and 
transportation. Any active refrigeration device is energy intensive, so they may not be 
feasible in resource-poor areas where energy is not always reliable (Xinhua, 2009). In 
addition, refrigerators are heavy and relatively fragile, which precludes frequent 
transport in areas where conditions are less than ideal. Due to these considerations, 
we will deploy PCMs as a primary passive cooling source. A cold box incorporating 
PCM is ideal for transportation because it does not require external energy input and 
is relatively light and durable compared to a refrigerator ("Product Information 
Sheets", 2000). Furthermore, PCMs are generally less costly and have a longer 
lifespan than compression refrigeration systems ("Landscape Analysis: Cool Chain 
Technologies", 2008). 
Benchmarking 
In Table 23 we outline the refrigeration products that are similar to our 
prototype and commercially available. We characterize each product in terms of the 




successfully detail each parameter. The first parameter reviewed was whether the 
product used active cooling by a compressor or another method of cooling, as this 
was one of our primary concerns when designing our prototype. We noticed that in 
general the active cooling devices, such as the CSafe, Waeco CF-11, Fridge Freeze, 
and SunFrost refrigerators were the most costly and least durable of the products we 
assessed. This finding confirmed our research that showed the impracticality of using 
compression refrigeration in a vaccine cold box. One device, the Envirotainer storage 
container, uses a unique active cooling method that utilizes dry ice. This product does 
not have a compressor, but it is designed for long-term storage rather than transport, 
making it different from our box.  
Next, we evaluated if the box or refrigerator could keep the inside 
compartment between the desired 2-8 ºC. The APEX cold box was the only product 
that could not maintain the desired temperature range because it uses ice packs in 
close proximity to the inte y to store vaccines 
between 2-8 ºC also shows that ice packs are not ideal for vaccine storage. 
durability, and ease of repair. We determined portability by considering the exterior 
dimensions and durability and we determined ease of repair by considering the 
materials used. Generally, we also considered any product that weighed over 50 lbs to 
not be portable. The only two products that were not portable were the CSafe 
refrigerator and the Envirotainer storage container, both of which are large, heavy 
boxes, designed for long-term or bulk storage, rather than transportation. The lightest 








storage compartment, which would give us an idea of how efficiently the product 
could store vaccines. The product with the least efficient storage capacity was the 
SunFrost refrigerator with the ratio of 0.070. As this is a solar-powered refrigerated 
box, it has many components, including the battery, solar cells, and compressor, all of 
which restricted the payload space available for vaccines. On the other hand, the 
Envirotainer had the most efficient storage capacity with the highest ratio of 0.739, 
primarily due to its unique cooling system that utilizes dry ice. 
Next, we determined whether each product had a reasonable cost, as this is a 
primary concern in developing regions. Among the products for which the pricing 
was available, the Fridge Freeze refrigerated boxes had the highest cost at $3995, 
while the Antifreeze Backpack had the lowest cost at $33.78. This data represents a 
possible, so our aim was to match or beat the price of the Antifreeze backpack. 
The penultimate parameter considered was maximum storage duration without 
any external energy source. The device with the shortest storage duration was the 
Tempak Plus box, which could keep its compartment cool for 24 hours. This shows 
that while its emphasis on mobility was effective, it sacrificed the ability to store 




duration was the CSafe refrigerator with a time of 100 hours, which was primarily 
achieved because it has a built in battery-powered compressor. 
The final parameter we considered was if there was any user input required. 
All of the products assessed required some level of user involvement, usually in the 
form of replacing melted ice/PCM packs or setting the temperature of the interior 
compartment. One of our main goals was to make our cold box user friendly and 
easily understood in different regions of the world. 






Team FRESH has produced a cold chain box that will be used in the cold 
chain system as the vaccine travels from a manufacturer in developed countries to the 
health organizations in the less developed countries.  
Although our product can be used in any places throughout the cold chain, we 
will be targeting the region between the intermediate vaccine storage and 
hospital/health centers.  
Presently, our product is in the introductory stage. We first developed our 
product in 2011 and have made continual improvements and redesigns after 
conducting more research.  
A complete marketing plan can be found in Appendix F. 
Suggestions for F uture Work 
Although our cold box design was optimized to the best of our working 
ability, many improvements can be made to bring it closer to real utility. The overall 
size and dimensions of the box could be adjusted for desired use; there was a large 
range of vaccine storage capacity (5-25L) given for working cold boxes. We merely 
chose a point within the range that fit our design consideration. In addition, other 
commercially available phase change materials could have been considered in the 
design. Unfortunately, funding and availability for small scale testing limited our 
choices. We did not extensively investigate the overall quality of the insulation, 
where more optimal density or thermal conductivity could allow for a lower thickness 




heavily considered in our design and fabrication processes, where some procedures or 
further optimization would need to be applied for real world mass production. 
 Moreover, a working cold box would have to be approved by the World 
Health Organization, complying with their Performance, Quality, and Safety (PQS) 
performance specifications for cold boxes. This would require a number of additional 
features that our current design lacks, including: an approved lid seal, hinges, lid stay, 
catches and carrying handles. The box must also be corrosion and chemical resistant. 
In addition, the box should be able to optimally accommodate the four specified types 
of ice packs used in the cold chain, with attention given to the WHO preferred type 
(Type 2: 163mm x 90mm x 34mm). Each ice pack type has its own denoted size 
regulations, and each cold box should be dimensioned to maximize the surface area 
covered by the ice packs, with minimal gaps. It is important to optimize the PCM-ice 
ratio for different types of ice pack thickness (Type 1 is 26 mm, and Types 2-4 are 34 
mm). Similarly, the vaccine storage compartment could be better dimensioned to 
accommodate the most vaccine packages. However, because there is no uniform 
secondary packaging for the vials, this was a difficult design constraint to follow. In 
the end, the final box should also meet the WHO testing standards for vaccine 
loading, cold life, and drop tests, as well as be tested under various thermal conditions 
and stresses that could occur in the large variable environment that is the cold chain. 
Conclusion 
We have developed a unique method for modeling the thermal characteristics 




that will keep vaccines cool but not freeze them. Our cold box employs the use ice as 
the cooling agent, and PCM as the stabilizing agent in an optimized geometry to 
maintain vaccines at 2-8 ºC for. As such, our findings can be used to build new and 
advanced cold chain transportation mediums that will eliminate vaccine freezing, a 
widespread issue in the current cold chain, ultimately saving money and lives.  
A unique aspect of our cold box is that the cooling agents, the ice packs, are 
the only parts that are ever stored in a freezer or refrigerator. The vaccines are packed 
in the box initially and are not removed until they are to be used at their destination. 
Rather the ice packs are continuously swapped for newly frozen packs. Moreover, 
since the PCM separates the ice from the vaccines, the vaccines will never freeze, 
even if a healthcare work
the only maintenance required of the vaccine cold box during transport is to make 
sure the ice packs are still frozen. As such, we have included sensors attached to the 
ice packs which change from green to red when the ice is no longer cold enough, 
indicating the need for new ice packs. In this way we provide protection from the 
three major causes (among others) that were mentioned above: 1) the vaccines are 
only packed once, not repacked numerous times, reducing the chance for error in 
improper packing, 2) the vaccines are never placed in any refrigerator or cold room, 
hence, adjustable thermostats on freezers and refrigerators are not an issue, and 
finally, 3) the PCM stabilizes the freezing temperature from the ice packs, and the 
color change sensors diminish the responsibility and room for error sue to inadequate 






Appendix A: Base Setup Code for ANSYS Models 
The following ANSYS code contains all the basic model parameters that are 
constants throughout each model iteration. By maintaining this generic file called 
 
 
/BATCH   
! /COM,ANSYS RELEASE 13.0    UP20101012       18:47:13    02/19/2012               
/input,menust,tmp,'',,,,,,,,,,,,,,,,1    
! /GRA,POWER   
! /GST,ON  
! /PLO,INFO,3  
! /GRO,CURL,ON 
! /CPLANE,1    
! /REPLOT,RESIZE   
WPSTYLE,,,,,,,,0 
/PREP7   
!*   
/NOPR    





KEYW,MAGNOD,0    
KEYW,MAGEDG,0    
KEYW,MAGHFE,0    
KEYW,MAGELC,0    
KEYW,PR_MULTI,0  
KEYW,PR_CFD,0    
/GO  
!*   
! /COM,    
! /COM,Preferences for GUI filtering have been set to display: 
! /COM,  Thermal   
!*   
!*   
ET,1,SOLID70 
!*   
TOFFST,273   
!*   
MPTEMP,,,,,,,,   
MPTEMP,1,-100    
MPTEMP,2,0   









MPTEMP,,,,,,,,   
MPTEMP,1,-100    
MPTEMP,2,0   
MPTEMP,3,0.001   
MPTEMP,4,100 
MPDATA,KXX,1,,2.22   
MPDATA,KXX,1,,2.22   
MPDATA,KXX,1,,.58    
MPDATA,KXX,1,,.58    
MPTEMP,,,,,,,,   
MPTEMP,1,-100    
MPTEMP,2,-.251   
MPTEMP,3,-.25    
MPTEMP,4,.25 




MPDATA,C,1,,668000   
MPDATA,C,1,,668000   
MPDATA,C,1,,4210 
MPDATA,C,1,,4210 
MPTEMP,,,,,,,,   
MPTEMP,1,0   
MPDATA,DENS,2,,37.24 
MPTEMP,,,,,,,,   
MPTEMP,1,0   
MPDATA,C,2,,1300 
MPTEMP,,,,,,,,   
MPTEMP,1,0   
MPDATA,KXX,2,,0.0227 
MPTEMP,,,,,,,,   
MPTEMP,1,0   
MPDATA,DENS,3,,1.293 
MPTEMP,,,,,,,,   
MPTEMP,1,0   
MPDATA,C,3,,1005 
MPTEMP,,,,,,,,   
MPTEMP,1,0   
MPDATA,KXX,3,,0.0243 





Appendix B: Sample Code for one of the geometry models in ANSYS 
 /BATCH   
! /COM,ANSYS RELEASE 13.0    UP20101012       16:29:02    01/29/2012               
/input,menust,tmp,'',,,,,,,,,,,,,,,,1    
! /GRA,POWER   
! /GST,ON  
! /PLO,INFO,3  
! /GRO,CURL,ON 
! /CPLANE,1    
! /REPLOT,RESIZE   
WPSTYLE,,,,,,,,0 
! /REPLOT,RESIZE   
/INPUT,'base','lgw','H:\Desktop\GEMS\Prototype_1\',, 0   
!*   
MPDE,ALL,2   
TBDE,ALL,2   
MPTEMP,,,,,,,    
MPDE,ALL,4   
TBDE,ALL,4   
MPTEMP,,,,,,,    
MPTEMP,,,,,,,,   
MPTEMP,1,-100    
MPTEMP,2,-.251   
MPTEMP,3,-.25    
MPTEMP,4,.25 





MPDATA,C,1,,668000   
MPDATA,C,1,,668000   
MPDATA,C,1,,4210 
MPDATA,C,1,,4210 
! LGWRITE,'base','lgw','H:\Desktop\GEMS\',COMMENT    
BLOCK,0,.3302,0,.3302,0,.3302,   
BLOCK,.0254,.3048,.0254,.3048,0.0254,.3048,  
BLOCK,0.0254,0.3048,0.0254,0.3048,0.0254,0.3048, 
BLOCK,.039605,.290595,.039605,.290595,.039605,.290595,   
BLOCK,0.039605,0.290595,0.039605,0.290595,0.039605,0.290595, 
! vlist, all   
VSBV,       1,       2   
! vlist, all   
! VPLOT    
VSBV,       3,       4   
! vlist, all   
FLST,2,3,6,ORDE,3    
FITEM,2,1    
FITEM,2,5    
FITEM,2,-6   
VGLUE,P51X   
! /VIEW,1,1,2,3    
! /ANG,1   




! /VIEW,1,,,1  
! /ANG,1   
! /REP,FAST    
WPSTYLE,,,,,,,,0 
WPSTYLE,,,,,,,,0 
! LGWRITE,'geom','lgw','H:\Desktop\GEMS\13-IN~3W\ALL_S~5W\',COMMENT  
! vlist, all   
SMRT,6   
SMRT,7   
SMRT,8   
SMRT,7   
SMRT,6   
CM,_Y,VOLU   
VSEL, , , ,       1  
CM,_Y1,VOLU  
CMSEL,S,_Y   
!*   
CMSEL,S,_Y1  
VATT,       1, ,   1,       0    
CMSEL,S,_Y   
CMDELE,_Y    
CMDELE,_Y1   
!*   
MSHAPE,1,3-D  
MSHKEY,0 
!*   
CM,_Y,VOLU   
VSEL, , , ,       1  
CM,_Y1,VOLU  
CHKMSH,'VOLU'    
CMSEL,S,_Y   
!*   
VMESH,_Y1    
!*   
CMDELE,_Y    
CMDELE,_Y1   
CMDELE,_Y2   
!*   
! NLIST,ALL, , , ,NODE,NODE,NODE   
! vlist, all   
! VPLOT    
WPSTYLE,,,,,,,,0 
WPSTYLE,,,,,,,,0 
CM,_Y,VOLU   
VSEL, , , ,       2  
CM,_Y1,VOLU  
CMSEL,S,_Y   
!*   
CMSEL,S,_Y1  
VATT,       5, ,   1,       0    
CMSEL,S,_Y   
CMDELE,_Y    
CMDELE,_Y1   
!*   




VSEL, , , ,       2  
CM,_Y1,VOLU  
CHKMSH,'VOLU'    
CMSEL,S,_Y   
!*   
VMESH,_Y1    
!*   
CMDELE,_Y    
CMDELE,_Y1   
CMDELE,_Y2   
!*   
! VPLOT    
WPSTYLE,,,,,,,,0 
WPSTYLE,,,,,,,,0 
CM,_Y,VOLU   
VSEL, , , ,       3  
CM,_Y1,VOLU  
CMSEL,S,_Y   
!*   
CMSEL,S,_Y1  
VATT,       3, ,   1,       0    
CMSEL,S,_Y   
CMDELE,_Y    
CMDELE,_Y1   
!*   
CM,_Y,VOLU   
VSEL, , , ,       3  
CM,_Y1,VOLU  
CHKMSH,'VOLU'    
CMSEL,S,_Y   
!*   
VMESH,_Y1    
!*   
CMDELE,_Y    
CMDELE,_Y1   
CMDELE,_Y2   
!*   
! LGWRITE,'meshed','lgw','H:\Desktop\GEMS\13-IN~3W\ALL_S~5W\',COMMENT    
!*   
ANTYPE,4 
!*   
TRNOPT,FULL  
LUMPM,0  
!*   
/UI,MESH,OFF 
! VPLOT    
WPSTYLE,,,,,,,,0 
WPSTYLE,,,,,,,,0 
! /VIEW,1,1,1,1    
! /ANG,1   
! /REP,FAST    
FLST,2,948,1,ORDE,2  
FITEM,2,1    
FITEM,2,-948 




FLST,2,3,1,ORDE,3    
FITEM,2,1    
FITEM,2,949  
FITEM,2,1418 
IC,P51X,TEMP,22.5,   
FLST,2,6,5,ORDE,2    
FITEM,2,1    
FITEM,2,-6   
!*   
/GO  
DA,P51X,TEMP,22.5    
FINISH   
/SOL 
DELTIM,60,0.01,300   
OUTRES,ERASE 







Appendix C: Images of Construction of Prototype 1.0 
 
Figure 58: Cutting a sheet of Lexan using the Black and Deck jigsaw 
 
 





Figure 60: Using glue to seal gaps between Lexan and Polyisocyanurate base 
 





Figure 62: Team effort in assembling PCM slot on underside of box cover 
 






Figure 64: Box cover being placed on box 
 





Appendix D: Images from Construction of Prototype 2.0 
 
Figure 66: Sahil Shah measuring the Polystyrene sheet for cutting 
 


























Figure 72: Corrugated plastic (white border) drying around box.  








Appendix E : Instruction Manual 
INSTRUCTIONS: Traveling Container 
 
Precautions 
 Take care when handling the PCM cold box. 
 Always make sure that the lid is tightly secured onto the PCM cold box. 
 Minimize time of exposure of inside of PCM cold box to external 
environment. 
 After leaving the central level, do not place the PCM cold box in a cold room 
or freezer. Only place ice packs in freezer. 
 
Emergency Scenarios 
 In the event of an emergency, adhere to the contingency plan prepared by 
responsible health officers at respective health centers. 
 Do not leave a cold box or vaccine carrier in a vehicle that is standing in the 
sun. Take it out of the vehicle and put it in the shade. 
 If there is no shade for PCM cold box when left outside, drape a material that 
reflects light over it. The ideal material is light-colored (preferably white) 
cloth or paper. 
 In case of power failure, place unfrozen ice packs in the bottom of a 
refrigerator to keep it cool, as indicated below. 
 
 




Unfrozen ice packs should be stored in freezer compartment (top) unless there is a 
power failure, at which point unfrozen ice packs should be stored in the bottom of the 
refrigerator. 
 If constrained for time to refreeze ice packs, and pre-frozen ice packs are not 
available at health center, freeze the ice pack as long as possible and place it 
back in the PCM cold box. In transport, keep the PCM cold box in the shade, 
and make another stop as soon as possible to fully freeze ice packs. 
 In the following situations, the condition of the PCM cold box is 
compromised. Vaccines must immediately be taken out of the PCM cold box, 
and placed back into the existing cold chain transportation/storage 
infrastructure. The PCM cold box should then be sent back to origin, where 
the container will be repaired and working parts will be recycled. 
a. PCM breaks or leaks. If PCM does not fill approximately 90% of its 
packaging, this means that it has been compromised. 
b.  Corrugated plastic gets punctured 
 
Responsibility 
 In order to successfully execute this plan, every transporter and at least one 
responsible officer at each respective health center (as identified by the head 
of the MOH or institution) should follow this flow chart. 
 There is never a situation in which the PCM cold box will require expertise to 
 section for situations in which there 
are easy repairs; otherwise send the PCM cold box back to distributor. 
 Over time, integrate the time sheet into tailored checklists that healthcare 
workers currently use when transporting/storing vaccines throughout the cold 
chain. 
 Over time, responsible health officers must strive towards these goals 
(adapted from PATH, USA) 
o C reate awareness of the problem among staff. Always explain 
global evidence and dangers of freezing certain vaccines to healthcare 
workers involved in the vaccine supply chain. 
o Establish routine surveillance as a practice. Establish practices of 
continual monitoring, evaluating, and adapting programs to the local 
environment. Conduct local cold chain freezing studies regularly. 
o Push policy change. Establish new guidelines and procedures for 
preventing accidental freezing in the cold chain. Network with 
advocacy groups for targeted local action. 
o Promote public awareness of immunization. Retrain, supervise, and 
provide materials such as posters and stickers. 
 
Optional Design Additions 
 Include sticker of the target c PCM cold box to 
further protect from mishandling. Collaborate with PCM cold box distribution 




 In collaboration with PCM cold box distribution site, ensure that all time 
sheets and instruction manuals are appropriately translated to local languages 
en route of cold chain. 
 
Note about F low Chart 
 Always start with the first problem shown in the problem-solving flow chart.  
 Make sure that a problem does not exist before moving on to the next step. 
Note all irregularities in IM E SH E E T: Traveling Container.  This sheet 
will be protected in a plastic sleeve attached to the outside of the PCM cold 
box. 




 Vaccines have already undergone the usual procedures for checking potency 
under supervision at the central level before being placed for the first time into 
PCM cold box. 
 Traveling containers will be distributed from the central level. 
 Responsibility has been given to responsible officers at every point of the cold 
chain for adhering to this flow chart. 
 Upon delivery of the vaccines to the target community, standard procedures 
regarding testing vaccine potency (VVM, Shake Test) will be followed. 
 Traveling containers will be returned to the central level by whatever means 











Figure 76: Color sensor on PCM panels in PCM cold box 
 Is the PCM cold box in working condition (No broken PCM panels, no visible 
leaks inside/outside the container, PCM panels look 90% full)?  
o IF NO, send back to PCM cold box distribution site. 
o IF YES, continue to next step. 
 Place vaccines in internal compartment. Is the internal compartment fully 
closed (plastic lid is fully pressed down to make a tight fit)?  N O T E : Do not 
open this compartment until shipment reaches end of chain. 
o IF NO, close it completely, so that the plastic lid makes a tight fit. 
o IF YES, continue to next step. 
 Is PCM cold box in the cold room?  
o IF NO, place in cold room. 
o IF YES, continue to next step. 
 Are WHO PQS pre-qualified ice packs available?  
o IF NO, acquire ice packs by asking head of health center. 
o IF YES, continue to next step. 
 Observe ice packs. Are WHO PQS pre-qualified ice packs completely frozen 
splashing; make sure that the center is frozen as well as the outside)? 
o IF NO, keep the ice packs in the freezer compartment of 
refrigerator/cold room to freeze thoroughly. Check if completely 
frozen before proceeding to next step. 




 Insert the ice packs into the vaccine carrier. Have ice packs been properly 
oriented within PCM cold box (Figure 75)? 
o IF NO, use Figure 75 as a guide to ensure proper orientation. 
o  IF YES, continue to next step. 
 Has the current local time/date/location been written in the T OP B O X  on the 
TIM E SH E E T: Traveling Container N O T E : I r regularities in the 
journey (emergencies as noted above, changed time schedule) will be 
 
o IF NO, record the local time/date/location on the  
Traveling Container  
o  IF YES, continue to next step. 
 In B O L D letters, Mark time (48 hours later) that ice pack must be refrozen 
based on projected transport route. Write in the F IRST C O L U M N on 
 Has projected time/date been recorded in 
appropriate time zone/language for the next stop?  
o IF NO, record the projected local time/date/location on the 
 
o  IF YES, continue to next step. 
 Traveling container is ready to be transported. Has the PCM cold box been 
placed on a level surface? 
o IF NO, try to ensure the most level surface possible so that the PCM 
cold box may stay tightly closed for the duration of transport. 
o  IF YES, continue to next step. 
 Upon reaching the next stop-over (within 48 hours of loading ice packs), has 
the responsible health officer been contacted? 
o IF NO, contact the responsible officer immediately. 
o  IF YES, continue to next step. 
 Have there been any irregularities in the journey? 
o ove in 
INSTRUCTIONS, and make sure there have been no irregularities. 
Then proceed to next step. 
o IF YES, indicate these to the responsible health officer using the 
 Answer any questions, and 
ensure that the health officer knows that he/she must continue filling 
the  for the next leg of the 
journey. Proceed to next step. 
 (Next health officer) Is the PCM cold box in working condition (No broken 
PCM panels, no visible leaks inside/outside the container, PCM panels are 
90% full)?  
o IF NO, send back to PCM cold box distribution site. 
o IF YES, continue to next step. 
 Bring the PCM cold box to an area at room-temperature. Quickly open the 
container, and check the color sensor on the PCM panels (Figure 76). Is the 
sensor red? 
o IF NO, quickly take out ice packs, and place them in the freezer 




o IF YES, quickly take out ice packs, and place them in the freezer 
compartment of refrigerator/cold room to refreeze. 
 Has the current local time/date/location been written for SE C O ND 
C O L U M N TIM E SH E E T: Traveling Container  
o IF NO, record the local time/date/location on the 
Traveling Container  
o  IF YES, continue to next step. 
 Has the PCM cold box been placed in a safe location where it will not be 
touched by others? 
o IF NO, secure a safe location so that the PCM cold box remains in 
optimal condition for the remainder of the journey. 
o IF YES, continue to next step. 
**If there are completely frozen WHO PQS ice packs available in the health center, 
you may swap those into the PCM cold box directly before the shipment leaves for 
transport. The same ice packs from the beginning of the journey do not need to be 
used. 
 Are ice packs completely frozen (no liquid inside the rigid pack; shake to 
make sure that the center is 
frozen as well as the outside)? 
o IF NO, keep the ice packs in the freezer compartment of 
refrigerator/cold room to refreeze. Check if completely frozen before 
proceeding to next step. 
o  IF YES, continue to next step. 
 Insert the ice packs into the vaccine carrier. Have ice packs been properly 
oriented within PCM cold box (Figure 75)? 
o IF NO, use Figure 75 as a guide to ensure proper orientation. 
o  IF YES, continue to next step. 
 Has the current local time/date/location been written in the T H IRD 
C O L U M N TIM E SH E E T: Traveling Container N O T E : 
I r regularities in the journey (emergencies as noted above, changed time 
 
o IF NO, record the local time/date/location on the 
Traveling Container  
o  IF YES, continue to next step. 
 In B O L D letters, Mark time (48 hours later) that ice pack must be refrozen 
based on projected transport route. Write in the F IRST C O L U M N , 
SE C O ND R O W , on  Has projected 
time/date been recorded in appropriate time zone/language for the next stop?  
o IF NO, record the projected local time/date/location on the 
 
o  IF YES, continue to next step. 
 Traveling container is ready to be transported. Has the PCM cold box been 
placed on a level surface? 
o IF NO, try to ensure the most level surface possible so that the PCM 
cold box may stay tightly closed for the duration of transport. 




**Repeat above steps to load and refreeze ice packs, while recording indicated time 
points in the next row of  until you arrive at 
the target community. 
 Upon reaching the target community, has the responsible officer been 
notified? 
o IF NO, immediately notify the point health officer. If there is 
difficulty, inform health professionals on site, and suggest contacting 
the Ministry of Health. 
o IF YES, continue to next step. 
 (Next health officer) Is the PCM cold box in working condition (No broken 
PCM panels, no visible leaks inside/outside the container, PCM panels look 
90% full)?  
o IF NO, send back to PCM cold box distribution site. 
o IF YES, continue to next step. 
 Open internal storage compartment within PCM cold box, and take out 
vaccines in a safe, stable, and shaded area if possible. Defer to check vaccine 
potency by WHO procedures (Shake Test, VVM). Have vaccines been 
unloaded and passed on to health staff? 
o IF NO, unload the vaccines and notify responsible health officer. Then 
close PCM cold box, and send it back to central level distribution site. 
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Appendix F : Marketing Plan 
E X E C U T I V E  SU M M A R Y  
Mission 
freezing and can be used throughout the cold chain.  
Company 
Team FRESH was founded in 2009 and we are an innovator in the vaccine 
storage marketplace. We aspire to develop and deliver to our customers a cheaper and 
more efficient product to be used in the cold chain system.  
Business 
We are a service provider that is seeking to sell its prototype design to a 
manufacturer that will be able to mass-produce our product. Our company is at the 
seed stage of business, having just developed an initial prototype. We will conduct 
more field-testing, experimentations and lab testing to develop a better-designed 
prototype. 
Currently, our company has continued to perform more research to determine 
the optimal dimensions for our second prototype. We have sufficient funding to start 
the initial research and development; however, we need more funds to conduct field-
testing that will help better emulate the conditions of our marketplace.  
Product or Service 
Team FRESH will produce a vaccine cold box design that will be used in the 
cold chain system as the vaccine travels from a manufacturer in developed countries 




Our product is unique because it has a larger vaccine storage capacity and is 
more cost effective than the current products in the market. 
The Market 
The organizations that oversee the cold chain in LMICs are the World Health 
both part of the GAVI alliance, an initiative started to coordinate and collaborate 
between Non-Governmental Organizations (NGOs) and target countries. These 
organizations are the main buyers of vaccine cold boxes such as ours, and they have 
stringent requirements that every refrigerator and cold box must meet before it can be 
considered for implementation in the cold chain. Therefore, our primary concern 
during testing is to prove that our concept can meet these requirements. 
Competition 
We outlined the commercially available refrigeration and cold boxes that are 
similar to our prototype, and we characterized each product in terms of the parameters 
that show its ability to store vaccines effectively by examining the literature available 
by the manufacturers. The parameters examined were: Active cooling, temperature 
stability between 2-8 °C, portability/weight, durability, ease of reparability, storage 
capacity to net volume ratio, cost-effectiveness, storage duration and user input.  
Risk/ Opportunity 
The greatest risks we face are limited field experience, not meeting WHO 
standards, production, and competition. We know that we can overcome these risks 




and completing a thorough benchmarking of the competition and emerging 
technologies. The latter we have already completed.  
We have an exciting and promising future, with many substantial 
opportunities ahead of us. We have the opportunity to become the primary vaccine 
cold box in the cold chain for LMICs, if we can overcome the risks we have outlined.  
Management T eam 
Our team is composed of 13 undergraduate students who come from diverse 
backgrounds and academic pursuits. We have five women and eight men whose 
disciplines vary from business, Spanish, Arabic, engineering, government and politics 
to biology.  
Capital Requirements 
We seek additional funds that will enable us to conduct more testing. This is a 
necessary step as we hope to address the demands and requirements of the World 
Health Organizations and the health centers in the less developed countries.  
 
M ISSI O N 
Mission Statement 
Our goal is to develop a vaccine cold box that prevents vaccine freezing and 
can be used throughout the cold chain. We aspire to carry a reputation in the 
marketplace for developing and delivering a cheaper, more efficient product that is 
sold at an affordable price for the primary use in the vaccine storage market. We will 
achieve this through extensive research into the product design and specifications, as 




To accomplish our goal, Team Fixing Refrigeration Efficiency to Sustain Health 
(FRESH) needs capital to continue improving our research and development, as well 
as expand our field-testing procedures to create an optimal prototype.  
In pursuit of our goal, we will treat customers and the community with the best 
customer service, answering any questions and concerns that they may have. The 
foundation of our relationship begins with a quality product; after developing a sound 
initial connection with the stakeholders, through first-class service, we hope to 
continue to work with our partners into the future.  
 
T H E C O M P A N Y 
Team FRESH was founded in 2009 under the Gemstone program, a unique 
multidisciplinary four-year research program for selected undergraduate honors 
students at the University of Maryland. Our company addresses the current need in 
the vaccine distribution m  
In addition to the effects on public health due to vaccine wastage, there is a 
significant loss of capital. We hope to design a cold box that will prevent freezing and 
reduce wasted capacity in vaccine carriers. We will develop a prototype that we can 
outsource to another company for mass-production.  
Strategic A lliances 
Team FRESH has developed important and profitable strategic alliance with 
the Centers for Disease Control (CDC). CDC is an organization under the Department 




promotion, prevention of disease, injury and disability, and preparedness for new 
health threats (Control, 2010). Through our partnership, we are able to receive 
current feedback about our findings concerning the cold chain. This partnership helps 
us understand what the optimal strategy is concerning our prototype design. 
 
T H E B USI N ESS 
Team FRESH is a service provider that seeks to sell its prototype to a 
manufacturer mass-production. Our company is at the seed stage of business, having 
just developed an initial prototype. We will conduct more field-testing, 
experimentations and lab testing to develop a better-designed prototype. 
Product or Service 
Team FRESH will produce a cold box that will 
be used in the cold chain system as the vaccine travels 
from a manufacturer in developed countries to the 
health organizations in the less developed countries 
(Figure 77). Although our product can be used at any 
stage throughout the cold chain, we will be targeting 
the region between the intermediate vaccine storage 
and hospital/health centers, as it is here where most of 
the deficiencies in vaccine transportation occur. 
Presently, our product is in the introductory stage. We first developed our 
product in 2011 and have made continual improvements and redesigns after 
conducting more research. 
Vaccine  manufacturer  
Primary  Vaccine  Store  








Cold  box/vaccine  carriers    




Unique Features or Proprietary Aspects of Product 
Although there are similar products that address the same market, we are able 
to differentiate ourselves because of two specific reasons: affordability and vaccine 
storage capacity. We believe that the prices for similar products in the current 
marketplace are too high. By selecting optimal materials and design, we believe we 
have created a better cold box than those currently in existence. In addition, most of 
the current cold boxes have a relatively low vaccine storage capacity compared to 
their external dimensions. We have addressed that issue and have a greater effective 
storage capacity than other products.  
Research and Development 
Our research will combine lab bench measurements and numerical 
simulations towards the optimization of temperature stability for vaccines as they 
move through the cold chain. Characterization of several phase change materials 
(PCMs) will use well-established experimental techniques in materials 
characterization to obtain data. This data will fill existing inhibiting gaps in these 
red for accurate simulation, prediction, and 
validation of temperature stability. The greatest impact of our proposed work is the 
development of novel strategies for more efficient integration of PCM technology 
into engineering design. The majority of current strategies that incorporate PCMs into 
passive refrigeration systems simply use more PCM to deliver temperature stability 
for a longer duration. The novelty of our approach is that we consider the 
arrangement of PCMs with respect to heat sources, heat sinks, and the environment 




addition to the quantity of PCM used. Our design criteria for the proposed project are 
guided by the necessity to decrease freeze damage to vaccines, increase payload 
volume, and maximize ease of use for operators in order to minimize human errors, 
thereby increasing efficiency of vaccine delivery. Through comprehensive materials 
characterization, novel and more accurate predictive simulation approaches, and 
experimental validation of these theoretical models, our work should broadly 
transform the engineering of passive refrigeration systems. This will lead to further 
innovations by allowing for a series of experiments that can develop a thermally 
optimized system, which is a unique approach to the use of modeling programs. 
New and Follow-up Products 
There are many alternative uses for our product. In addition to vaccines, our 
box can be adapted to be used in various other markets, such as blood, organs, food, 
insulin, and other pharmaceuticals.  
Production 
Our product will be subcontracted in order to mass-produce our prototype. We 
do not possess the resources necessary to produce a cold box in large quantities. 
Uniqueness 
Our product is unique because we will have an advantage in the marketplace 








T H E M A R K E T  
Market Definition 
Since vaccines contain temperature-sensitive biological substances, they must 
be kept between 2-8 °C from the time of production until usage to maintain efficacy 
and prolong shelf life (Craig, 2008). If subjected to improper refrigeration 
(overheating or freezing), vaccines are rendered ineffective. Conditions conducive to 
vaccine storage are achieved through the cold chain, which is the temperature-
regulated supply network for vaccine transport and storage. The cold chain equipment 
that keeps vaccines cool consists of various cooling systems including refrigerated 
vehicles, vaccine carriers, cold storage rooms, freezers, refrigerators, and cold boxes. 
In a typical cold chain, large shipments of up to 150,000 vials of vaccines are shipped 
or flown in refrigerated containers or compartments from the manufacturer to the 
national airport of the destination country (UNICEF, 2004). The vaccines are stored 
in a cold room at the airport until a refrigerated truck delivers them to the primary 
v om where 
vaccines are delivered periodically to regional centers, provincial health centers, local 
health centers, and eventually individual outreach clinics (Figure 77) ("Guidelin for 
Establishing or Improving Primary and Intermediate Vaccine Stores," 2002). 
The entire delivery process, depending on demand, can be as short as a month 
or as long as three months (UNICEF, 2004). Various studies have shown that 
vaccines in the cold chain within a wide range of countries including Thailand, India, 
Malaysia, Indonesia, Papua New-Guinea, Vietnam, New Zealand, Australia, Bolivia, 




freezing (<0 °C) temperatures, likely rendering them impotent due to the inactivation 
of key organic components (D. M. Matthias, Robertson, J., Garrison, M. M., 
Newland, S., Nelson, C., 2007; C. M. Nelson, Wibisono, H., Purwanto, H., Mansyur, 
I., Moniaga, V., & Widjaya, A., 2004; Techathawat, 2007; T. Wirkas, Toikilik, S., 
Miller, N., Morgan, C., & Clements, C.J., 2007). Such vaccine losses result in great 
financial loss for immunization programs, as well as potential danger to patients. 
One of the most prevalent factors attributed to vaccine freezing is the lack of a 
stable temperatures in the cold boxes, which contain ice packs that freeze at 0 °C 
("Landscape Analysis: Cool Chain Technologies", 2008). In one study, a staggering 
70% of vaccines were discarded upon delivery, mostly due to freeze-damage 
(Techathawat, 2007). The widespread freezing of vaccines can be attributed to many 
factors, the most prevalent of which is the lack of stable temperatures in the 
refrigeration cell during transport and storage. A study of the cold chain in Papua 
New Guinea showed that during transport from the provincial vaccine stores (PVS) to 
local health centers and outreach clinics, vaccine loads were partially freeze-
damaged, reaching an average temperature of -3 °C (T. Wirkas, Toikilik, S., Miller, 
N., Morgan, C., & Clements, C.J., 2007). 
Freezing during transport is ascribed to the storage method en route, which 
generally consists of boxes lined with ice packs. Vaccines that come in direct contact 
with the ice packs will likely freeze; however, placing a buffer region in between the 
vaccines and ice requires larger transport containers and greater transport capacity, 
thus increasing costs and decreasing efficiency. There is also no regulation of 




2008). In addition, trucks carrying vaccines often struggle to transport vaccines due to 
poor roads or lack of roads in remote areas (Hopkins, 1985). 
Once the vaccines reach the villages, the most basic refrigeration technology 
and transportation methods are used to deliver and store the vaccines. The power 
supply becomes increasingly intermittent and transportation becomes more 
difficult. These problems manifest themselves throughout the local level of the cold 
chain, resulting in inefficient and unsafe delivery of vaccines. In terms of 
refrigeration, it is at this stage that many vaccines are kept in ice-lined boxes, which 
can cause the vaccines to freeze, rendering them useless (WHO, 1999). A PEPFAR 
for AIDS Relief) evaluation of local vaccine stores 
in Ethiopia showed that the intermittent power supply there necessitated the use of 
back-up power sources that are often not reliably in place. In theory, the back-up 
power sources are designed to safely power down the equipment when the main 
power supply cuts off, but improper wiring of these sources leads to unstable 
conditions for the vaccines. The evaluation concluded that electricity needs are not 
integrated in health center planning (USAID, 2008). Furthermore, in many regions of 
South East Asia, particularly in Indonesia, local midwives are the intermediaries 
administering the vaccines. They often have to store vaccine vials in their households 
for the entire village. Standard refrigerators are cumbersome in size and energy 
demands (C. M. Nelson, Wibisono, H., Purwanto, H., Mansyur, I., Moniaga, V., & 
Widjaya, A., 2004). 
Other recent studies have also shown similar issues in relation to regional cold 




identified issues such as cold chain maintenance, placement of vaccines, and 
availability of some equipment. The authors were able to address some of these 
problems, but the issue of long-term storage persisted (Dasgupta S, 2010). In another 
recent article published by Lee et al. in 2011, the authors replaced the traditional ten 
dose vials with one dose vials in an effort to reduce the amount of wasted 
vaccines. The increased number of vials proved problematic, however, as it presented 
space issues in the refrigerators, and the doctors noticed more broken vials as a result 
of mishandling (Lee et al., 2011). These studies show the importance of strengthening 
the cold chain infrastructure. 
In 2008, the WHO released an analysis of the current cold chain landscape 
and the main challenges and necessities for the future. The analysis notes that there 
will be a eight-fold increase in the number of vaccines distributed in the next few 
years, necessitating an increase in storage capacity. The landscape analysis also 
underscored the importance of developing passive cooling technologies and improved 
temperature monitoring devices ("Landscape Analysis: Cool Chain Technologies", 
2008). 
The needs presented by these studies represent an opportunity for a novel 
icebox design that would address these issues in a cost-effective manner. There are a 
number of possible refrigeration methods that can help minimize vaccine freezing. 
Compression refrigeration, as is used in common household refrigerators, is the most 
used method of active cooling, but it has significant drawbacks that prevent it from 
being practical for vaccine storage and transportation. Any active refrigeration device 




is not always reliably available (Xinhua, 2009). In addition, refrigerators are heavy 
and relatively fragile, which precludes frequent transport in areas where conditions 
are less than ideal. 
Due to these considerations, we will deploy PCMs as a primary passive 
cooling source. A cold box incorporating PCM is ideal for transportation because it 
does not require external energy input and is relatively light and durable compared to 
a refrigerator ("Product Information Sheets", 2000). Furthermore, PCMs are generally 
less costly and have a longer lifespan than compression refrigeration systems 
("Landscape Analysis: Cool Chain Technologies", 2008). 
Market Segment 
The organizations that oversee the cold chain in LMICs are the World Health 
both part of the GAVI alliance, an initiative started to coordinate and collaborate 
between these NGOs and the target countries. These organizations are the main 
buyers of vaccine cold boxes such as ours, and they have stringent requirements that 
every refrigerator and cold box must meet before it can be considered for 
implementation in the cold chain. Therefore, our primary concern during testing is to 
prove that our concept can meet these requirements. The main standards have been 
compiled in the Performance and Quality Standards (PQS) published by the WHO. 
The different points relevant to our long-range vaccine cold box concept are 






Table 24: WHO requirements ("PQS Performance Specification: Vaccine Cold Box", 
2008) 




5.0  25.0 Liters 8.4 L 
Cold Life 96 hours 96 hour cold life 
Shape Square or rectangular Square shaped payload 
Stacking Multiple units must be 
stackable 
Flat top, bottom, and 
sides 
Robustness Withstand a one meter 
drop on all sides/angles 
Testing pending 
Environmental Considerations 
Ambient Temperatures Usable in temperatures 
from -30 °C - +50 °C 
Testing Pending 
Physical Characteristics 
Weight Max: 50 kg. Weight: 
Interface Compatibility 
Ice Packs Must accommodate 
different types of 
approved ice packs 
PCM slots can 
accommodate ice 
packs 
Vaccine Packaging Must accommodate 
different vaccine 
packaging 
Versatile cube for 
vaccine payload space 





Casing Resistant to UV 
degradations and must 
be water proof 
Corrugated plastic is 
rugged material 
Disposal All materials must be 
environment-friendly 
All materials can be 
disposed of safely 
 
Our final prototype has been designed specifically to follow the PQS 
requirements, and we have tested some properties to verify that they meet the 
standards. Our prototype still needs to be tested in the field in an actual cold chain 
setting in order for us to confirm its practical versatility, usability, and durability. 




UNICEF that our concept can lead to an improved cold box design that can help 
decrease vaccine wastage by preventing freezing during transport. 
Marketing 
Our marketing plan is unorthodox in the sense that we hope to prove our 
concept so that we may contract our prototype to be mass-produced by a third party. 
If WHO approves our design, we will be able to distribute our product design. We 
hope to become the leading product in the cold chain system market. 
Position 
We will be position our product design as an exceptional product at an 
affordable cost. We have increased the vaccine storage capacity in our product, a 
characteristic that was not answered as best as possible by other products.  
Pricing 
Our pricing strategy is to price our prototype as a cheap, yet quality product. 
We want to have the highest market share in the marketplace. We are focused on 
becoming a market share leader because we believe our product will answer the 
problems in the cold chain the most efficiently. 
Distribution Channels 
Our distribution channel is the third-party that we contract to mass-produce 
our prototype. This makes sense because the manufacturers have more resources to 
distribute the products.  
C O M P E T I T I O N 
In Table 23 in the text (also reproduced below), we outlined the refrigeration 




vaccines effectively by examining the literature available from the manufacturers. 
The first parameter reviewed was if the product used active cooling by a compressor, 
as this was one of our primary concerns when designing our prototype. We noticed 
that in general, the active cooling devices, such as the CSafe, Waeco CF-11, Fridge 
Freeze, and SunFrost refrigerators were the most costly and least durable of the 
products we assessed. This finding confirmed our research that showed the 
impracticality of using compression refrigeration in a traveling vaccine cold box. One 
device, the Envirotainer uses a unique active cooling method that utilizes dry ice. 
This product does not have a compressor, but it is designed for long-term storage, 
rather than transport. 
Next, we evaluated if the box or refrigerator could keep the inside 
compartment between the desired 2-8 °C. The APEX cold box was the only product 
that cannot maintain the desired temperature range because it uses ice packs in close 
proximity to the internal compartment. This lack of ability to store vaccines between 
2-8 °C also shows that ice packs are not ideal for vaccine storage. 
The next parameters we 
durability, and ease of repair. We determined portability by considering the exterior 
dimensions, and durability and ease of repair by considering the materials used. 
Generally, we also considered any product that weighed over 50 lbs to be not 
portable. The only two products that were not portable were the CSafe refrigerator 
and the Envirotainer storage container, both of which are large, heavy boxes, 




products considered were the Antifreeze backpack at 17.4 lbs. and the Tempak Plus 
cold box at 5.5 lbs. We used these as guidelines as to how much our product should 
weigh. 
ume ratio. This 
compartment, which would give us an idea of how efficiently the product stores 
vaccines. The product with the least efficient storage capacity was the SunFrost 
refrigerator with the lowest ratio of 0.070. As this is a solar-powered refrigerated box, 
it has many components, including the battery, solar cells, and compressor, all of 
which restrict the payload space available for vaccines. On the other hand, the 
Envirotainer had the most efficient storage capacity with the highest ratio of 0.739, 
primarily due to its unique cooling system that utilizes dry ice. 
Next, we determined whether each product had a reasonable cost, as this is a 
primary concern in developing regions. Among the products for which the pricing 
was available, the Fridge Freeze refrigerated boxes had the highest cost of $3995.00, 
while the Antifreeze Backpack had the lowest cost of $33.78. This data represents a 
large variable range of prices
possible, so our aim was to match or beat the price of the Antifreeze backpack. 
The penultimate parameter considered was maximum storage duration without 
any external energy source. The device with the shortest storage duration was the 
Tempak Plus box, which could keep its compartment cool for 24 hours. This shows 
that while its emphasis on mobility was effective, it sacrificed the ability to store 




duration was the CSafe refrigerator with a time of 100 hours, which was primarily 
achieved because it has a built-in battery-powered compressor. 
The final parameter we considered was if there was any user input required. 
All of the products assessed required some level of user involvement, usually in the 
form of replacing melted ice/PCM packs or setting the temperature of the interior 
compartment. One of our main goals was to make our cold box user friendly and 
easily understood in different regions of the world. 
 
Description of Competitors  
 
Table 25: Benchmarking of competitor products 
 
CSafe is an active cooling refrigerator that utilizes a compressor. Having a 




compressor allows CSafe to effectively regulate temperature, it also restricts its 
portability. CSafe is too fragile and heavy to be used as a reasonable carrier for 
vaccines in the cold chain. 
APEX is a vaccine carrier box that uses ice packs to keep vaccines cool. This 
small box makes for a lightweight, portable box. However, as it is so small, its 
storage capacity to net volume ratio is very poor. Therefore, while it is portable, it 
does not provide an efficient means of transportation. Also, since it uses ice packs, 
the box does not keep vaccines between the desired range of 2-8 ºC. APEX is a 
product that has the advantage of having already passed the WHO testing protocols.  
Greenbox is another vaccine carrier that uses passive cooling. Instead of ice 
packs, however, it uses PCM. Greenbox is mobile and has a long storage duration 
time. Furthermore, its storage capacity to net volume ratio is relatively high. The 
downsides to Greenbox are that it is expensive and more focused on a developed 
market.  
 The Model Antifreeze Backpack is another product that has passed WHO 
testing. Similar to APEX, the backpack uses ice packs, however the goal with this 
carrier is to use proper insulation to prevent the ice packs from freezing the vaccines. 
This allows for a more stable temperature. Yet, while it is more reliable, the vaccines 
are not entirely protected from freezing since ice packs are used. The Model 
Antifreeze Backpack has a short storage duration and small storage to capacity ratio. 
It is cost effective, however, as it is a product already used by the WHO.  
 Envirotainer uses dry ice-based refrigeration. This provides a stable 




very efficient in keeping vaccines at the proper temperature and for transporting a 
large quantity of vaccines. Envirotainer is very heavy and not feasible for mobile 
transport of vaccines. A container like this is more suited for the large-scale shipment 
of vaccines, rather than for use as a vaccine carrier. Envirotainer is also very 
expensive with a cost of $300 for every day it is recharged.  
 Waeco is a mobile vaccine carrier that also applies active cooling 
technologies. Since it uses a compressor, the Waeco cooler provides a very safe and 
stable environment for vaccines. It also has a very high payload space, relative to 
other coolers. Waeco has a high price tag, and is not intended for use in the cold chain 
of LMICs. The main issue with compression-based cooling, refrigerators and cold 
boxes are not easily repaired, especially in a developing region. 
 Fridge Freeze is a product similar to Waeco; however, it is designed more 
specifically for the transport of medical supplies, such as vaccines and organs. This 
product is targeted to developed countries, and its exorbitant cost is too high for use 
in the cold chain.  
 Tempak Plus is another vaccine carrier that, similar to Greenbox, uses PCM. 
Tempak Plus is small and lightweight, with a greater payload space ratio than 
Greenbox. The only negative is that it is designed for short transport and can only 
carry a limited quantity of vaccines. 
SunFrost is a different solution, as it uses solar energy to power its 
compressor. This provides a system that is not only temperature stable but also 
environmentally friendly. With this type of compressor vaccine carrier, a power 




the carrier is heavy and only semi-portable. With the solar panels and compressor, the 
system is also fragile and not easily repaired. It also has a very poor storage capacity 
to net volume ratio.  
When designing our own vaccine carrier we took into account all of the 
information we learned from our competitors. Our box uses PCM, so temperature 
remains at a stable and safe range. We designed our box to be lightweight and 
portable, while still being durable and able to pass WHO guidelines. The vaccine cold 
box we have designed has optimized geometries and the storage capacity to net 
volume is higher than our direct competitors. Our carrier also has the ability to last for 
long periods of time and still maintain vaccines safely. Finally, it is our goal to 
produce and sell this product at a low cost, thereby making it readily available to the 
cold chain market in LMICs.  
 
R IS K  
When starting any new business there are many different risks. As we are just 
starting in this industry, there are many problems we will face as newcomers. Many 
times when businesses fail it is because they do not make themselves aware of the 
risks their business faced. It is important to not shy away from risk but rather to 
define it as clearly as possible.  
We have limited field experience, so what we do know is based solely off of 
our extensive research. We do not know how things are in the actual cold chain, as we 
have not seen it or experienced it ourselves. When it comes to being around the 




Another risk is that in order for a product to be used in the cold chain, it must 
pass certain tests defined by WHO in their Product, Quality, and Safety (PQS) 
guidelines. Therefore, we need to meet these PQS standards in order to be placed on 
chain suppliers. There is a risk that if we do not get on this list that our product will 
not be available to cold chains in LMICs and we will not meet our goal.  
Also, as a new, small project, the production of our project is a significant 
risk. Even if we have the best product, being able to produce enough of our product to 
meet demand is a real concern.  
A final risk involved with our business is that there are always new, 
innovative technologies being developed. The field of medicine is an ever-changing 
landscape, and there are vaccines currently being developed that are temperature 
stable, which would obviate the need for a temperature stable cold box.  
While these are some of the risks we face as a new entity, it is imperative that 
we not only understand these risks, but also have a plan for overcoming them. 
Defining our risks is one of the first steps on our road to success.  
 
O PP O R T U N I T Y  
We are very excited about our idea, and there are many different opportunities 
that we look forward to taking advantage of in the future. While our team does have 
very little field experience, this will not stop us from being successful. We have done 
the research to paint an accurate picture of what the cold chain currently looks like. 




feedback on our product. Also, WHO clearly defines what a vaccine carrier should be 
able to do and what tests it must pass in the PQS document. If our carrier passes these 
tests, it will be competitive in the field.  
However, it is another concern of ours that we must pass these PQS 
guidelines. In order to pass PQS guidelines we must perform all of the testing 
outlined by WHO. Once we meet the PQS, it is our hope that we will be able to 
outsource the assembly of our vaccine carrier. 
As for the future of our product and the industry in general, the future is 
always hard to predict. During our research on the industry we learned of new 
temperature stable vaccines. While we are aware and do acknowledge that these other 
products do exist, we also know that these technologies are years away from the 
market, ensuring that our cold box will have a place in the cold chain at least for the 
near future. 
If our business can overcome the obstacles we face, we have the opportunity 
to be the primary vaccine cold box utilized in the cold chain. Our product has the 
chance to revolutionize the industry and save many lives. We will bring the most 
effective technologies to the developing world. Our product improves performance 
over what is in the field now and is the best choice in safe vaccine transportation. 









Table 26: SWOT Analysis 
ST R E N G T HS 
 Cost-effective 
 Tailored geometry allowing optimal 
storage capacity 
 Capable of holding vaccines for 
entire duration of cold chain 
 No risk of exposure to sunlight or 
fluorescent light 
 Employs the same directions for the 
orientation of all vaccines in the box 
 Rarely requires expert repair 
 May be integrated into existing cold 
chain 
 Includes culturally relevant 
flag/logo to reduce risk of 
mishandling 
 Will be supplemented with time 
sheet and translated instructions to 
promote uniformity in use 
W E A K N ESSES 
 Does not currently meet WHO PQS 
standards 
 Requires more product 
development 
 Requires field testing 
 Management team has little field 
experience  
OPPO R T UNI T I ES 
 Increasing vaccine 
production/distribution 
 Alternative markets (food, 
pharmaceuticals, blood) 
 Contacts with existing organizations 
T H R E A TS 
 Competing products from 
established cold chain technology 
businesses 
 Switch to OCC (Out-of-cold-
chain) practices 
 Substitution of temperature-
sensitive vaccines  with 



















M A N A G E M E N T T E A M 
 
Our team is composed of thirteen undergraduate students that come from 
diverse backgrounds and academic pursuits. We have five women and eight men 
whose disciplines include business, Spanish, Arabic, engineering, government and 
politics, and biology. In addition, we have a mentor who is a bioengineering professor 
at the University of California, San Diego.  
T eammate    Major(s) 
Amanda Pereira   Spanish/Pre-Med 
Amina Goheer   Government and Politics/Arabic 
Andrew Foo    Mechanical Engineering 
Anthony Mazzella   Operations Management 
Divya Raghavachari   Neurobiology and Physiology/Spanish 
George Peabody V   Chemical Engineering 
Jason Felder    Mechanical Engineering 
Kelly Daniluk    Mechanical Engineering 
Matt Conway    Chemical Engineering 
Ravi Vaswani    Neurobiology and Physiology/Spanish 
Sahil Shah    Neuroscience 
Veena Katikineni   Biology 







We seek additional funding for our research and development. The initial stage of 
funding will be used to conduct more testing on our prototype so we can improve the 











PR O F O R M A 
ERROR! NOT A VALID LINK. 
Appendix G: Costing Model MATLAB Code 
Cost Optimizing without PC M  
  
%%  Insulation  vs.  Ice  Thickness  Color  Plot    
    
%%  Assumptions  
%  We  wanted  a  20  liter  box  that  fit  a  real  number  of  50  mm  boxes  
%  250  mm  square  is  the  storage  area  side  length.  This  is  9.84  
inches.  
%  we  are  considering  half  of  a  box  so:    
s  =  9.84/2;;  %  storage  side  length  
    
%  The  maximum  possible  width  for  the  box  is  30  inches.  Then  it  
starts  not  
%  to  fit  through  doorways.    
    
maxL  =30/2;;    
    
L  =  maxL  -­  s;;    
    
%%  Costing  parameters  
    
ice.rho  =  62.4  ;;  %  lb/ft^3  
ice.rho  =  ice.rho*(1/12^3);;  %  lb/in^3  
ice.cost  =  5*0.25/231;;  %  25  c/gal  -­>  dollars/cubic  inch  
    
ins.rho  =    0.00134548874;;  %  37.24300  (kg  /  (m^3))  =  0.00134548874  
pound  /  (in^3)  
ins.cost  =  900*(1/  39.3700787^3);;  %  dollars/in^3  (East  &  Smale)    
    
weightcost  =@(mass)  2*4.75*mass/2.2  +  30;;  %  heavy  packages  ship  on  
weight  cost  
volumecost  =@(mass)  800*(1/  39.3700787^3)*mass  +  30;;  %  small  
packages  ship  on  volume  cost    
    
%%  Define  feasible  space  
    
%  We  could  have  no  ice,  all  insulation;;  all  ice,  no  insulation;;  or  
no  ice,  
%  no  insulation.  This  forms  a  right  triangle.    
    
%              |\    




%              |    \  
%              |      \  
%              |        \  
%th_ins  |          \  
%              |            \  
%              |              \  
%              |                \  
%              |_________\  
%                    th_ice  
    
n  =  1000;;  %  number  of  subdivisions  
    
Z  =  zeros(n,n);;    
C  =  zeros(n,n);;    
X  =  zeros(n,1);;  
Y  =  zeros(n,1);;  
T  =  zeros(n,n);;  
for  i  =  1:n  
        x  =  L/(n-­1)*(i-­1);;  
        X(i)  =  x;;  
        Y(i)  =  x;;  
        m  =  142.4*x+0.0016;;  
        for  j  =  1:n    
                y  =  L*(j-­1)/(n-­1);;    
                T(j,i)  =  x+y;;    
                Z(j,i)  =  m*y;;    
%                  if  x+y  >  L;;  
%                          Z(j,i)  =  NaN;;    
%                  end  







plot([0  10.08],[0  10.08],'w');;  
title('Time  in  hours  until  8  degrees');;  
xlabel('Ice  Thickness  (inches)')  




for  i  =  1:n  
        x  =  L/(n-­1)*(i-­1);;  
        X(i)  =  x;;  
        Y(i)  =  x;;  
        m  =  142.4*x+0.0016;;  
        v_ice  =  (x+s)^3-­s^3;;  
        C_ice  =  v_ice*ice.cost  ;;  
        
        for  j  =  1:n    
                y  =  L*(j-­1)/(n-­1);;    
                v_ins  =  (x+s+y)^3  -­  (x+s)^3;;    




                if  
(v_ice*ice.rho+v_ins*ins.rho)>160/(2.2*39.3700787^3)*(v_ice+v_ins)+.
2/2.2  %  if  mass  box  >  some  factor  times  volume  of  box  
                        C_ship  =  weightcost(v_ice*ice.rho+v_ins*ins.rho);;  
                        %disp('costed  by  weight')  
                else  
                        C_ship  =  volumecost(v_ice*ice.rho+v_ins*ins.rho);;  
                  %      disp('costed  by  volume')  
                end  
                C(j,i)  =  C_ice  +  C_ins  +  C_ship;;    
                Z(j,i)  =  m*y;;    
%                  if  x+y  >  L;;  
%                          C(j,i)  =  NaN;;    
%                  end  







plot([0  10.08],[0  10.08],'w');;  
title('Cost  estimate  for  ice  and  insulation');;  
xlabel('Ice  Thickness  (inches)')  




%%  optimize  time/$  
H  =  Z./C;;    
colormap(winter)  
[ch,ch]  =  contourf(X,Y,H,50);;  
%[ch,ch]  =  contourf(H,50);;  
  set(ch,'edgecolor','none');;  
hold  on  
title('Find  an  optimum  please?');;  
plot([0  10.08],[0  10.08],'w');;  
xlabel('Ice  Thickness  (inches)')  
ylabel('Insulation  Thickness  (inches)')  
axis  square  
    
%%  Regress  left-­lower  value  of  every  contour  
    
H  =  flipdim(H,1);;  
Y  =  flipdim(Y,1);;  
IND=find(H==max(max(H)));;  
[I,J]  =  ind2sub(size(H),IND);;  
%  Xs(1)  =  X(I);;  %x  values  corresponding  to  the  points  where  Z  is  
maximum  
%  Ys(1)  =  Y(J);;  %y  values  corresponding  to  the  points  where  Z  is  
maximum  
    
kinit  =  whichdiag(H,IND);;    
siz  =  size(H);;    




clear  Xs  Ys  
    
for  i=1:param;;  
        k  =  kinit-­(i-­1);;  
        Hd  =  tril(H,k);;  
          
        IND=find(Hd==max(max(Hd)));;  
        [Jd,Id]  =  ind2sub(size(Hd),IND);;  
        if  length(Id)  >  1  
                Id  =  mean(Id);;  
        end  
        if  length(Jd)  >  1  
                Jd  =  mean(Jd);;  
        end  
        Xs(i)  =  Id;;  %x  values  corresponding  to  the  points  where  Z  is  
maximum  




Xs  =  max(X)*Xs./(n);;  
























axis  equal  square  
grid  
hold  on;;  plot(Xs,a*Xs.^k,'g')  
legend('Data',sprintf('y=%.3f{}x^{%.3f}',a,k));;  
  
Cost optimizing with the PC M 
  








%  We  wanted  a  20  liter  box  that  fit  a  real  number  of  50  mm  boxes  
%  250  mm  square  is  the  storage  area  side  length.  This  is  9.84  
inches.  
%  we  are  considering  half  of  a  box  so:    
s  =  9.84/2;;  %  storage  side  length  
    
maxL  =(9.84+6.4)/2;;    
    
L  =  maxL  -­  s;;    
    
%%  Costing  parameters  
    
ice.rho  =  62.4  ;;  %  lb/ft^3  
ice.rho  =  ice.rho*(1/12^3);;  %  lb/in^3  
ice.cost  =  5*0.25/231;;  %  25  c/gal  -­>  dollars/cubic  inch  
    
ins.rho  =    0.00134548874;;  %  37.24300  (kg  /  (m^3))  =  0.00134548874  
pound  /  (in^3)  
ins.cost  =  900*(1/  39.3700787^3);;  %  dollars/in^3  (East  &  Smale)    
    
pcm.rho  =  .9*62.4  ;;  %  lb/ft^3  
pcm.cost  =  0.0944510035    ;;  %  $/in^3  %  From  Mark  Barakat's  Email  
dated  16  Feb  12.    
    
weightcost  =@(mass)  4.75*mass/2.2  +  30;;  %  heavy  packages  ship  on  
weight  cost  
volumecost  =@(mass)  800*(1/  39.3700787^3)*mass  +  30;;  %  small  
packages  ship  on  volume  cost    
    
%%  Define  feasible  space  
    
%  We  could  have  no  ice,  all  insulation;;  all  ice,  no  insulation;;  or  
no  ice,  
%  no  insulation.  This  forms  a  right  triangle.    
    
%              |\    
%              |  \    
%              |    \  
%              |      \  
%              |        \  
%th_ins  |          \  
%              |            \  
%              |              \  
%              |                \  
%              |_________\  
%                    th_ice  
    
n  =  1000;;  %  number  of  subdivisions  
    




C  =  zeros(n,n);;    
X  =  zeros(n,1);;  
Y  =  zeros(n,1);;  
T  =  zeros(n,n);;  
for  i  =  1:n  
        x  =  L/(n-­1)*(i-­1);;  
        X(i)  =  x;;  
        Y(i)  =  x;;  
        m  =  142.4*x+0.0016;;  
        for  j  =  1:n    
                y  =  L*(j-­1)/(n-­1);;    
                T(j,i)  =  x+y;;    
                Z(j,i)  =  m*y;;    
                if  x+y  >  L;;  
                        Z(j,i)  =  NaN;;    
                end  







plot([0  10.08],[0  10.08],'w');;  
title('Time  in  hours  until  8  degrees');;  
xlabel('Ice  Thickness  (inches)')  




for  i  =  1:n  
        x  =  L/(n-­1)*(i-­1);;  
        X(i)  =  x;;  
        Y(i)  =  x;;  
        p  =  x*334/178*1/2;;    %  pcm  thickness  (must  be  at  least  half  of  
the  length  where  PCM  and  ice  would  have  equal  latent  heats)  
        m  =  142.4*x+0.0016;;  
        v_pcm  =  (s+p)^3  -­  s^3;;    
        v_ice  =  (x+s+p)^3-­(s+p)^3;;  
        C_ice  =  v_ice*ice.cost  ;;  
        C_pcm  =  v_pcm*pcm.cost  ;;    
        for  j  =  1:n    
                y  =  L*(j-­1)/(n-­1);;    
                v_ins  =  (x+s+y+p)^3  -­  (x+s+p)^3;;    
                C_ins  =  v_ins*ins.cost  ;;  
                if  
((v_ice+v_pcm)*ice.rho+v_ins*ins.rho)>160/(2.2*39.3700787^3)*(v_ice+
v_ins+v_pcm)+.2/2.2  %  if  mass  box  >  some  factor  times  volume  of  box  
                        C_ship  =  
weightcost((v_ice+v_pcm)*ice.rho+v_ins*ins.rho);;  
                        %disp('costed  by  weight')  
                else  
                        C_ship  =  
volumecost((v_ice+v_pcm)*ice.rho+v_ins*ins.rho);;  
                  %      disp('costed  by  volume')  




                C(j,i)  =  C_ice  +  C_ins  +  C_pcm  +  C_ship;;    
                Z(j,i)  =  m*y;;    
                if  x+y  >  L;;  
                        C(j,i)  =  NaN;;    
                end  







plot([0  10.08],[0  10.08],'w');;  
title('Cost  estimate  for  ice  and  insulation');;  
xlabel('Ice  Thickness  (inches)')  




%%  optimize  time/$  
H  =  Z./C;;    
colormap(winter)  
[ch,ch]  =  contourf(X,Y,H,50);;  
%[ch,ch]  =  contourf(H,50);;  
  set(ch,'edgecolor','none');;  
hold  on  
title('Find  an  optimum  please?');;  
plot([0  10.08],[0  10.08],'w');;  
xlabel('Ice  Thickness  (inches)')  
ylabel('Insulation  Thickness  (inches)')  
axis  square  
    
%%  Regress  left-­lower  value  of  every  contour  
    
H  =  flipdim(H,1);;  
Y  =  flipdim(Y,1);;  
IND=find(H==max(max(H)));;  
[I,J]  =  ind2sub(size(H),IND);;  
%  Xs(1)  =  X(I);;  %x  values  corresponding  to  the  points  where  Z  is  
maximum  
%  Ys(1)  =  Y(J);;  %y  values  corresponding  to  the  points  where  Z  is  
maximum  
    
kinit  =  whichdiag(H,IND);;    
siz  =  size(H);;    
param  =  abs(abs(kinit)  -­  (siz(1)-­1))  ;;    
clear  Xs  Ys  
    
for  i=1:param;;  
        k  =  kinit-­(i-­1);;  
        Hd  =  tril(H,k);;  
          
        IND=find(Hd==max(max(Hd)));;  
        [Jd,Id]  =  ind2sub(size(Hd),IND);;  




                Id  =  mean(Id);;  
        end  
        if  length(Jd)  >  1  
                Jd  =  mean(Jd);;  
        end  
        Xs(i)  =  Id;;  %x  values  corresponding  to  the  points  where  Z  is  
maximum  




Xs  =  max(X)*Xs./(n);;  
























axis  equal  square  
grid  







function  [  k  ]  =  whichdiag(  X,  IND  )  
%  Find  which  diaganol  of  matrix  an  index  is  on  
%      Input  a  matrix,  and  the  index  of  an  element  either  as  a  linear  
indices  
%      (IND)  
%      or  coordinates  [I,J]  
    
%  Convert  coordinates  to  linear  indices  




        IND  =  sub2ind(size(X),  IND(2),  IND(1));;  
end  
    
%  Recreate  matrix  of  size  X  where  every  value  is  it's  linear  indices  
s  =  size(X);;  
l  =  s(1);;  
w  =  s(2);;    
n  =  numel(X);;    
for  i  =  1:n  
        X(i)  =  i;;  
end  
    
%  Find  total  number  of  diagonals  
nd  =  l  +  w  -­1;;    
%  X  has  w-­1  superdiaganol  diags,  l-­1  sub  diaganol  diags,  and  1  
diagonal  
%    
%  Create  a  matrix  where  the  diagonals  of  the  X  index  matrix  are  the  
columns  
    
%  preallocate  based  on  biggest  diagonal  
h  =  length(diag(X,0));;    
S  =  zeros(h,nd);;    
j  =  1;;  
for  i  =  (1-­l):(w-­1)  
        v  =  diag(X,i);;  
        S(1:length(v),j)  =  v;;    
        j=j+1;;  
end  
    
%  Search  for  which  column  of  S  has  the  desired  index  
q  =  find(IND==S);;  
    
[x,y]  =  ind2sub(size(S),q);;  
    
%  convert  index  to  k=0  being  the  diagonal.    









Appendix H : Animation: A Journey Through the Cold Chain 
In collaboration with Vishnu Priya Ganti, Motion Graphics Designer and 
student at the Maryland Institute College of Art, Team FRESH developed an 
animation illustrating the journey of a typical vaccine shipment through the cold 
chain. Vishnu Priya Ganti is a Bachelor in Fine Arts: Graphic Design candidate (May 
2012). She is pursuing a concentration in Animation, and she is also completing a 
minor in Culture and Politics (Literature). 
 
Below is the introductory excerpt, story-line, and screen-shots for the 
animation. The full two- imeo 
page, which can be found at the following URL: http://vimeo.com/16537015. By 
linking this animation to our open-source Google Map, blog, as well as external sites 
such as the Vimeo page, Team FRESH hopes viewers will be able to better 
understand the nature of the cold chain. Equipped with this understanding, our viewer 
base of students, professionals, and others may join the effort towards reaching the 




Vaccines have earned a place among the best public health technologies and 
investments in the human history. They are currently estimated to prevent 2.5 million 
deaths per year. There are 28 vaccine-preventable diseases, which contribute to 1.76 
million deaths per year. In line with the Millennium Development Goals, the 
international community has devoted heavy resources and programming towards 
improving vaccine efficacy, ease of administration, and most recently, the 
infrastructure behind vaccine transport and distribution, otherwise known as the cold 
chain. Most vaccines require a 2-8 °C temperature range to remain potent. The cold 




pical route that lasts 
anywhere from 3-8 weeks. Please keep an eye on the dashboard below showing 
important parameters: the amount of time that has passed, current location, the 
el of 






We start in the United States, and the vaccine shipment boards international air 
freight; here the crate moves around and are sometimes exposed to slight heating. 
  
 
Upon reaching the destination country, vaccines are often placed outside, where they 
are exposed to high temperatures. Vaccines may be neglected by staff that is unaware 
of the requirements for vaccine handling. 
Time passed 
Current Location 
Vaccine Power Lvl 







In Customs, literature has demonstrated that vaccines may be stalled for as much as 
2-3 weeks due to confusion among staff or changing delivery schedules. They are 




At the central level, often a government-run institution, there are warehouses with 
freezer rooms set to extremely low temperatures, often around -20 °C, resulting in 
freezing of vaccines if left unprotected. Since we are at the central level, and there are 
more trained personnel than at any other stage of the cold chain, improper storage or 
handling is unlikely. Still these locations are subject to electricity fluctuations, which 
create an unstable environment for vaccines. Precautions may not be systematically or 






In transport to the health centers, vaccines are stored in Ice-lined Refrigerators or cold 
boxes, which are equipped with ice packs. The bulky refrigerators often bump into 




Other issues in transport include unscheduled stopovers that strand vaccines for 
indefinite period of time, as well as poor road conditions. The drivers and staff are 
often unaware of the careful conditions that vaccines require, or they may not have 






At the provincial vaccine store, we see an ice-line refrigerator holding vaccines. They 
are filled in an organized fashion, and the position of each vaccine often corresponds 
to the sensitivity to temperature. For example, some are more susceptible to freezing 
or light exposure than others. 
Just like the freezer rooms, however, refrigerators may be plugged in, and therefore 
vulnerable to electricity fluctuations. This not only creates an unstable temperature 
environment for vaccines, but also can lead to damage to the equipment itself, which 
may halt temperature-controlled vaccine storage altogether. When equipment breaks, 
there is lag-time for a trained technical expert to help repair it; significant time, 




Finally, these same shipments that are no longer useful are delivered by bus, 
scooter/motorcycle, foot, or sometimes with the help of domesticated animals, to the 
target community. Although there are color-ink sensors (Vaccine Vial Monitors) that 
indicate diminished potency of the vaccines, many staff in small health clinics are not 




the public, who are desperate for protection from disease, as well as campaigns who 
seek to complete the work for which they have been funded. People are checked off 
as immunized by larger eradication campaigns when they are not always protected 
from disease. Furthermore, the spoiled vaccines can have adverse effects on the 
recipient. These realities lead to harsh consequences for meeting the greater goal of 
universal immunization. Failure of immunization reduces the trust of the public in 
vaccination, and fuels resistance against health campaigns. Some return to clinics and 
seek repeat vaccinations, which may not be available to them, while others revert to 













Absorption refr igeration: A refrigerator that uses an external heat source as the 
driving force for refrigeration. 
Adjuvant: An additive to a vaccine that can change its effect or potency. 
Adsorption refr igeration: A refrigerator that uses an external heat source as the 
driving force for refrigeration; the heat source releases an adsorbed fluid from an 
adsorbent bed, which replaces the conventional compressor. 
A NSYS: Finite Element Analysis software. 
 
C A D: Computer aided design; 3-D modeling software used for the visualization of 
concepts and in the process of designing prototypes. 
Convective heat transfer : Heat transfer through movement, similar to a fan. 
Cold Box: A portable storage container that utilizes a passive cooling system to store 
and transport vaccines. 
Cold chain: The distribution system of temperature-sensitive products, such as 
vaccines, from the manufacturer to the end user. 
Compression refr igeration: A refrigerator that operates on the compression and 
expansion of a substance, the same as a typical household refrigerator. 
C O MSO L : Multiphysics Finite Element Analysis software. 
 
Data Logger : A device that can record temperature at a specified location. 
Differential scanning calorimetry: A data collection method in which the heat input 
to change the temperature of a substance over time is recorded. 
EPI - Extended Program on Immunization; a WHO initiative started in the 1970s to 
expand vaccinations to children worldwide. 
Eutectic mixture: A mixture with a composition of materials that provides the lowest 
melting temperature, and for which upon cooling, no phase separation occurs. 
F E A : Finite Element Analysis. Creation of a geometric model with defined material 
properties that is then stressed with physical conditions, like forced loads or thermal 
conditions. 
F reeze Indicator: A device that can indicate whether a vaccine has frozen, usually 




G A V I A lliance  Global Alliance for Vaccines and Immunisation; a partnership 
between the WHO, UNICEF, Bill and Melinda Gates Foundation, World Bank, and 
other public and private organizations dedicated to increasing immunizations rates in 
developing countries. 
H eat of Fusion-Latent H eat-Latent H eat of Fusion: The energy per mass or mole 
that is needed to convert a substance from a solid to a liquid. 
H ermetic seal: A vacuum seal. 
Ice-lined refr igerators: Refrigerators equipped with large amounts of ice lining the 
walls to help keep vaccines cool. They typically require the ice to be separated from 
the vaccines in order to prevent freezing. 
Immunization: The act of inoculating a patient with a vaccine. 
Impotent vaccines: Vaccines that will no longer provide immunity due to denatured 
proteins. Some of the causes of impotency include freezing, overheating, or extended 
duration of storage. 
Isothermal: A process in which the temperature of the system does not change. 
L ead (thermocouple): The location at which a thermocouple measures the 
temperature. 
Local health center: A small distribution center that is or is one step away from the 
actual inoculation stage.  
Mass heat capacity-Specific heat capacity: Energy to raise a unit mass of a 
substance one degree. 
Mesh: A series of locations at which a FEA program will solve the input data. 
Nucleating agents: Substances that trigger nucleation, typically in the form of 
crystallization. 
Outreach clinic: A clinic that provides health care free of charge. 
Passive refr igeration: Refrigeration that does not involve any electrical or 
mechanical movement of heat. 
PA T H  - Founded in 1977 by family planning researchers, PATH is an international 
non-profit organization dedicated to resolving public health issues such as 
immunization programs; PATH often works in conjunction with the WHO and 
UNICEF. 
PEPF A R -  Started by President 
George W. Bush in 2008, PEPFAR consists of a $50 million commitment to combat 




Phase change materials: Materials with a high latent heat, otherwise known as 
materials requiring a large amount of energy to change from solid to liquid. 
PQS specifications: Performance, Quality, and Safety standards established by 
WHO. All products must meet them before they can be used in the cold chain. 
Ramp rate (PC M testing): The rate at which temperature is changed by the DSC, a 
slower rate has higher accuracy. 
Refr igerant: A substance that can be used in a refrigerator as the cycling liquid. 
Regional center : A larger national distribution center that stores various resources 
ready for distribution. 
Steady state: The state at which a system is non-changing. 
Thermal conductivity: The relative ability of a substance to transfer heat through 
itself. 
Thermal equilibrium: The time at which a system is at a uniform temperature. 
Thermochromic ink : An ink that changes color based on the temperature. It is a 
technology utilized in various devices that monitor freezing. 
Thermocouple: A device with multiple leads that can be used to measure 
temperature in different locations inside a cold box. 
T ransient analysis: A solution that occurs over time. 
Vaccine V ial Monitor: A heat sensitive label that changes color according to 
changes in temperature and time. It can indicate to a healthcare worker if a vaccine 
has been exposed to freezing temperatures. 
Vaccine: a preparation of killed microorganisms, living attenuated organisms, or 
living fully virulent organisms that is administered to produce or artificially increase 
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